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Abstract
Hypervalent iodine compounds are molecules o f increasing interest to the 
synthetic chemist. Their low toxicity when compared to heavy metal reagents and 
their ease o f use in the laboratory are helping to establish them into the armoury 
o f the synthetic chemist. More recently, research into chiral hypervalent iodine 
compounds has been the main focus.
The work performed during this research tenure is based upon the 
development of new chiral hypervalent iodine reagents for use in stereoselective 
synthesis and this research can be summarised into three main sections:
•  Synthesis o f novel chiral iodine(III) compounds
• Reactivity o f chiral iodine(III) compounds
• Novel oxididative procedure
The synthesis of new chiral iodine(III) compounds and their use in 
asymmetric oxidative functionalisations are described herein. The use of 
stoichiometric quantities o f these iodine(III) reagents with 1 eq of pTsOHThO in 
the a-oxytosylation o f ketones and 2  eq o f //TsOHTkO in the dioxytosylation of 
alkenes, have given the corresponding products in good yields, 57-76% (3-12% 
ee) and 48-75% (9-16% ee) respectively.
Additionally, a new catalytic method is described in which the presence of 
a stoichiometric oxidant, 1 eq o f //TsOHT^O and only catalytic quantities of the 
chiral iodine(l) reagent is necessary to afford a-oxytosylated ketones.
The final aspect o f the research has dealt with the problems associated 
with oxidizing iodine(I) compounds to iodine(III) compounds. The development 
o f a new method to oxidise iodine(I) compounds to 
[bis(trifluoroacetoxy)iodo]arenes through the use o f urea-hydrogen peroxide 
adduct and trifluoroacetic anhydride is also described.
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Chapter One: Introduction
Chapter 1
1 Introduction
1.1 Hypervalency
Musher introduced the word ‘hypervalent’, and applied it to polyvalent 
molecules in 1969.1 According to Musher, hypervalent compounds are ions or 
molecules of the elements o f groups 15-18, bearing more than eight electrons in 
their valence shell.
An atom has two ways o f keeping electrons beyond the octet in its valence 
shell:
1. By hybridisation of higher energy d-orbitals, forming dsp3 or d2sp3 hybrid- 
orbitals.
2. By forming highly ionic orbitals.
In 1951, Pimentel and Rundel published the idea of a three-centre, four- 
electron bond (3c^le) using molecular orbital theory. A more recent 
investigation by Schleyer on hypervalent bonding led to the rejection o f the 
hybridisation concept. Contribution of d-orbitals to hypervalent bonds seems not 
to be fundamental. The energy gap between sp- and d-orbitals in main group 
elements is too large to allow hybridisation. However, d-orbitals play an
1
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important role in ab initio calculations. In these calculations, the stability o f SF2, 
SF4 and SF6 increases in proportion with the d-orbitals. The central atom accepts 
electrons from ligands. This observation is explained with the back bonding 
model. Reed and Schleyer showed that, with an increasing d-orbital proportion, 
the a*-orbital o f the central atom bond becomes more polarised and therefore the 
7r-bonding between the two atoms is strengthened by a negative hyperconjugation.
The concept of a 3c-4e bond has been accepted to explain hypervalent 
bonding. One pair of bonding electrons from the central atom in hypervalent 
compounds is delocalised to the two substituents.
L
L
Figure 1.1: A 3c^le hypervalent bond.
The 3c^le bond leads to a charge distribution of almost -0.5 charge on the 
ligands and about +1.0 charge on the central atom. These linear bonds are 
electron-rich and the non-bonding molecular orbital becomes the highest occupied 
molecular orbital (HOMO). Therefore, in a 3c-4e bond, electrons are distributed 
to the ligands. The actual number of electron pairs in the valence shell o f the 
central atom is less than four and the octet rule is not affected. Although there 
have been, and still are, discussions about whether one can use the expression 
“hypervalent” for these compounds, it is already accepted in chemical literature.
The general definition of hypervalent compounds is given by Martin and 
Arduengo:4
Hypervalent compounds are main group element compounds that contain a 
number (N; N>8) o f  formally assignable electrons in the valence shell, 
directly associated with the central atom (X) in directly bonding a number (N)
2
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o f  ligands (L). The designation N-X-L is conveniently used to describe 
hypervalent compounds (Martin-Arduengo nomenclature).
Hypervalency is not very common in organic chemistry, but there are a large 
number of hypervalent compounds that find application in organic synthesis. 
Sulphuric acid and phosphates belong to this class o f compound as well as 
phosphorus ylides, sulphones and sulphoximines, as shown in Figure 1.2.
Ph R 1 Ov O O N — R3
\   /  V  V /
Ph— P = <  Y  S%
Ph7  R2 R ‘ r2 r1 r2
Phosphorus ylide Sulphone Sulphoxime
10-P-4 12-S-4 12-S-4
Figure 1.2: Hypervalent compounds using the Martin-Arduengo nomenclature.
1.2 A Brief History of Iodine
In 1811 a French saltpetre manufacturer, Bernard Courtois, became the 
first person to isolate the element iodine. He was able to do so by treating the ash 
o f seaweed (Fucus, Laminaria and other brown seaweed) with an excess of 
sulphuric acid, and collecting the violet crystals o f the condensed iodine vapour. 
Courtois, unable to continue his research on the substance, passed his knowledge 
on to two Dijon chemists, Charles-Bemard Desormes and Nicolas Clement. 
Having acquired his permission, they announced his work to the Institut de 
Chemie de France in 1813, for which he was acknowledged with the discovery of 
iodine. However, it was another Dijon chemist Louis-Joseph Gay-Lussac, who 
gave iodine its name, referring to it as iode, from the Greek loeidrjq [ioeides], 
meaning ‘violet coloured ’ .5 The suffix -ine added in analogy with chlorine, the 
apparently similar element.
3
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It is a group 17, fifth row element, with the electron configuration 
[Kr]d10s2p5, having seven electrons in its valence shell. Therefore, the preferred 
oxidation state of iodine is - 1 .
Organoiodine compounds have long been known to play an important 
biological role in the function of many organisms. Thyroxine 1 (Figure 1.3) is a 
metabolism-controlling hormone that is produced naturally by the thyroid. Iodine- 
containing compounds have been used since 1819 as a remedy for thyroid 
disorders. Another well-known iodine compound is ‘Tincture of iodine’, which is 
widely used as an antiseptic .6
HO OH
HO
1
Figure 1.3: Thyroxine.
Although the first iodine-containing mineral (Agl) was discovered in 
Mexico in 1825, the most industrially significant discovery was that o f IO3' in 
Chilean saltpetre in 1840.7
Use of organoiodine compounds in synthesis began in the middle of the 
19th century, most notably in reactions such as the Hoffmann alkylation of amines, 
Williamson’s ether synthesis and in Wurtz coupling reactions. Currently, one of 
the most important and common uses of organoiodine compounds involves 
various metal-mediated cross-coupling reactions where they serve as electrophilic 
partners in Heck, Negishi, Suzuki, Sonogashira, Stille, and similar cross-coupling 
reactions. These metal-catalysed cross-coupling reactions are extensively 
employed in preparative organic chemistry, the synthesis o f complex natural 
products, and the manufacture of drugs, as well as in supramolecular and 
materials chemistry.
4
Chapter One: Introduction
Iodine forms relatively weak bonds with first row elements, for example 
the bond dissociation energy of an iodine-carbon bond is typically about 55 
kJ/mol. Because it is the largest, the most polarisible, and the least electronegative 
of the common halogens, it can readily bear a positive charge. Also, a very 
prominent feature resulting from these properties is its ability to form 
polycoordinated compounds with two to eight relatively weak bonds to mostly 
electronegative groups or elements such as oxygen, nitrogen, sulphur or a halide. 
In these compounds iodine can be in the following oxidation states: I, III, V, VII
o
along with - I  in iodate anions of the general formula IX2’.
1.3 History of Hypervalent Iodine
A German chemist, Willergodt, was the first to discover iodine in its 
hypervalent form. He found that iodine had the ability to form organic compounds 
having a valency of 3 or 5, towards the end of the 19th century. Willergodt 
synthesised the first member o f this class of compounds (dichloroiodo)benzene 3, 
by reacting iodobenzene 2 with ICI3, in a cooled solution o f chloroform in 1886 
(Scheme l . l ) . 9
Scheme 1.1: Willergodt’s synthesis of (dichloroiodo)benzene 3.
Subsequently, Willergodt discovered that by passing chlorine gas through 
a solution of iodobenzene in chloroform, he could obtain this iodine compound 3 
in higher yields. This was rapidly followed by the synthesis of 
(diacetoxyiodo)benzene10 6  (PhI(OAc)2) and diphenyliodonium hydrogen 
sulphate11 (Ph2l+HS0 4 ), the first iodonium salt along with derivatives of 
iodoquinolines (Figure 1.4) containing both acetoxy and hydroxy moieties (4, 5).
ICl
2 3
5
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Figure 1.4: Willergodt’s isoquinoline derivatives.
Since then, the interest in hypervalent iodine compounds in organic 
chemistry has risen and declined over the decades. The early 1970’s saw a 
renaissance o f hypervalent iodine compounds amongst synthetic chemists. This 
rise is attributed to the chemical properties and reactivity of iodine(III) 
compounds, being similar to those of heavy metal containing compounds such as 
Hg(II), Ti(II) and Pb(IV), but without the toxicity and environmental concerns
1 9associated with them.
1.4 Structure, Bonding and Nomenclature
The various structural classes o f hypervalent compounds known differ in 
three ways: The number of electrons (N) surrounding the central atom (X) and the 
number of ligands (L) that are bound to it. As described by the Martin-Arduengo 
designation,4 there are four main structural types of hypervalent iodine 
compounds that play an important role in organic chemistry (Figure 1.5):
8 - 1-2 10 - 1-3 10 - 1-4 12 - 1-5
Figure 1.5: The four main structural types o f hypervalent iodine compounds.
6
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Following IUPAC rules, any compound with a non-standard bonding 
number, are denoted with a lambda notation. Therefore H3I is referred to as a
geometry with an aryl group and two lone pairs o f electrons occupying equatorial 
positions with two heteroatom ligands (L) in apical positions. Bonding in ArIL2 
uses an essentially pure 5p orbital in the linear L-I-L bond. This is a hypervalent 
three-centre four-electron bond (3c—4e) with two electrons from the doubly 
occupied 5p orbital on iodine and one electron from each of the ligands L. The 
aryl group is bound by a standard two-electron covalent bond with 5sp2 
hybridisation to form a CAr-I a-bond (Figure 1.6) . 13,14
The T-shaped structure, which stems from the stereoelectronic 
requirements o f a 3-centre 4-electron system, is a typical feature o f hypervalent 
iodine compounds.
group in an apical position and four heteroatom ligands in basal positions (Figure 
1.7). Two orthogonal hypervalent 3c^le bonds accommodate all o f the 
heteroatom ligands and the apical aryl group has the character o f a normal 
covalent bond using a hybridised 5sp orbital. 15
3 5X -iodane and H5I a X -iodane.
Aryl-A.3-iodanes (ArIL2) have a 10 electron, psuedotrigonal bipyramidal
Figure 1.6: An aryl- >.3-iodane.
Aryl-A.5-iodanes (ArIL4) have a square pyramidal structure with an aryl
Figure 1.7: An aryl- X5-iodane.
7
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1.4.1 Orbitals
The two lower energy molecular orbitals, bonding and non-bonding, o f the 
three required for hypervalent 3c^te bond are filled (Figure 1.8). Partial positive 
charge develops on the central iodine atom, while partial negative charge develops 
on the axial heteroatom ligands, due to the fact that the filled non-bonding 
molecular orbital has a node at the central iodine. The presence o f the node 
implies a separation of charges with a consequent positive polarisation o f the 
iodine atom.
-  Anti-bonding 
V  It— Non-bonding
o « # o o #  V  { \  n
—!—  Bonding
A 3c-4e orbital diagram.
The partial positive charge on the iodine of the highly polarised 3c-4e 
bond makes the aryl-X3-iodane an electrophilic agent. The intrinsic nature o f a 
3c^te bond explains the preferred orientation of more electronegative ligands in 
the apical positions. The presence o f more electropositive central atoms is 
energetically favourable for hypervalent species, thus in general; X -iodanes are 
more stable than analogous X -bromanes and X -chloranes.
Aryl->o5-iodanes ArIL4 have a 12-electron square pyramidal geometry with 
an aryl group in an apical position and four heteroatom ligands in basal positions.
This species has two orthogonal hypervalent 3c-4e bonds, which accommodate 
all o f the heteroatom ligands with the apical aryl group having the character o f a 
standard covalent bond using a hybridised 5sp orbital. 15
R—I
l
L
Figure 1.8:
8
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1.4.2 General Mechanistic Pathways
Once formed, hypervalent iodine compounds e.g. >.3-iodanes and 
A.5-iodanes can readily exchange their ligands with nucleophiles, in one of three 
ways;
• Ligand exchange
• Reductive elimination
• Reductive elimination with subsequent substitution
When only nucleophiles are involved, reactions follow an associative 
pathway (Scheme 1.2), in which an iodate(III) or (V) species is formed. The 
“mixed” tetracoordinated iodine intermediate is initially formed and is sometimes 
isolable but usually this procedure takes place with both ligands so that eventually 
the new species has two new ligands. 16
Scheme 1.2: Associative pathway in the ligand exchange.
The other pathway is dissociative and usually requires a good electrophile 
to help the removal o f one ligand with formation of a high energy cationic 
iodonium species Phl+L, which can react with the nucleophile to produce ArlLNu 
(Scheme 1.3). Additional steps o f elimination and addition afford ArINu2 or 
ArlNuNu ' . 16
9
Chapter One: Introduction
Scheme 1.3: Dissociative pathway in the ligand exchange.
The mechanism shown in Scheme 1.4 involves a reductive p-elimination 
with formation of the oxidised product. Here, the hypervalent aryl iodide is
1 7transformed into the reduced iodoarene. It has been shown that the p-elimination 
occurs with syn stereochemistry. The combination of ligand exchange and 
p-elimination provides an excellent method widely used for oxidation of 
sulphides, alcohols and amines into the corresponding sulphoxides, carbonyl 
compounds and imines.
Scheme 1.4: Reductive p-elimination (shown in chapter 1.5.6).
A final mechanistic pathway follows a reductive elimination with 
subsequent substitution (Scheme 1.5). The first step of ligand exchange is 
followed by nucleophilic attack on the carbon atom bonded to the iodine, with 
subsequent production o f substituted products. When this mechanism is in 
operation, the addition o f several functionalities into a substrate is possible.
10
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Arl
/ “A  j <
L
L
R
LJ
2. RNu + L
Scheme 1.5: General mechanism for the reductive elimination with substitution.
The displacement of heteroatom ligands in iodine(III) or iodine(V) species 
with external nucleophiles is a facile, low energy process. The high leaving group 
ability o f iodine(III) ligands is amongst the most important features o f hypervalent 
iodine compounds. This makes it possible to generate highly reactive species such 
as carbenes, nitrenes, cations and arynes under mild conditions as well as the 
possibility to oxidise a wide range of functionalities. The leaving process is 
referred to as reductive elimination, in which the iodine(III) species eliminates 
with the energetically preferable reduction to monovalent iodide.
1.5 Common Representatives of Hypervalent Iodine 
Compounds in Organic Chemistry
The general approach for preparation of the most common hypervalent 
iodine compounds is the initial oxidation of iodine(I) to iodine(III) or (V). This 
requires the correct choice o f strong electrophilic reagents as well as conditions 
which will lead to the formation of either one, (for iodine(III)), or two, for 
(iodine(V)), hypervalent bonds.
1.5.1 Iodosobenzene
Of all the polycoordinated iodine compounds known, one o f the most 
important and thoroughly investigated I(III) reagents (ArIL2) is iodosobenzene 7 
(PhIO). Although iodosobenzene is polymeric {-(Ph)I-0-}n, it is frequently 
written as monomeric PhIO. It is a yellow amorphous powder, which cannot be 
recrystallised due to its polymeric nature. It undergoes disproportionation to
11
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iodobenzene 2  and explosive iodylbenzene PhI0 2  on storage at room temperature. 
Iodosobenzene 7 is best synthesised by hydrolysis o f (diacetoxyiodo)benzene 6  in 
aqueous NaOH (Scheme 1.6) . 15
Scheme 1.6: Preparation of iodosobenzene 7.
Iodosobenzene 7 can be applied to the synthesis of a wide range of other 
hypervalent iodine compounds. For example, iodonium salts, by reaction with the 
corresponding nucleophilic organic substrates. Practical usefulness in oxidation 
reactions is restricted due to its insolubility in most organic solvents. However, it 
can be activated by pulverisation of the polymer with an acid-treated silica gel by 
pestle and mortar or by ultrasonic irradiation. 18
1.5.2 (Diacetoxyiodo)benzene (DIB)
Commercially available (diacetoxyiodo)benzene 6  (DIB) is one of the 
most common hypervalent iodine compounds in organic chemistry. It can easily 
be synthesised by several routes: Dissolving iodosobenzene 7 in acetic acid ; 10 
oxidation o f iodobenzene 2 in peracetic acid at 40 °C ; 19 treatment o f iodobenzene 
2 with sodium perborate in acetic acid (Scheme 1.7).
NaOH
6 7
N a B 0 y H 20
AcOH
2 6
Scheme 1.7: Preparation of (diacetoxyiodo)benzene 6.
12
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Because o f the acetoxy ligands ability to back-bond to the iodine atom, the 
molecule has a pentagonal plane shape. The free electron pairs of the carboxyl 
ligands overlap with the a* orbital of the iodine.
(Diacetoxyiodo)benzene 6  has found application in various 
transformations, including oxidations and substitutions with organic substrates, 
are the most widely observed reactions performed with hypervalent iodine 
diacetates.
Use of lead tetra-acetate allowed Fiseur and co-workers to convert tri­
nitrotoluene 8  into trinitro-w-xylene 9 with yields of up to 32%. As early as 1945 
Sandin and McCormack21 rationalised that since tetra-lead esters were similar to 
some iodoso compounds, DIB may produce similar results (Scheme 1.8).
+ PhI(O Ac)2
2 0 %
Scheme 1.8: PhI(OAc)2 as a methylating agent.
When they applied (diacetoxyiodo)benzene to the above reaction they 
found that they obtained a 20% yield o f trinitro-m-xylene 9. To account for the 
formation of the product they proposed a free radical mechanism, shown in 
Scheme 1.9.
13
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heat
PhI(OAc)2 Phi + 2CH 3COO
2 CH3COO 2H 3C + 2 C 0 2(g)
+ PhI(O Ac)2
Scheme 1.9: Free radical mechanism for the formation of trinitro-m-xylene 9.
Acetic acid solutions o f (diacetoxyiodo)benzene 6  may also be used to 
cleave 1,2-diols to form ketones or aldehydes (Scheme 1.10). Within this 
transformation, introduction of electron-withdrawing substituents on the iodoaryl 
ring increases the rate o f reaction, while electron-donating substituents decrease
it.22
OH OH PhI(O Ac)2
R3 R2
O
A
R3 R4
O
A
R 1 R2
Scheme 1.10: Glycol cleavage with (diacetoxyiodo)benzene 6.
1.5.3 [Bis(trifluoroacetoxy)iodo] benzene (BTI)
Bis(trifluoroacetates), in the form of ArI(C0 2 CF3)2, originally synthesised
23by Yagupolskii et al. (Scheme 1.11), have been applied as potent and often 
chemoselective oxidants, which have a broad appeal throughout organic synthesis. 
They are easily prepared through a ligand exchange reaction between 
(diacetoxyiodo)benzene 6  and trifluoroacetic acid (scheme 1 .1 1 ).
14
Chapter One: Introduction
2 CF3COOH  
 »
- 6 0  °C. 8-10 h
77 % CF
10
Scheme 1.11: Preparation of [bis(trifluoroacetoxy)iodo]benzene 10.
[Bis(trifluoroacetoxy)iodo]benzene 10, also known as BTI or PIFA, is an 
useful precursor in the generation o f new iodine(III) compounds (Scheme 1.12). 
For example, the reaction of [bis(trifluoroacetoxy)iodo]benzene 10, trimethylsilyl 
triflate and cyano trimethylsilane produces (cyano)aryliodonium triflate 1 1  in high 
yields (scheme 1 .1 2 ) . 24
CF
  pn
TM SOTf. TM SCN, CH 2C12, f i  ^  |
20 °C, 1 h \ = /  (l)T f
8 8 %
10 11
Scheme 1.12: [Bis(trifluoroacetoxy)iodo]benzene 10 as a precursor for new 
iodine(III) compounds.
Under acidic conditions, [bis(trifluoroacetoxy)iodo]benzene 10 may be 
used to a-hydroxylate enolisable ketones.
o
0  CF3C 0 2H, M eCN, H20  II 2
1  R2 + Phl(OCOCF3)2 ---------------------------------- ► R i / V / R
R' ^  l 0  30 -9 4 %
Scheme 1.13: Hydroxylation of ketones with [bis(trifluoroacetoxy)iodo]benzene 
10.
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After initial attack of the enol tautomer o f the ketone on the 
[bis(trifluoroacetoxy)iodo]benzene 1 0 , and nucleophilic substitution of the 
iodonium intermediate, results in the a-hydroxy-substituted ketone observed.25
Alkynes can also be oxidised with [bis(trifluoroacetoxy)iodo]benzene 
(Scheme 1.14), giving the corresponding 1,2-diones. In many cases, the oxidative 
cleavage reaction breaks the triple bond on the alkyne, to form carboxylic acids. 
The following reaction (Scheme 1.14) shows the oxidation of bisphenylethynyl 
durane 1 2  with [bis(trifluoroacetoxy)iodo]benzene 1 0  to give two products: a 
carboxylic acid 14 and a 1,2-dione 13.25
Ph
11
BTI. CHC13. H20  
reflux. 1-3 h
Ph
12
Scheme 1.14: Oxidative cleavage of bisphenylethynyl durane 12 with 
[bis(trifluoroacetoxy)iodo]benzene 10.
1.5.4 (Hydroxy(tosyloxy)iodo] benzene (HTIB)
Another high profile aryl- X -iodane is [hydroxy(tosyloxy)iodo]benzene 15 
(HTIB). It is more commonly known as Koser’s reagent, although it was 
originally prepared by Nieland and Karele26 in 1970 (Scheme 1.15).
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A _ ,  N » * v 4 > * >  v  T s 0 H H f  f \ _ j T s
\ = /  AcO H  \ = /  I  „  M eCN \ = /  I
UH
15
Scheme 1.15: Preparation of Hydroxy(tosyloxy)iodobenzene 15.
Koser’s name is synonymous with [hydroxy(tosyloxy)iodo]benzene 15 as 
it was he who realized its synthetic potential and therefore investigated its
77reactivity. Around the same time, Stang reported that the chemical properties 
and reactivity of iodine(III) compounds was similar to those o f heavy-metal 
containing compounds (Hg(II), Ti(II) and Pb(IV)), but without the toxicity and 
environmental concerns associated with them .25 In addition, it was also noted that 
the iodoarene by-product o f these reactions is relatively environmentally friendly, 
as it may be recovered, oxidised and reused in later synthesis.
Analysis of the reaction pathways of various alkenes with
78[hydroxy(tosyloxy)iodo]benzene was carried out by Koser and Rebrovic, in 
which they proposed (Scheme 1.16) a mechanism for the conversion of alkenes 
into vic-bis(tosyloxy)-alkanes with HITB.
rV - - , ^ R3
R1^ "^ R 2
r ]  r 3
r<*M*r2
TsO OTs
PhI(OH)OTs
S m2
Ph^+^OH
R4 * £ v „ r 3
R 1^  R2 
OTs
TsO
OTs
and / or
/7-TsOH
H .O
H
o — I-
R »
R * \  R
OTs
"|R
2
Ph
3
Sm2
HO.
R
TsO
T -^-R2
Ph
R 3
Scheme 1.16: Reaction mechanism for bis oxytosylation of alkenes.
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In order to account for the c/s-stereochemistry of the addition o f the 
tosyloxy ligands to the carbon-carbon double bond, Koser and Rebrovic 
concluded that some type of cyclic organoiodine intermediate formed, by 
electrophilic addition to the double bond o f the alkene. Collapse of the 
intermediate, nucleophilic substitution with the tosylate followed by displacement 
of iodobenzene with a second tosylate ion, leads to the final product of syn 
dioxytosylation.
[Hydroxy(tosyloxy)iodo]benzene 15 is reactive toward many nucleophilic 
organic substrates. These include alkenes, alkynes, ketones, enol ethers and 
aromatic compounds.24 It can form alkynyl- and alkenyl-iodonium tosylates as 
well as transform ketones and ethers into tosyloxy ethers. 15 also dioxytosylates 
alkenes and converts sulphides to sulphoxides. It is also widely used as an 
effective oxidising agent. [Hydroxy(tosyloxy)iodo]benzene 15 has been used by 
Kirschning as a reagent for the chemoselective oxidation of protected glycals 
(Scheme 1.17). In this reaction other hypervalent iodine reagents such as 
(diacetoxyiodo)benzene 6  and [bis(trifluoroacetoxy)iodo]benzene 1 0  showed no 
oxidizing power.
AcO'
AcO'
AcO'M eCN,
+ PhI(OH)OTs
AcO'0-25 °C, 1.25 h
34-37 %
16 17
Scheme 1.17: Oxidation of protected glycal 16 with HTIB 15.
Additionally, [hydroxy(tosyloxy)iodo]benzene may be used to facilitate
• TOthe tosyloxylactonisation reactions of various alkenoic acids , as shown in 
Scheme 1.18.
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o
o
OH
HTIB, 3 h, reflux  ►
c h 2c i 2
TsO
P
18 19
Scheme 1.18: Tosyloxylactonisation o f alkenoic acid 18.
Koser and Rebrovic showed a remarkable solvent effect in the reactions of 
phenyl-substituted alkenes with [hydroxy(tosyloxy)iodo]benzene 15 (Scheme 
1.19). When styrene 20 was reacted with [hydroxy(tosyloxy)iodo]benzene in the 
presence of solvent, 1 -phenyl-1,2-bis(tosyloxy)ethane 22 was obtained in a 63% 
yield, but when the reagents were mixed in the absence o f solvent, 1 , 1 - 
bis(tosyloxy)-2-phenylethane 21 (63%) was formed.
Unfortunately, there was no stereospecificity observed during the 
oxytosylation in the neat reaction. In order to prevent the migration o f the phenyl 
moiety, this reaction is best done slowly in CH2CI2 . A similar phenyl migration
1
was noted by Moriarty.
OTs
HTIB 15, TsOH, 
CH2C12
12.5 h, r.t.
21
HTIB 15. TsOH.
neat
5 min, r.t.
20 22
Scheme 1.19: Solvent effect on the reaction of styrene 20 with 
[hydroxy(tosyloxy)iodo]benzene 15.
19
Chapter One: Introduction
Like (diacetoxyiodo)benzene 6 , [hydroxy(tosyloxy)iodo]benzene 15 is an 
aryl-X3-iodane with a T-shape structure. Its hydroxy and tosyloxy ligands are in 
the axial position of the trigonal bipyramid. The phenyl ligand builds up a trigonal 
plane with the two free electron pairs of the iodine atom.
Figure 1.9: The X-ray crystal structure o f [hydroxy(tosyloxy)iodo]benzene.
The 1-0 bond length between the central iodine atom and the coordinating 
tosyloxy oxygen atom (02) is 2.47A. This is much longer than the usual covalent 
bond length and the I-OTs bond is considered to be ionic.
1.5.5 0 -Iodoxybenzoic acid (IBX)
From the range of I(V) reagents that have been synthesised, 
o-iodoxybenzoic acid or IBX 24, has had use by the synthetic chemist for many 
years. Although, its synthetic usefulness has been limited due to its low solubility 
in most organic solvents along with practical problems associated with its 
synthesis.33
It was first obtained by reacting o-iodobenzoic acid 23 with nitric acid and 
then further oxidizing this compound with KMn0 4 . In most instances, the 
synthesis o f IBX was difficult for synthetic chemists. An alternative method for 
its preparation introduced by Meyer, used 2-iodobenzoic acid 23 as a starting
20
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material. This transformation requires several steps of purification and is 
extremely low yielding. More recently using Oxone® (potassium 
monopersulphate) as the oxidant o f 2-iodobenzoic acid 23, has allowed for a more 
practical method for the preparation of IBX 24 (Scheme 1.20) . 34
O xone® , 1.3eq
Scheme 1.20: Preparation o f IBX 24 from 2-iodobenzoic acid 23 using Oxone®.
In contrast to other oxidizing agents, IBX is relatively inexpensive to 
prepare, easy to handle, moisture tolerant and isolated in high yield. Recently IBX 
has been used successfully in the chemoselective oxidation of alcohols. In the 
presence of sulphides, alcohols have been cleanly oxidised, with no sulphoxide or 
sulphone by-products being produced (Scheme 1.21).
DM SO . 24 h
25 26
Scheme 1.21: Oxidation o f alcohol 25 with IBX 24 in the presence o f a sulphide.
Additionally, IBX 24 may be used for the oxidation of amino alcohols into 
amino ketones (Scheme 1.22) without the use o f protecting groups or the 
anhydrous/low temperature conditions necessary for the more frequently used 
Swem oxidation.
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OH
N H ,
1.1 eq IBX
5 h
O
91 % 
N H 2
27 28
Scheme 1.22: Conversion of amino alcohol to amino ketone.
IBX 24 may also be used for the oxidation of benzylic carbons. It is not 
affected by the presence of halogens or or/Zzo-substituents and over-oxidation to 
the corresponding carboxylic acid is not observed. Although IBX 24 can only be 
fully dissolved in the DMSO, it has been found that, despite its insolubility in 
most organic solvents, IBX 24 is able to oxidize alcohols without complete 
dissolution within the solvent.
1.5.6 l,14-Tris-acetoxy-l,2-benziodoxolin-3(l/J)-one (DMP)
The pentacoordinate iodine reagent l,l,l-tris-acetoxy-l,2-benziodoxolin- 
3(l//)-one, better known as the Dess-Martin periodinane 29 (DMP) has been 
prepared (Scheme 1.23) by warming a mixture of IBX 24 in acetic 
anhydride/acetic acid.
A c20 / A cO H
Scheme 1.23: Preparation o f Dess-Martin periodinane 29.
The Dess-Martin periodinane has been used effectively to convert primary 
alcohols to aldehydes (Scheme 1.25) and secondary alcohols to ketones (Scheme
22
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1.24) under mild conditions,38 even in the presence of sensitive functional groups 
such as sulphides, enol ethers, furans and secondary amines.
Mechanistically, the reaction proceeds as shown in Scheme 1.24. A lone 
pair of electrons from the alcohol substrate promotes the first step of the ligand 
exchange. Subsequent reductive p-elimination results in the formation of the 
carbonyl product and the release of the reduced iodo reagent.
OH
X .
OAcAcO
O Ac X
HO
-AcOH
AcO OAc
OAc
AcO
O
A
R 1 R2
Scheme 1.24: Oxidation of a generic secondary alcohol performed by DMP 29.
DMP 29 is favoured both to chromium(VI) reagents and dimethyl 
sulphoxide-derived reagents, which are some of the most common oxidizing 
agents used in organic synthesis. Reactions with DMP have shorter reaction times 
than most chromium(VI) reagents and usually do not require an excess of reagent 
to push a reaction to completion. Work-up of DMP 29 reactions is relatively easy 
compared to that of chromium(VI) derived reagents and it is neither toxic nor a 
known carcinogen like the chromium(VI) containing compounds. In contrast to 
dimethyl sulphoxide derived reagents, which have to be prepared at low 
temperatures in-situ, DMP 29 is storable and relatively easy to prepare .36
23
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OH
30
38 °C. 20 min
84%
31
Scheme 1.25: Oxidation o f a geraniol 30 with DMP 29.
DMP 29 is an important precursor to many other hypervalent iodine 
reagents. Decomposition or ligand exchange with this reagent yields several 
useful compounds including benziodoxole 32 (Scheme 1.26).
O AcAcO
OAc
AcOH  
2 h. 25°C
29
Scheme 1.26: Preparation o f benziodoxole 32 from DMP 29.
The hypervalent iodine chemistry discussed within this section has only 
scratched the surface for uses of these safer, cleaner, heavy metal alternatives. The 
reactions have stimulated the application of hypervalent iodine reagents in 
synthesis. The discovery of new transformations with these compounds will 
certainly be the basis for future improved synthetic strategies and concepts. The 
subsequent chapters within this thesis will discuss the synthesis and application o f 
a new range of chiral hypervalent iodine compounds.
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Chapter 2
2 Chiral Hypervalent Iodine Compounds
2.1 Introduction
This chapter reviews the previous work that many groups around the 
world have made towards the synthesis of chiral hypervalent iodine reagents. This 
has been driven by the requirement for enantiopure products where the synthetic 
chemist is concerned.
As the interest in hypervalent iodine compounds grew, so did the number 
of reactions in which they were used. In many of these reactions new stereogenic 
centres were created (Scheme 2.1).
As racemic reagents were used in these reactions, the products formed 
were subsequently racemic. As asymmetric synthesis has gained more importance 
in organic chemistry, methods of synthesising stereogenic centres o f known 
configuration became paramount. Hypervalent iodine compounds are of high 
synthetic potential by virtue of the fact that they are non-metallic oxidation and 
oxygenation reagents, thus circumventing the problem of toxicity associated with 
many of the transition metals commonly used for carrying out such reactions.
27
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The possible directions, in which the hypervalent Chemist could research, 
were to integrate centres, axes or planes o f chirality.
R w _ J ^ R
r T
L L
OH
O
L
Ar— ! < S :  
L
OH
OH
OH
OHR
Ar,
▼ A r1
'R 1
O
H*S
R? ^R1
Ar
A rC  O .
O Ov
Scheme 2.1: Transformations using hypervalent iodine reagents leading to 
products containing new stereogenic centres.
2.2 Early Chiral Hypervalent Iodine Reagents
The first chiral hypervalent iodine compound synthesised was in 1986, 
when Inamoto and Koto reported compounds with C2 symmetry (Scheme 2.2).
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O O
1 = 0  + o
O
kOCOR
'OCOR
AcOH. r '""OCOR
kOCOR
57% O
7 34 35
Scheme 2.2: Synthesis of Inamoto and Koto’s C2 symmetric iodine 35.
These chiral hypervalent reagents were synthesised in situ from
However, it was Koser who first isolated this type of hypervalent iodine
2
compound in 1992.
Following the work of Inamoto and Koto, Ochiai, Koser and Varvoglis 
reported two independent concepts for chiral hypervalent iodine compounds, 
derived from homochiral alkoxy ligands.
Figure 2.1: General structure o f chiral hypervalent compounds prepared by 
Koser and Varvoglis.
To introduce chirality into compounds shown in Figure 2.1 above,
(-)-menthyloxy groups.
Koser’s chiral iodine was prepared via a ligand exchange reaction between 
[methoxy(tosyloxy)iodo]benzene 36 (MITB) and (2/?,5S)-(-)-menthol 37. This 
gave [menthyloxy(tosyloxy)iodo]benzene or MnTIB 38 in good yield. The 
application of these reagents in stereoselective synthesis yielded mixed results. 
Many of them were unsuccessful in the oxidation of sulphides to sulphoxides 
producing racemic products. However, the iodoarene shown in Scheme 2.3
iodosylbenzene 7 by treatment with derivatives o f L-tartaric anhydride 34.
Varvoglis3 used the (+)-10-camphoryl group, whereas Koser4 utilised the (+) and
29
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produced the highest enantiomeric excesses o f sulphoxides, ranging from 4% to 
57% ee .4
OTs
38
j y OMe
\ — |  +  [  1  — — ►  p  9 5 %
OTs
36 37
Scheme 2.3: Koser’s preparation of [(-)-menthyloxy(tosyloxy)iodo]benzene 
(MnlTB) 38.
Around the same time (ca. 1990), Ochiai5 reported (*S)-2-(diacetoxyiodo)- 
U'-binaphthyl 39 (Figure 2.2) where the chirality is derived by the biaryl axis.
39
Figure 2.2: Ochiai’s chiral (5)-2-(diacetoxyiodo)-l,l'-binaphthyl compound 39.
Further work by Koser6 and later by Zhdankin7 created a new class of 
chiral hypervalent iodine compounds, which are structurally close to 
iodosobenzoic acid or IB A 23, and are shown in Figure 2.3. They contain the 
iodine atom in a 5-membered ring. Koser utilised a tetra-substituted carbon in the 
benzylic position, ortho to an iodine, as seen in benziodoxole, to introduce the 
chirality (Scheme 2.4). Alternatively, Zhdankin introduces chirality through the 
addition of an amino acid as seen in benziodazoles (Figure 2.3).
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N a N 0 2, HC1 
H20
KI, H20
40 41
Me-MgBr 
Dry Ether
H
P
Resolution
[Ox]
OH
/Cl
43 42
Scheme 2.4: The synthesis of Koser’s chiral benziodoxole 43.
The preparation of Koser’s chiral benziodoxole 43 begins with 2- 
aminobenzo ketone 40. The initial step is the displacement of the amino group by 
an iodine atom, followed by a Grignard reaction, optical resolution and finally 
oxidation, to afford the hypervalent product. To prepare the chiral benziodazole 
type iodo compounds, Zhdankin used peracetic acid to oxidise 2-iodobenzamides, 
which were derived from alanine or valine (Figure 2.3).
0
/ci Ph
43 44
Figure 2.3: Koser 43 and Zhdankin 44 chiral iodanes.
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2.3 Wirth Type Chiral Hypervalent Iodine Compounds
In 1997 Wirth presented another type of chiral iodoarene 45, loosely 
modelled on the IBA type compounds o f Koser. They based the structure on a 
pseudo 5-membered ring with the iodine atom in close proximity to the 
asymmetric centre. The chirality is induced through an asymmetric carbon in the 
benzylic position, which contains a protected alcohol. These ethers show a large 
degree of coordination to the hypervalent iodine atom. The hypervalent bond 
shows the characteristic T-shape observed with Koser’s reagent, with an oxygen- 
iodine-oxygen bond angle of 167.3° (the Koser reagent 0-1-0 bond angle is 
178.8°).s
.0 —
OTs
OH
45
Figure 2.4: (R)-1 -(l-Hydroxy-l-tosyloxy)-iodo-2-( 1 -methoxyethyl)-benzene 45.
Interestingly, the oxygen o f the methoxy group replaces the oxygen o f the 
tosylate. They observed, through X-ray crystallographic data, a short distance 
from the oxygen atom of the methoxy-group to the iodine of about 2.47 A and a 
longer (tosylate)-oxygen iodine distance o f 2.91 A. The bond length o f the 
(hydroxy)-oxygen atom to iodine is 1 .94 A and of the iodine-carbon bond 2.08 A 
and therefore showing strong similarity in both structures. 8
2.3.1 Functionalisation in the a-Position
Carbonyl compounds can be functionalised at the a-position under various 
conditions. Treatment o f ketones with (diacetoxyiodo)benzene 6  under basic 
conditions provides an efficient route to a-hydroxylated dialkylacetals.9,10 This 
reaction has also been applied to functionalisation in natural product synthesis, 11,12
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because the a-hydroxylated dialkylacetals can be easily hydrolysed under acidic 
conditions to a-hydroxy ketones in good yield (Scheme 2.5).
o  DIB R 'ov p R 1 h + 9
,R ---------------------► R
K O H .R 'O H  R
OH OH
Scheme 2.5: Synthesis o f a-hydroxy ketones from ketones.
Using other hypervalent iodine compounds or different reagent
combinations, various functional groups can be introduced into the a-position of a
ketone (Scheme 2.6). Oxytosylations o f ketones in the a-position can be
1 ^performed with [hydroxy(tosyloxy)iodo]benzene 15 (Koser reagent). This 
reaction can be described mechanistically as an electrophilic attack of the iodine 
at the double bond of the enol with subsequent Sn2  substitution of the iodine by 
the tosylate. The major drawback is the low stereoselectivity observed in these 
reactions when using chiral hypervalent reagents.
r v !
OH
O
A
\
OTs
15 O
R OTs
Scheme 2.6: a-Oxytosylations o f ketones using the Koser reagent 15.
The Wirth group investigated several chiral hypervalent iodine compounds 
in this reaction with modest results. The chiral iodane is dissolved in 
dichloromethane and treated with an excess o f propiophenone. The enantiomeric 
excess of the a-(tosyloxy)propiophenone product 47 was determined by HPLC 
after purification on silica gel (40-75%  yield). The selectivity observed in the 
oxytosylated product using chiral derivatives o f 45 was up to 40% ee.
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1 eq /?T s0H H 20 ,C H 2Cl2
Scheme 2.7: a-Oxytosylation of propiophenone 46 using a Wirth chiral 
hypervalent reagent 45.
The products of this reaction are of high interest as they can be used in a 
variety of subsequent reactions.
2.3.2 Functionalisation of Alkenes
Hypervalent iodine compounds can also be used to functionalise alkenes. 14 
Koser showed that during the reaction with an alkene, an iodonium intermediate is 
formed which then reacts twice with tosylates to yield the bis(tosyloxy)alkane. In 
reactions with non-symmetrically substituted alkenes, new stereogenic centres are 
formed.
The Wirth group investigated the functionalisation of alkenes using their 
range o f chiral hypervalent compounds with successful results (Scheme 2.8). The 
chiral iodane and / 7-toluenesulphonic acid monohydrate were dissolved in 
dichloromethane (DCM) and styrene 20 was added. The solution was stirred at 
this temperature for 4-24 hours. After filtration through silica gel the solvent was 
removed and the residue purified by flash chromatography on silica gel to obtain 
the 1,2-bis(tosyloxy)phenylethane 48 in good yields, ranging from 30-70%. The 
enantioselectivity observed within these reactions was between 13 and 65% ee.15
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Scheme 2.8: Dioxytosylation of styrene 20 using Wirth chiral reagent 45.
2.4 Conclusion
As discussed earlier, chiral iodanes have the potential to be very useful 
reagents for the synthesis of new chiral centres, of known configuration. The aim 
of the chiral hypervalent iodine chemist is to develop reagents that will ensure 
exceptionally high enantiomeric excess in their products. This is the driving force 
of this project and the initial ideas and further research are based around the Wirth 
chiral iodanes. The natural progression was to investigate and improve upon the 
results obtained previously, via greater functionalisation of these iodoarenes to aid 
the transfer of chiral information from the reagent to the substrate. Chapter Three 
will outline the synthesis of these next generation chiral hypervalent compounds.
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Chapter 3
3 Synthesis of Chiral Hypervalent Iodine 
Compounds
3.1 Introduction
In this chapter, the synthesis of the next generation of chiral hypervalent 
iodine(III) reagents will be reported. As discussed in Chapter One, there are many
•j
known procedures for the synthesis of aryl-A. -iodanes which were applied to the 
novel chiral iodine precursors described.
3.1.1 Determination of (/?) and (5) Configuration
The (R) and (S) configuration of all the chiral compounds describe herein 
have not been determined unequivocally. The proposed configuration is based 
upon the asymmetric reduction of the corresponding ketone using (-)-/?- 
chlorodiisopinocampheylborane ((-)-IpC2BCl). Brown et al. proposed a transition 
state model for this transformation (Scheme 3.0) . 1 They proposed a transition state 
that is similar to the mechanism proposed by Midland for Alpine borane 
reductions. It forms a six membered, cyclic, ‘boat like’ transition state, with the 
boron moiety and p-hydrogen cis, resulting in a syn-elimination. In the preferred 
transition state, only the smaller alkyl group (Rs) has to face the syn axial methyl
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interaction, whereas the bulky group (Rl) assumes an equatorial orientation. This 
lends itself toward the predominant formation of the S  isomer of the alcohol.
Acetophenone derivatives, where the halide is in the ortho position on the 
aromatic ring, give very high enantioselectivities (up to 99% ee) but the ketones 
described in this chapter give varying levels of enantiomeric excess. As the chiral 
chain length increases, the distance from the phenyl ring to the carbonyl increases. 
Subsequently, the discrimination between R l and Rs decreases. This results in 
decreased selectivity in the transition state and decreased asymmetric induction.
Scheme 3.0: The transition state model proposed by Brown et al for the
In addition to this proposal of configuration, each of the racemic alcohols 
were synthesised using a sodium borohydride reduction, to determine optical 
purity o f the ketones reduced in an asymmetric manner. In each case, the retention 
time of the proposed S  enantiomer (fa) was longer than that o f the R enantiomer 
(fa). Therefore, the assignment of configuration used throughout this thesis is 
based upon these two assumptions and is in no way definitive.
Favoured
Less favoured
asymmetric reduction of ketones.
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3.2 Synthesis of Pseudo 6-Membered Chiral Iodine 
Reagents
The focus here was to develop a range of chiral aryl-A, -iodanes based on 
the Wirth chiral compounds (Figure 3.1). An increase in the length o f the chiral 
side chain ortho to the iodine atom may help to encompass a greater proportion of 
the iodine atom into the chiral ring and increase the transfer of chiral information 
from the chiral reagent to the substrate. Several different iodoarenes were 
synthesised to investigate this effect.
R1
HO
Figure 3.1: Wirth pseudo 5-membered ring chiral
[hydroxy(tosyloxy)iodo]arene.
3.2.1 Attempted Synthesis of (S)-3-(2-hydroxy(tosyloxy)- 
iodophenyI)-2-alkoxypropane
The chiral iodoarenes with one extra carbon atom in the chiral side chain 
ortho to the iodine were planned to be synthesised over 7 steps (Scheme 3.1).
The commercially available 2-iodobenzyl alcohol 50, was converted into 
2-iodobenzaldehyde 51 over 24 hours by oxidation using pyridinium 
chlorochromate (PCC) in dichloromethane.3 Following purification over celite® 
and silica gel, the 2-iodobenzaldehyde was isolated in 96% yield.
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GC“ PCC96%
50
-OMe
91%
OMe
Optical separation. 
O - functionalisation
[Ox]
0-39%
69-96%
R1 : Me 
Et 
Bn
COCF
*Bu
TsOH«H20
X *
58
59
60 
61 
62
OH
55
MeMgCl
97%
OTs
HCOOH
97%
(XT
54
Scheme 3.1: The attempted synthesis o f (5)-3-(2-hydroxy(tosyloxy)- 
iodophenyl)-2 -alkoxypropane.
To introduce an extra carbon atom into the chain, the aldehyde 59 was 
subjected to a Wittig reaction using (methoxymethyl)triphenylphosphonium 
chloride to give the (2-iodophenyl)-2-methoxyethenes 52 & 53. Purification of the 
vinyl ethers was performed using column chromatography eluting with a diethyl 
ether/petroleum ether (1:10) mixture to afford both E and Z-isomers in a 1:1 ratio 
(91% yield) . 4
The methoxy group o f the ether was cleaved through acid hydrolysis. This 
was achieved by stirring the vinyl ether in the dark with concentrated formic acid, 
to give the (2-iodophenyl)acetaldehyde 54 in 97% yield .4 The acetaldehyde was 
unstable and decomposes if left at room temperature, although it was safe to store 
at temperatures below 0°C.
40
Chapter Three: Synthesis o f  Hvnervalent Iodine Compounds
To synthesise the racemic alcohol, a simple Grignard reaction was 
performed, using a methyl magnesium chloride to give Grignard product 55 in 
97% yield. To obtain the enantiomerically enriched alcohol, two different routes 
were investigated. The first was oxidation of the racemic alcohol 55, using PCC to 
afford the propanone derivative 57 (90%), followed by an asymmetric reduction 
of the carbonyl using (-)-/?-chlorodiisopinocampheylborane ((-)-Ipc2BCl) to give 
the enantiomerically enriched (S) alcohol 56 (Scheme 3.2) in 67% yield and 34% 
ee. As this enriched ratio was not sufficiently high enough to proceed with, an 
alternative approach was examined.
(-) Ipc2BCl
Scheme 3.2: Asymmetric reduction o f the carbonyl moiety in 57.
The second method involved separation of the two enantiomers of 55 by 
preparative chiral HPLC using a Shimadzu LC-10 series HPLC. Several attempts 
were made using different chiral analytical columns, varying the column 
temperature, solvent ratios and flow rate. Finally, the conditions for adequate 
separation were found using an analytical OD-H column and the enantiomers of 
( ± )-1-(2-iodophenyl)propan-2-ol 55 were separated by preparative chiral HPLC. 
The retention times of the two enantiomers were 128 (R) and 144 (S) minutes 
using an OD preparative column. The solvent ratio was hexane/2-propanol (99:1), 
with 10 °C as the column temperature and a 3 ml/min. flow rate (Figure 3.1). The 
practical separation o f the racemic alcohol required a long time, mainly due to the 
insolubility of (±  )-l-(2-iodophenyl)propan-2-ol 55. The solubility o f the alcohol 
in the solvent mixture used to separate them was around 50 mg/ml. Additionally, 
only injections with a maximum of 250 pL were possible. Injections with a 
greater volume produced a severe overlap o f the two chromatographic peaks.
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Figure 3.1: HPLC chromatogram of ( ± )-l -(2-iodophenyl)propan-2-ol 55.
In each of the following cases, enantiomer 2 (5)-56, was carried forward. 
Alkylation of the alcohol led to the range o f chiral hypervalent iodine precursors 
shown in Table 3.1. Substrates 58-60 were prepared through treatment of the 
alcohol with sodium hydride followed by addition of an alkyl halide. 5 Ester 61 
was prepared by reacting the alcohol with trifluoroacetic anhydride in a solution 
o f triethylamine in dichloromethane. 6 Ether 62 was prepared by the addition of a 
solution of the alcohol and /-butanol in cyclohexane to a vigorously stirred 
suspension of magnesium sulphate and concentrated sulphuric acid in 
cyclohexane.
Compound R 1 group Yield%
58 Me 96
59 Et 90
60 Bn 72
61 COCF3 69
62 lBu 87
Table 3.1: Yield o f ethers synthesised from the (S) chiral alcohol 56.
The penultimate step in the synthesis of our proposed chiral reagents was 
the oxidation of the iodine atom to the iodine(III) state. The oxidation was carried 
out using the general procedure developed by McKillop, 8 reacting sodium 
perborate tetrahydrate (NaB0 3 *4 H2 0 ) in acetic acid at 40°C with the 
corresponding iodoarene. Oxidation o f 58 led to the iodine(III) product 63 that 
was isolated in 17% yield. The temperature was raised to 50 °C and the reaction
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repeated to give an increase in yield of 63 to 26%. Raising the temperature higher 
than this afforded no further increase in product yield.
An in situ generation o f peracetic acid from acetic anhydride and 30% 
hydrogen peroxide,9 at 40°C gave 63 in 39% yield.
Commercially available peracetic acid was then used as the oxidant at 
40°C and this also afforded the (diacetoxy)iodoarene 63 in 39% yield. In each of 
the above cases, the reaction was performed on a 0.5 mmol scale. Scale up of the 
reaction proved difficult, as there was a non-linear increase in yield. Other 
oxidants were employed (Scheme 3.3) to improve on these modest yields.
Scheme 3.3: Oxidation o f iodoarenes 58-62 with peracetic acid and
Table 3.2 highlights the oxidants applied to the hypervalent precursors 
58-62 and the subsequent yields o f compounds 63-66.
The Cr0 3 /AcOH/conc.H2S0 4  liquid system developed by Skulski, 10 is an 
alternative reagent used in the synthesis o f hypervalent iodine compounds. This 
also failed, as no oxidation products were observed.
1 The external examiner o f  this thesis suggested that the magnitude o f  the isolated yields o f  the 
desired iodine(III) compounds from the oxidation step is simply a solubility issue.
Any individual repeating the oxidation step shown here, will need to monitor the work-up 
procedure and consider the solubility o f  the iodine(III) compound.
OR1
I(OAc)2
Bn
COCF
*Bu
OR1
l(OCOCF3)2
R 1 : Me = 66, 6%
R 1 : Me = 63, 39% 
Et = 6 4 , 15% 
Bn = 6 5 , 9%
trifluoroperacetic acid.
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Compound R1 Oxidant Conditions Product Yield %
58 M e 63 26
59 Et N a B 0 3-4H 20 4 0 -7 0 ° C , 2 4  h 64 15
60 Bn 65 9
61 C O C F 3 - 0
62 'Bu - trace
58 M e 63 39
59 Et P eracetic  acid  or 4 0 - 7 0 ° C , 2 4  h 64 12
60 B n A c 20 ,  30%  H 20 2 65 5
61 C O C F 3 - 0
62 - trace
58 M e 66 6
59 Et U H P , C F 3C 0 2H - 6 5  °C  to  rt., 2 4  h - trace
60 Bn - trace
61 C O C F 3 - 0
62 lBu - trace
5 8 -6 0 m C P B A , A cO H 2 0 -6 0 ° C , 2 4 —48 h - 0
5 8 -6 0 K oser  reagent r.t., 4 8  h - 0
5 8 -6 0 C r 0 3/A c 0 H /H 2S 0 4 4 0 °C , 2 h - 0
Table 3.2: Oxidative reagents used in the synthesis of the hypervalent
iodine(III) reagents.
An attempt to oxidize the iodine atom in compounds 58-62 using 
[hydroxy(tosyloxy)iodo]benzene 15 (Koser reagent), did not result in the expected 
ligand exchange with formation o f the [hydroxy(tosyloxy)iodo]arene derivative. 11 
This reaction was monitored for 48 hours, and resulted in the recovery o f both 
starting materials.
The novel urea-hydrogen peroxide/trifluoroacetic anhydride method (as
discussed in Chapter Five) was applied to generate the trifluoroacetoxy reagent
1
6 6 , with a poor resulting yield o f 6 %. Once again, the starting iodoarene 58 was 
easily recoverable.
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The final oxidant applied to these iodoarenes, was commercial m-
• ITchloroperbenzoic acid (mCPBA) 70-77% ‘wet’ in acetic acid. Unfortunately, no 
iodine(III) product was observed during the reaction that was followed for 48 
hours and starting material recovered.
TLC analysis during each o f the reactions showed the formation of a new 
spot consistent with that of a hypervalent iodine product. However, recovery was 
affected by the stability of the iodoarenes to aqueous work-up and to temperature. 
In each reaction, the remainder of the reaction mixture was the starting material, 
which could be recovered easily, through extraction with petroleum ether and 
evaporation of the solvent under reduced pressure.
The ligand exchange reaction to afford the (S)-3-(2-hydroxy(tosyloxy)- 
iodophenyl)-2-methoxypropane product was performed (Scheme 3.4) using p- 
toluenesulphonic acid monohydrate (pTs0 H*H2 0 ), at room temperature in 
acetonitrile (CH3CN). Unfortunately, no [hydroxy(tosyloxy)iodo]arene product 
was observed, using either the diacetoxy 63 or trifluoroacetoxy analogues 66 as 
the starting material. The hypervalent iodine precursors 58-60 were recovered in 
quantitative yields after this reaction.
Scheme 3.4: Failed ligand exchange reaction.
To summarise, the use of the most common methods for oxidising 
hypervalent iodine compounds proved disappointing. To be synthetically useful, 
we required stoichiometric quantities of the chiral hypervalent product to react 
with the alkene and ketone test substrates. The failure of the iodine atom of the 
hypervalent precursor to oxidise could be related to steric hindrance. The chiral 
chain now contains an extra carbon that introduces an extra degree of free 
rotation. This rotation can allow the methoxy group to get closer to the iodine 
atom to interfere with the oxidation process (Scheme 3.5).
I(OAc)2
63 63a
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Scheme 3.5: Possible conformers o f 1 -iodo-2-(2-alkoxypropyl)benzene.
3.2.2 Attempted Synthesis of (S)-3-(2-hydroxy(tosyloxy)- 
iodophenyl)-l-a!koxyethyl)benzene
The synthesis o f (5)-3-(2-hydroxy (tosyloxy)iodophenyl)-1- 
alkoxyethyl)benzene 73a is analogous to that of (£)-3-(2- 
hydroxy(tosyloxy)iodophenyl)-2-methoxypropane 63a. Both can be synthesised 
over 7 steps, and are identical up to the Grignard addition, where in this case a 
phenyl Grignard is used, to introduce the phenyl moiety to the end of the chiral 
side chain.
OCT
54
PhMgCl
85 %
73a
Optical separation, 
O - functionalisation
5 5 - 9 4 % OROH
R 1 : Me = 69 
= 70 
= 71 
= 72
[Ox]
0 - 3 %
OTsHO
Scheme 3.6: Synthesis toward (S)-3-(2-hydroxy(tosyloxy)-iodophenyl)-l-
alkoxyethyl)benzene 73a.
The racemic alcohol 67 was separated by preparative chiral HPLC. The 
conditions for adequate separation were found using an analytical OD-H column.
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The enantiomers o f (±)-2-(2-iodophenyl)-l-phenylethanol 67 were resolved by 
preparative chiral HPLC. The retention times of the two enantiomers were 17 (R) 
and 20 (S) minutes using an OD preparative column. The solvent ratio required 
was hexane/2-propanol (93:7), with 10 °C as the column temperature and a 3 
ml/min. flow rate (Figure 3.2).
600
400
200
20
Figure 3.2: HPLC chromatogram of (±  )-2-(2-iodophenyl)-l -phenylethanol 67.
The alkyl ethers that were synthesised from alcohol (S) - 6 8  were prepared 
under standard reaction conditions in very good yields as shown in Table 3.3.
Compound R 1 group Yield%
69 Me 95
70 Et 85
71 Bn 74
72 COCF3 55
Table 3.3: Yield of alkyl ethers synthesised from the (S) enantiomer of the
chiral alcohol 6 8 .
As with the attempted synthesis of (5)-3-(2-hydroxy(tosyloxy)- 
iodophenyl)-2-methoxypropane 63a, the yields to the iodine(III) precursor
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compounds 69-72 from the chiral alcohol were very good (55-95%), but the 
oxidation step again revealed problems.
Several different oxidants were employed to give the hypervalent product 
but with very limited success. Table 3.4 shows the range of oxidants used along 
with their respective conditions and yield of product.
Scheme 3.7: Oxidation of iodoarenes 69-72 with peracetic acid and
Analogous to (5)-3-(2-hydroxy(tosyloxy)iodophenyl)-2-methoxypropane 
63a synthesis, the oxidation did not proceed as planned. When using either Koser 
reagent or mCPBA in acetic acid, no hypervalent product was observed. In 
addition to this, the stalwart oxidations using sodium perborate in acetic acid, 
commercial peracetic acid, in situ preparation of peracetic acid and the novel 
method generating trifluoroperacetic acid all generated product, but with very low 
yield. Scale up of the successful reactions did not produce the expected increase in 
mass of the hypervalent product.
O R 1
I(O A c)2
Bn = 7 1  
COCF = 72
O R 1
I(OCOCF3)2
R 1 : M e = 74, 2%
R 1 : M e = 73, 2%
trifluoroperacetic acid.
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Compound R 1 Oxidant Conditions Product Yield %
69 Me 73 2
70 Et N a B 0 3 4H 20 40-70°C , 24 h - Trace
71 Bn - Trace
72 COCF3 - 0
69 Me 73 2
70 Et Peracetic acid 40-70°C , 24 h - 0
71 Bn - 0
72 COCF3 - 0
69 Me 73 2
70 Et A c 2 0 ,  30% H2 0 2 40-70°C , 24 h - 0
71 Bn - 0
72 COCF3 - 0
69 Me 74 2
70 Et UHP, CF3 C 0 2H -65°C  to rt., 24 h - Trace
71 Bn - Trace
72 COCF3 - 0
69-72 mCPBA, AcOH 20-60°C , 2 4 -48  h - 0
69-72 Koser reagent r.t., 48 h - 0
Table 3.4: Oxidative reagents used in the synthesis of the hypervalent
iodine(III) reagents.
From these results it was clear that the [bis(acyloxy)iodo]arenes of this 
type of compound are lower yielding than those of the 3-(2-diacetoxyiodophenyl)- 
2-alkoxypropane. Without isolation of sufficient quantities of the
[bis(acyloxy)iodo]arenes to perform ligand exchange reactions to give the 
[hydroxy(tosyloxy)]iodoarenes, this type of hypervalent compound would have 
very limited synthetic use.
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3.2.3 Attempted Synthesis of (/?)-3-(2-hydroxy(tosyloxy) 
iodophenyl)-2-aIkoxy-3-methylbutane
The synthesis o f (/?)-3-(2-hydroxy(tosyloxy)iodophenyl)-2-alkoxy-3- 
methylbutane 81a mirrors that of (S)-3-(2-hydroxy(tosyloxy)iodophenyl)-2- 
methoxypropane 63a. Both were proposed to be synthesised over 7 steps (Scheme 
3.8), and are analogous up to the Grignard addition. In this case, an isopropyl 
halide was used to form the Grignard reagent, to introduce the branched isopropyl 
side chain in 87% yield.
ccv
54
PrMgCl
OH
8 7 %
75
81a
HO OTs
Optical separtion, 
O - functionalisation
6 5 - 9 6 %
R 1 : Me
Et
Bn
COCF3
= 77 
= 78 
= 79 
= 80
[Ox]
0- 2%
Scheme 3.8: Synthesis toward (7?)-3-(2-hydroxy(tosyloxy)iodophenyl)-2- 
methoxy-3-methylbutane 81a.
The racemic alcohol 75 was resolved by preparative chiral HPLC using a 
Shimadzu LC-10 series HPLC. The conditions for adequate separation were found 
using an analytical OD-H column and the enantiomers of (±  )-l-(2-iodophenyl)-3- 
methylbutan-2-ol 75 were resolved and separated by preparative chiral HPLC. 
The retention times o f the two enantiomers were 20 (R) and 24 (S) minutes using 
an OD preparative column. The solvent ratio required was hexane/2-propanol 
(92:8), with 10 °C as the column temperature and a 2 ml/min. flow rate (Figure 
3.3).
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Figure 3.3: HPLC chromatogram o f (±  )-l-(2-iodophenyl)-3-methylbutan-2-ol
75.
The subsequent alkylation/acylation step afforded the various ethers or 
ester in good yields (65-96%).
Compound R 1 group Yield%
77 Me 96
78 Et 81
79 Bn 72
80 COCF3 65
Table 3.5: Yield o f alkyl ethers synthesised from the (R) enantiopure alcohol
76.
The yields of the hypervalent iodine precursors 77-80 from (R)-16 were 
very good, ranging between 65-96% , so there is good atom economy up to this 
point.
The oxidation o f the iodine atom to the iodine(III) compound was 
performed using a range o f oxidants with varying oxidising power (Table 3.6).
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i f :
k A , O R 1
R 1 : Me = 77
Et = 78
Bn = 79
COCF, = 80
ho—o'
40-70°C , 4 -24 h
6 5 ° C -r .t . .  24 h
X
H O —C T X F 3
R 1 : Me = 81. 2% 
Et = 82, 2%
O R1
I (O A c)2
O R 1
I(OCOCF3)2
Scheme 3.9: Oxidation o f iodoarenes 77-80 with peracetic acid and 
trifluoroperacetic acid.
Compound R1 Oxidant Conditions Product Yield %
77 Me 81 2
78 Et N a B 0 3 4H 20 40-70°C , 24 h - 2
79 Bn - Trace
80 COCF3 - 0
77 Me 81 2
78 Et Peracetic acid or 40-70°C , 24 h 82 1
79 Bn A c 2 0 ,  30% H2 0 2 - 0
80 COCF3 - 0
77-79 UHP, CF 3 C 0 2H -65°C  to rt., 24 h - Trace
80 COCF3 - 0
77-80 mCPBA, AcOH 20-60°C , 24-48  h - 0
77-80 Koser reagent r.t., 48 h - 0
Table 3.6: Oxidative reagents used in the synthesis o f the hypervalent
iodine(III) reagents.
As a starting point, sodium perborate tetrahydrate was used, generating 
only a trace of iodine(III) product 81. The novel urea hydrogen peroxide method 
also only generated traces o f product, whereas /wCPBA in acetic acid and Koser 
reagent did not afford any product. The only oxidants that produced any
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recoverable iodine(III) product were sodium perborate tetrahydrate and peracetic 
acid (both commercial and in situ preparation) as shown in Table 3.6.
In keeping with the iodoarenes discussed in sections 3.2.1 and 3.2.2, the 
final ligand exchange step failed to produce the target compound in any 
appreciable quantity. The [bis(acyloxy)iodo]arenes were reduced to their 
corresponding precursor molecules, which were recovered quantitatively each 
time.
To summarise, it was clear that a recurring feature of these pseudo 6 - 
membered ring chiral iodine reagents was their instability and difficulty in 
oxidising to the [bis(acyloxy)iodo]arene. As discussed earlier, for these iodine(III) 
reagents to be useful in generating new chiral centres in reactions such as 
dioxytosylation of alkenes and a-oxytosylation of ketones, we would require them 
in stoichiometric quantities. Therefore, this type of hypervalent iodine compound 
in its current application has severe limitations.
3.3 Synthesis of Pseudo 7-Membered Ring Chiral Iodine 
Reagents
Running parallel to the research into the pseudo 6 -membered compounds 
was the investigation of pseudo 7-membered ring compounds. This was to enable 
us to observe a wider range o f reactivity with alkenes and ketones, from the 
addition of carbon atoms into the chiral side chain. Analogous to the smaller chain 
compounds, a range o f iodoarenes were synthesised with different substituents 
attached to the chiral centre and to the hydroxy oxygen.
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3.3.1 Attempted Synthesis of (S)-4-(2-hydroxy(tosyloxy) 
iodophenyl)-2-methoxy-3-methylpropane
The chiral iodoarenes with two extra carbon atoms in the chiral side chain 
ortho to the iodine were synthesised over 5 steps as outlined in Scheme 3.10.
Commercially available 2-iodobenzyl chloride 83 was refluxed with 2,4- 
pentanedione and potassium carbonate in ethanol for 24 hours to afford 4-(2- 
iodophenyl)butan-2-one 84 in excellent yield (84%).14
To obtain the enantiomerically pure alcohol, there was a choice of two 
methods to reduce the carbonyl moiety in 84. By using (-)-/?- 
chlorodiisopinocampheylborane ((-)-Ipc2BCl) it would be possible to perform an 
asymmetric reduction, or alternatively, by synthesising the racemic alcohol 85 by 
a sodium borohydride reduction followed by HPLC. Both routes were 
investigated.
2.4-pentanedione.
a \ c l  K2C 0 3, EtOH{ 84%83
- O R
NaBH 4, EtOH
Optical
Separation,
O - functionalisation
58-92%
R 1 : Me = 88
Et = 89
Bn = 90
OCOCF3 = 91
*Bu = 92
O R 1
0-47%
'1(R2)2
OTs
Scheme 3.10: The synthesis toward (S)-4-(2-hydroxy(tosyloxy)iodophenyl)-2- 
alkoxybutane.
The asymmetric reduction o f 84 using (-)-Ipc2BCl was performed in dry 
tetrahydrofuran at -2 5 °C (temperature controlled using a cold finger) for 24
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hours. This reaction yielded the (S) enantiomerically enriched alcohol 8 6  (Scheme
3.11) in 57% yield and 53% ee.
QH
Optical
Separation
(R)  - 87
+ OH
(5) - 8 6
85
NaBH,
97%
57%, 53% ee-
(5 ) - 8 6
Scheme 3.11: Reduction o f 4-(2-iodophenyl)butan-2-one 84 with NaBfLt and 
(-)-Ipc2BCl.
The failure to obtain the enantiomerically pure alcohol via an asymmetric 
reduction prompted the search for alternative method. The reduction performed 
with sodium borohydride in ethanol at reflux for 3 hours, afforded the racemic 
alcohol 85 in excellent yield (97% ) . 15 The separation of the enantiomers was 
performed using preparative HPLC. As discussed in section 3.2.1, a range of 
analytical columns and conditions were investigated to give separation of the 
enantiomers.
Figure 3.4: HPLC chromatogram of ( ± )-4-(2-iodophenyl)butan-2-ol 85.
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Suitable conditions were found using an OD-H analytical column to allow 
separation o f the enantiomers o f ( ± )-4-(2-iodophenyl)butan-2-ol 85 (figure 3.4). 
The retention times using an OD preparative column were longer than those with 
the OD-H column coming in at 25 (R ) and 32 (S) minutes, possibly due to the 
larger particle size and smaller interaction with the hydroxy moiety. The solvent 
ratio was hexane/2-propanol (93:7), with 15°C as the column temperature and a 
4.5 ml/min flow rate. Solutions o f up to 200 mg/ml were possible with injection 
volumes of up to 400 pL.
In each of the following cases, enantiomer 1 (assumed to be the S- 
enantiomer) was carried forward and a simple alkylation of chiral alcohol (S) - 8 6  
gave the corresponding alkyl ether/ester in good yields as shown in Table 3.7.
Compound R 1 group Yield %
8 8 Me 96
89 Et 81
90 Bn 72
91 COCF3 71
92 lBu 58
Table 3.7: Yield o f alkyl ethers synthesised from the (5) chiral alcohol 86.
Oxidation o f the iodine atom began with the general procedure of using 
sodium perborate tetrahydrate in acetic acid. The [bis(acyloxy)iodo]arenes were 
obtained in yields ranging from 5 to 12%. The use of both commercially available 
peracetic acid and the in situ generation using acetic anhydride/hydrogen peroxide 
provided the iodine(III) product 93 in 47% yield from compound 8 8 .
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H O -O '
40-70°C , 4 -24 h
R 1 : Me = 8 8
Et = 89
Bn = 90
COCF3 = 91
‘Bu = 92
I (O A c)2
R 1 : Me = 93, 47%  
Et = 9 2 ,  12% 
Bn = 9 5 ,  5%
65 C - r.t„ 24 h
H O - O  CF3 R 1 : Me = 96, 21%  
Et = 97. 15% 
l(OCOCF3)2 Bn = 98, 6%
Scheme 3.12: Oxidation o f iodoarenes 88-92 with peracetic acid and 
trifluoroperacetic acid.
Attempts to oxidize the iodine atom using 
[hydroxy(tosyloxy)iodo]benzene16 15 did not result in the expected ligand 
exchange. This reaction was monitored for 48 hours, with the recovery of both 
starting materials.
The novel urea-hydrogen peroxide/trifluoroacetic anhydride method was
applied to generate the trifluoroacetoxy analogue, with a low resulting yield of 93
1 0at 21%. Once again, the remaining starting iodoarene 8 8  was easily recoverable.
The final oxidant applied to these iodoarenes, was w-chloroperbenzoic 
acid13 (mCPBA) in acetic acid. Unfortunately, only a trace of iodine(III) product 
was observed during the reaction that was followed for 48 hours with the 
remaining starting material recovered.
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Compound R1 Oxidant Conditions Product Yield %
8 8 M e 9 3 12
8 9 Et N a B 0 3-4H 20 4 0 -7 0 ° C , 2 4  h 94 6
9 0 Bn 9 5 5
91 O C O C F 3 - 0
92 'Bu - trace
8 8 M e 93 4 7
89 Et P eracetic  a c id  or 4 0 - 7 0 ° C , 2 4  h 9 4 12
9 0 Bn A c 20 ,  30% 9 5 4
91 O C O C F 3 h 2o 2 - 0
92 'Bu - trace
8 8 M e 96 21
8 9 Et U H P , C F 3C 0 2H - 6 5 ° C  to  rt., 2 4  h 9 7 15
9 0 Bn 9 8 6
91 O C O C F 3 - 0
92 'Bu - trace
8 8 - 9 2 m C P B A , A cO H 2 0 - 6 0 ° C ,  2 4 —48 h - trace
8 8 - 9 2 K o ser  reagent r.t., 4 8  h - 0
Table 3.8: Oxidative reagents used in the synthesis of the hypervalent
iodine(III) reagents.
The final step in this procedure was the ligand exchange with 
toluenesulphonic acid monohydrate to generate the [hydroxy(tosyloxy)iodo]arene. 
However, analogous to the pseudo 6 -membered ring chiral iodine reagents, the 
ligand exchange step failed to afford the [hydroxy(tosyloxy)iodo]arene. The 
hypervalent precursors were recovered quantitatively in each case.
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3.3.2 Attempted Synthesis of (5)-l-(2-(Hydroxy(tosyloxy) 
iodophenyI)-l-methoxypropyl)benzene
The proposed synthesis o f («S)-l-(2-(hydroxy(tosyloxy)iodophenyl)-l- 
methoxypropyl)benzene is analogous to the synthesis described in section 3.3.1 
and is outlined in Scheme 3.13 .
D ibenzoyl m ethane  
c , K2C 0 3. EtOH  
 ►
84%
83
OH
O R 1
[Red]
79-90%
Resolution,
O - functionalisation
71-92%
[Ox]
R 1 : Me 
Et 
Bn
O R 1
-OTs
'I(R 2)2
0-59%
103
104
105
Scheme 3.13: The synthesis toward (S)-l-(2-(hydroxy(tosyloxy)-iodophenyl)-l- 
methoxypropyl)benzene.
The 2-iodobenzyl chloride 83 was reacted with dibenzoyl methane to yield 
the 3 -(2 -iodophenyl)-l-phenylpropan-l-one 99 in 84% yield as a pale yellow oil. 
The reduction to the (±  )-3-(2-iodophenyl)-l-phenylpropan-l-ol 100 was initially 
performed using sodium borohydride to give the racemic alcohol 100 in 90% 
yield. The enantiomers o f 100 were easily separated using preparative HPLC, 
however, this step was time consuming and an alternative approach to yield the 
enantiomerically pure alcohol was chosen. Through an asymmetric reduction of 
the carbonyl group using (-)-Ipc2BCl, it was possible to synthesise the 
enantiomerically enriched alcohol derivative (S)-101 in 79% yield and 99% ee.
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OH
HPLC
Separation
OH
100
90%
(5)-101
OH
79%. >99%  ee-
(S>101
Scheme 3.14: Reduction o f 3-(2-iodophenyl)-l-phenylpropan-l-one 99 with 
NaBH4 and (-)-Ipc2BCl.
Alkylation of the hydroxy group o f (S)-101 yielded the corresponding 
chiral ethers in good yields, as shown in Table 3.9.
Compound R 1 group Yield%
103 Me 85
104 Et 80
105 Bn 71
Table 3.9: Yield o f alkyl ethers synthesised from the (S) chiral alcohol 101.
The sodium perborate method o f oxidation using reagents 103 and 104 
resulted in (diacetoxy)iodo arenes in excellent yields p to 87% for 106 and 89% 
for 104.
Oxidation efforts using mCPBA gave only a trace of product and Koser 
reagent yielded no [hydroxy(tosyloxy)iodo]arene. However, the 
[bis(trifluoroacetoxy)iodo]arene 109 was successfully produced and isolated using 
the novel urea hydrogen peroxide method with yields up to 59%. Detailed yields 
are shown in Table 3.10.
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OR1
O R 1
H O -O ' I(O Ac)2
i C r  372
R 1 : M e = 106, 87% 
Et = 107,89%  
Bn = 108, 5%
- 65°C  - r.t., 24 h
R1 : Me
HO—O CF3
R 1 : M e = 109, 59% 
Et = 110. 17%
Scheme 3.15: Oxidation o f iodoarenes 103-105 with peracetic acid and 
trifluoroperacetic acid.
Compound R1 Oxidant Conditions Product Yield %
103 Me 106 87
104 Et N a B 0 3 -4H20 40-70°C , 24 h 107 89
105 Bn 108 3
103 Me 106 38
104 Et Peracetic acid 40-70°C , 24 h 107 1 2
105 Bn 108 4
103 Me 106 38
104 Et Ac2 0 ,  30% H2 0 2 40-70°C , 24 h 107 1 1
105 Bn 108 5
103 Me 109 59
104 Et UHP, CF3 C 0 2H -65°C  to rt., 24 h 110 17
105 Bn - Trace
103-105 mCPBA, AcOH 20-60°C , 24^48 h - Trace
103-105 Koser reagent r.t., 48 h - 0
Table 3.10: Oxidative reagents used in the synthesis of the hypervalent
iodine(III) reagents.
To afford the target [hydroxy(tosyloxy)iodo]arene, the ligand exchange 
reaction was performed and again no product was observed. The 
[bis(acyloxy)iodo]arenes appeared to undergo decomposition into the precursor 
iodine(I) molecule, which in each case were recoverable quantitatively.
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3.3.3 Attempted Synthesis of 1-(Hydroxy (tosyloxy )-iodo)2-((/?)-3- 
methoxy-4,4-dimethylpentyl)benzene
The final range o f compounds in the pseudo 7-membered ring series 
contained a large sterically demanding tertiary butyl group, attached to the chiral 
carbon of the side chain (Scheme 3.16). The tertiary butyl group was introduced 
through the reaction o f 2-iodobenzyl chloride 83 with 2,2,6,6-tetramethyl-3,5- 
heptanedione. The l-(2-iodophenyl)-4,4-dimethylpentan-3-one 111 was obtained 
in only 49% yield. Standard reduction using sodium borohydride was performed 
on 111 to give the racemic (±  )-l-(2-iodophenyl)-4,4-dimethylpentan-3-ol 112 as 
a pale yellow oil in 64% yield.
2 ,2 ,6 ,6 -tetramethyl 
heptane-3,5-dione, 
K2C 0 3, EtOH
4 9 % *
83 111
O R 1
-OTs
I(R2)2
N aB H 4 
 »
64%
Optical separation, 
O - functionalistion
4 6 - 7 0 %
[Ox]
R 1 : M e = 115 
Et = 116 
Bn = 117
O R 1
0- 6%
Scheme 3.16: Synthesis towards l-(hydroxy(tosyloxy)-iodo)2-((/?)-3-methoxy- 
4,4-dimethylpentyl)benzene.
Preparative HPLC was successful in separating the enantiomers of 112. 
The separation was possible using an OD column and a solvent ratio of 95% 
hexanes and 5% 2 -propanol. The retention times were 10 (R) and 16 (S) minutes 
(Figure 3.5).
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400
f *• II I
o . ' • -
0 10 20 
Mnum
Figure 3.5: HPLC chromatogram of (±  )-l-(2-iodophenyl)-4,4-
dimethylpentan-3-ol 112.
Simple alkylation o f the hydroxy group of (i?)-l-(2-iodophenyl)-4,4- 
dimethylpentan-3-ol 113 afforded the corresponding ethers (115-117) up to 70% 
yield as shown in Table 3.11.
Compound R 1 group Yield%
115 Me 70
116 Et 69
117 Bn 46
Table 3.11: Yield of alkyl ethers synthesised from the chiral alcohol (R)-113.
The oxidation of the ether precursors followed the pattern of the other 
pseudo 7-membered ring compounds. mCPBA only generated a trace of product 
and using the Koser reagent no product was observed. The yields obtained using 
sodium perborate and peracetic acid was again disappointingly low.
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O R1
O R 1
I(OAc)2
R 1 : Me = 118. 6% 
Et = 119, 5%
R 1 : Me =115
Et =116
Bn =117
I(OCOCF3)2
R 1 : Me = 120, 2%
Scheme 3.17: Oxidation o f iodoarenes 115-117 with peracetic acid and 
trifluoroperacetic acid.
Finally, using the urea hydrogen peroxide method, only the methyl 
substituted hypervalent iodine compound 1 2 0  was isolated, although traces of 
product were observed with the ethyl and benzyl precursors 116 and 117 (Table
Once again we were frustrated by the final step as the ligand exchange 
reaction failed to produce and o f the desired [hydroxy(tosyloxy)iodo]arenes. In 
each case, the reduced precursor molecules 115 and 116 were recovered 
quantitatively.
3.12).
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Compound R 1 Oxidant Conditions Product Yield %
115 Me 118 6
116 Et N a B 0 3-4H20 40-70°C , 24 h 119 5
117 Bn - Trace
115 Me 118 5
116 Et Peracetic acid or 40-70°C , 24 h 119 5
117 Bn A c20 ,  30% H20 2 - Trace
115 Me 120 2
116 Et UHP, CF3C 0 2H -65°C  to rt., 24 h - Trace
117 Bn - Trace
1 1 5 -1 1 7 mCPBA, AcOH 20-60°C , 2 4 -48  h - Trace
115-117 Koser reagent r.t., 48 h - 0
Table 3.12: Oxidative reagents used in the synthesis of the hypervalent
iodine(III) reagents.
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3.4 Conclusion
This chapter has covered the attempted synthesis of a wide range of 
pseudo 6 - and 7-membered ring chiral iodine compounds. The most common 
feature of these iodoarenes was the difficulty in oxidising them to the iodine(III) 
state. With the myriad o f oxidants available, the highest yield of hypervalent 
product was 89%. This excellent yield was achieved with compound 107, along 
with compound 106 returning an 87% yield using sodium perborate as the 
oxidant.
The novel UHP oxidation method had some success with the difficult 
chiral iodoarenes particularly compound 109, which was afforded in 59% yield. 
However, none of the [bis(acyloxy)iodo]arenes that were isolated were stable 
enough to undergo the ligand exchange step to yield the 
[hydroxy(tosyloxy)iodo]arene. In each case, the iodine(I) precursor molecule was 
recovered. This has implications in the application of this type of chiral 
hypervalent iodine compound. Currently, to be able to utilize the unique features 
offered with this type o f chiral hypervalent iodane, stoichiometric quantities are 
required for the functionalisation o f alkenes and ketones.
A possible reason for the lack o f oxidation may be related to the increased 
length of the chiral side chain. Compared to the pseudo 5-membered ring 
compounds previously studied by the Wirth group, the 6 - and 7-membered 
compounds have 1 and 2 extra carbon atoms respectively in the chiral chain. The 
extra rotation around these carbon carbon bonds could interfere with the 
formation of the hypervalent species. The chiral hypervalent compounds that were 
synthesised in very good yield and were stable at room temperature were 106,107 
and 109. These reagents contain two phenyl rings, so their stability may be due, in 
part, to 7c-stacking of the phenyl rings or quadrapole-quadrapole interactions. 
Either or both of these could reduce the ability of the carbon-carbon single bond 
to rotate and affect the oxidation process.
66
Chapter Three: Synthesis o f  Hypervalent Iodine Compounds
Overall, only five chiral hypervalent compounds were synthesised in 
sufficient quantities to allow further stoichiometric studies (63, 93, 106, 107 and 
109). The remaining chiral compounds, at present, could not be studied further. 
Chapter Four will describe the effectiveness of these chiral hypervalent 
precursors.
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Chapter 4
4 Reactivity of Chiral Hypervalent Iodine 
Compounds
4.1 Introduction
In this chapter, the reactivity o f the next generation chiral hypervalent 
iodine(III) reagents will be reported. As discussed earlier, there are several known 
procedures for the synthesis o f asymmetric centres using hypervalent iodine 
compounds and these methods were applied to the novel chiral iodine compounds 
as well as their precursors, to investigate their effectiveness as enantioinducing 
reagents.
4.2 Asymmetric Functionalisation of Alkenes and 
Ketones
The use of hypervalent iodine reagents in asymmetric synthesis can lead to 
useful synthetic intermediates. Previous work by the Wirth group produced chiral 
hypervalent reagents that yielded products with new chiral centres in good yield 
and modest selectivity. They developed optically active reagents to a-oxytosylate 
ketones and dioxytosylate alkenes. The research was initially based on chiral 
selenium electrophiles where they found that selenium cations, which are
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coordinated to the oxygen atom of a chiral alcohol, could perform addition 
reactions to various alkenes with high diastereoselectivities. 1 The formation of a 
pseudo 5-membered ring with a close proximity to the chiral centre and the 
selenium electrophile was found to be advantageous. The earlier chiral 
hypervalent derivatives were either chiral carboxylate derivative A or chiral
• • 2 3sulphonic acid adducts B (Figure 4.1). ’ The stereogenic centres in those chiral 
hypervalent compounds, were far away from the iodine atom. Therefore Wirth et 
al. planned the synthesis o f hypervalent iodine compounds, where the stereogenic 
centre was much closer to the iodine atom e.g. type C (Figure 4 .1) . 4
Figure 4.1: Early chiral hypervalent iodine compounds A, B and the Wirth
chiral reagent C.
The chiral hypervalent iodine compounds can be used as stoichiometric 
reagents in oxytosylation reactions o f alkenes and ketones. Therefore, they need 
to be accessible in a short scalable synthetic sequence. The synthesis of 
compounds of type C starts with the chiral alcohol 122. Compound 122 is 
commercially available or can be prepared by addition of diethyl zinc to 
benzaldehyde in the presence o f chiral catalysts (>98% ee) . 5 After ortho- 
lithiation6 of 1 2 2 , iodine can be introduced and the secondary alcohol then 
converted to the methyl ether 123. Iodine oxidation can be performed with sodium 
perborate in glacial acetic acid7 and leads to the (diacetoxyiodo)benzene 
derivative. Subsequent treatment with p-toluenesulphonic acid monohydrate 
yields the [hydroxy(tosyloxy)iodo]arene compound 124. Although the yield from 
the introduction o f iodine in 124 is only 40%, the subsequent formation of the 
ether and the synthesis o f the diacetate are reactions that proceed in very good
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yield. The hypervalent iodine compound 124 can be purified by crystallization 
and is obtained in 6 8 % yield (Scheme 4.1).
1. «B uE i. TM EDA
2 . U
l .N a B 0 3 H20 ,
AcOH
2. p-TsOH  
61%
122 123 124
Scheme 4.1: Synthesis o f Wirth chiral reagent 124.
Application o f this type o f reagent in the functionalisation of styrene 20, 
resulted good yields o f (R)~ 1,2-bis(tosyloxy)phenylethane 125 in up to 75%. The 
enantioselectivities observed using styrene 20 and reagents o f Type C was
o
between 13 and 65% ee. Scheme 4.2 shows that chiral reagent 124 yields 125 in 
2 1 % ee.
'OMe
OTs
•OTs124 HO "OTs
60%, 21 % ee1 eq TsOH  
C H 2C12, 25 °C
20
Scheme 4.2: Stereoselective dioxytosylation of styrene 20 with 124.
The a-oxytosylation o f propiophenone 46 is less efficient than the 
dioxytosylation of styrene 20. Scheme 4.3 shows that reagent 124 produces 15% 
ee of 126 although, up to 40% ee can be obtained with this type of reagent and the 
(/?)-l-phenyl-oxo-2-tosyloxypropane 126 was isolated in 35% yield. It is known 
that some ketones show low conversions in the reaction with the Koser reagent.9
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'OMe
124 HO 'O T s
OTs 27%, \ 5 % e e
12646
Scheme 4.3: Stereoselective a-oxytosylation of propiophenone 46 with 124.
During their work using the Koser reagent and its analogues in oxidative 
functionalisations, the Wirth group observed a dramatic increase of the reaction 
rate in the dioxytosylation reaction, after the addition of a catalytic quantity of 
/?TsOH-H20  to the reaction mixture o f the hypervalent iodine compound and the 
alkene. The reactions at room temperature were completed after approximately 4 
hours and can be performed even at -30°C . Only a small amount of the additional 
//TsOHThO dissolved in the reaction mixture. It was postulated that the Koser 
reagent (and its analogues) only partially dissociate in the dichloromethane and 
the additional /7-toluenesulphonic acid attacks the activated double bond . 10
4.2.1 Reactivity of Novel Chiral Hypervalent Iodine Reagents 
with Styrene
To allow us to investigate the effectiveness o f the new range of chiral 
hypervalent iodine reagents, we needed to generate 
[hydroxy(tosyloxy)iodo]arenes. As discussed in Chapter Three, it was only 
possible to isolate five hypervalent compounds in sufficient quantities to allow 
stoichiometric studies. Reagents 106 and 109 were based on the same iodine(I) 
precursor, therefore, only 106 was taken forward within these investigations. The 
four that were studied are shown in Figure 4.2.
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OM e
I (O A c )2
(S>63
OMe
O M e
' I ( O A c ) 2 
(S)-106
OEt
'I (O A c)2
(S)-107
Figure 4.2: Chiral iodine(III) reagents used in stoichiometric quantities.
With this in mind an alternative strategy was implemented. The 
(diacetoxy)iodoarenes were suspended in dichloromethane and 2  equivalents o fp- 
toluenesulphonic acid monohydrate was added portion-wise at room temperature. 
The resulting mixture was cooled to -30°C  (the initial test reaction was carried 
out at room temperature) and after 15 minutes freshly distilled styrene 20 was 
added dropwise (Scheme 4.4). After filtration through silica gel the solvent was 
removed under reduced pressure and the residue purified by flash chromatography 
on silica gel to yield 2-bis(tosyloxy)phenylethane 125 (Table 4.1).
1. 2 equiv /?TsOH-H20 .  
CH 2C12
OTs
I(OAc)2 2 ‘
R* OTs
Scheme 4.4: Synthesis o f (S)-l,2-bis(tosyloxy)phenylethane 125.
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Chiral Reagent Temperature
°C
Yield of 
125: %
ee of 125:
%CO'"'-I(OAc)2 25-3 0 5551 11 (R)14 W
cc!" * " 25-3 0 4849 9 (R) 11 (R)
ccro 25- 3 0 6770 10 (R)16 W
ccro'*-"” 25-3 0 7559 1 0 W  14 W
Table 4.1: Results o f dioxytosylation o f styrene 20 at room temperature and at
-30°C.
The results show good yields o f the dioxytosylated product (48-75%) but 
low selectivity (9-14% ee). As expected, the reaction performed at -30°C showed 
higher levels of asymmetric induction than those performed at room temperature, 
however, these were inferior to those obtained from the iodoarenes with a shorter 
chiral side chain e.g. 124.10
Although the [hydroxy(tosyloxy)iodo]arene products o f 63, 93, 106 and 
107 have not been isolated, it is proposed that they do form when the 
(diacetoxy)iodoarene is stirred in the presence o f toluenesulphonic acid. The 
reaction of (S)-configured compounds 63, 93, 106 and 107 with 2 equivalents of 
//TsOHFhO and styrene 20, yields the dioxytosylate 125 with (/^-configuration. 
This corresponds to a Re facial attack of styrene as seen in the intermediate 127 
and 128. (Figure 4.2). The diastereomeric intermediate 127 (Figure 4.2) can 
possibly benefit from ^--stacking but is assumed to be higher in energy, analogous
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to the calculations performed in the Wirth group for the corresponding 
seleniranium ions. 11
127 Re attack 128
Si attack
Figure 4.2: Possible intermediates 127-130 in the attack of chiral hypervalent
reagent 63 on styrene 20.
A possible way to determine whether 127 is an intermediate would be by 
altering the electronics of the iodoarene ring. Placing an electron donating 
substituent (methoxy or amine group) on the iodoarene ring would effectively 
increase the electron density o f the ring and aid the n -n  interaction. The greater 
the 7r-orbital overlap, the more attracted the two aromatic rings will become. The 
net result of this should be an observed increase in the stereoselectivy of the 
dioxytosylated product. This would increase the likelihood of the tosylate 
nucleophile attacking from the anti side. Conversely, by introducing an electron 
withdrawing substituent, one would expect to see a decrease in asymmetric 
induction.
This effect has been investigated by the Wirth group, and they observed an 
increase in selectivity when a methoxy group was introduced in the second ortho 
position of the iodoarene ring 131 (Figure 4.3). This evidence leads toward 
intermediate 127.
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Figure 4.3: Comparison o f ee o f (7?)-125 when chiral iodanes (S)-121 and (S)-
131 are used to dioxytosylate styrene 20.
To further investigate whether it is in fact 127 or 128 we could increase 
the steric demand of the styrene moiety. Introducing methyl groups onto both 
ortho positions of the styrene ring would increase the steric requirements of the 
ring and intermediate 128 may be favoured over 127.
Scheme 4.5 proposes the possible origin o f the sense of asymmetric 
induction observed within these transformations. It is believed that 63 forms the 
[hydroxy(tosyloxy)iodo]arene intermediate 63a upon the addition of /?Ts0 H H 2 0 . 
Intermediate 63a subsequently undergoes electrophilic addition with styrene 20 to 
form the activated heterocyclic intermediate 127. The attack of the tosylate anion 
occurs from the anti-side. The activated heterocyclic intermediate 127, shields the 
syn face of the intermediate, directing the nucleophile to add from the anti face. 
The second tosylate anion attacks intermediate 132 from the anti side to give 125, 
with the leaving group being the reduced chiral iodine(I) precursor 58.
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OMe
I(OAc)2
/>TsO H H 20
H < /  OTs OTs
63 63a 127
pTsOH-H20
O Ts
- ( OH)
OTs J
58 132
Scheme 4.5: Proposed mechanism o f the dioxytosylation of styrene 20 with 63.
4.2.2 Reactivity of Novel Chiral Hypervalent Iodine Reagents 
with Propiophenone
The second model reaction examined was the a-oxytosylation of 
propiophenone. Analogous to the stoichiometric reaction with styrene, only chiral 
reagents that have been oxidised to the hypervalent state can be used to a- 
oxytosylate ketones.
I(OAc)2
1. 1 equiv /?T s0H -H 20 ,  
CH 2C12
O
Scheme 4.6: Synthesis o f (S)-l-phenyl-oxo-2-tosyloxypropane 126.
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This reaction, like the dioxytosylation of styrene, was only studied with 
four of the hypervalent compounds that were prepared in Chapter 3
The (diacetoxy)iodoarenes were suspended in dichloromethane and 1 
equivalent of / 7-toluenesulphonic acid monohydrate was added portionwise at 
room temperature. The resulting mixture was cooled to 0°C and after 15 minutes 
propiophenone was added dropwise (Scheme 4.6). After filtration through silica 
gel, the solvent was removed under reduced pressure and the residue purified by 
flash chromatography on silica gel to yield (S)-1 -phenyl-oxo-2-tosyloxypropane 
126 (Table 4.2).
Chiral Reagent Temperature °C Yield of 
126: %
ee of 
126: %ccr\«I(O Ac)2 25
0
76
76
3(5)
5(S)
25
0
6 6
60
2(5)
3(5)
ccro®- 250 7074 9(5)12(5)
ccfo®'*’ 250 6757 7(5)9(5)
Table 4.2: a-Oxytosylation o f propiophenone 46 at room temperature and at
-30°C
The results highlight a decrease in selectivity when the chiral chain length 
increased from a 6 - to 7-membered ring. This is observed in the enantioselectivity 
of product 126 in reactions using reagents 63 (5% ee) and 93 (3% ee). However, 
the introduction o f a phenyl group at the terminal position of the side chain in
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reagent 106 has increased the chiral induction to the substrate providing the 
oxytosylated product in 1 2 % ee.
The a-oxytosylation o f propiophenone is a little more complicated than 
the dioxytosylation o f styrene. Both Koser (A) and Moriarty (B) have proposed 
mechanisms for this transformation and it is not clear which pathway is favoured. 
Both mechanisms are plausible and the low enantiomeric excess could be the 
result of the following:
The enol formed in Mechanism A can be either of Z  or E  configuration. If 
transition state 134a with the enoxy iodane in the Z  configuration was present, the 
dehydration step would be followed (via an Sn2  type reaction) by a nucleophilic 
attack of the tosylate ion on the Sz-face to give the {K)-A1. But if  the E  enoxy 
iodane formed 134b, then the tosylate nucleophile would attack from the Re-face 
to generate the (S)-126. In addition to this, the hypervalent leaving group is 
attached to the oxygen o f the enol, and this single bond can undergo free rotation. 
Subsequently, the chiral iodine moiety can move and this is not necessarily 
directing the tosylate nucleophile to one face, resulting in low enantioselectivities 
(Scheme 4.7) . 912
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Mechanism A
Scheme 4.7: Possible transition states during Mechanism A.
A similar problem is occurring during Mechanism B. The electrophilic 
addition of the iodine(III) reagent to the enol will determine the stereochemistry 
of the final product. Presently, we have no direct control over which face the 
addition will occur on. The electrophilic attack of the iodine(III) reagent to the Z  
enol would occur on the Re-face and direct the incoming tosylate nucleophile to 
attack from the Si-face leading to (R)-41. Whereas, attack on the E  enol will occur 
on the Si-face and lead the tosylate nucleophile to attack form the Re-face, to also 
give the (R)-41 (Scheme 4.8) . 13
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Mechanism B
Scheme 4.8: Possible transition states during Mechanism B.
If mechanism B takes place then you would expect the final product to 
have good enantiomeric excess. The configuration o f 136a and 136b are the same, 
and would therefore lead to predominantly one enantiomer (R)-47. This is not 
observed in the results. It is possible the that propiophenone substrate is simply 
not a good molecule to monitor the effectiveness o f these iodine(III) compounds 
as chiral transfer reagents. Further research will need to be done to identify 
suitable substrates to demonstrate usefulness of the chiral iodine(III) compounds.
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4.3 Catalytic Use of Chiral Hypervalent Iodine 
Compounds
Hypervalent iodine compounds can be used in many synthetic reactions to 
generate new chiral centres. Until recently, stoichiometric quantities and often an 
excess of the iodine(III) reagents were required to achieve the desired 
transformation. The driving force of these reactions was the reduction of the 
hypervalent iodine to the univalent iodine species, in the reductive elimination 
step. As previously stated, the stoichiometric quantities required for the oxidation 
reaction, produce equimolar quantities o f aryl iodides as a waste product. Several 
publications have shown that it is possible to use a catalytic amount of an iodine- 
containing molecule with a stoichiometric quantity of oxidant and they have 
recently been reviewed. 14,15 The oxidant generates a hypervalent species in situ, 
and after the key bond forming reaction, the reduced aryl iodide can be re­
oxidised. A proposed catalytic cycle is shown in Scheme 4.9.
Substrate
Oxidising
agent
Product
Scheme 4.9: Catalytic cycle with hypervalent iodine compound, where L = OTs,
OH, OAc, OR, OCOCF3.
Key to the successful catalytic application of hypervalent iodine 
compounds is the selective oxidation o f the aryl iodide in the presence of the 
substrate. The oxidising agent must be carefully chosen to achieve this selective 
oxidation. Known oxidants used in the preparation of hypervalent iodine 
compounds include sodium perborate, peracetic acid and hydrogen peroxide. 
Recent work reported by Kita et al. show the use of mCPBA as an oxidant in the 
synthesis of novel recyclable adamantane-based hypervalent reagents. 16 As a
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follow up to this, the same research group reported the use of catalytic quantities 
of iodine(III) reagent in the spirocyclisation of phenol derivatives 137. Only 5 
mol% iodotoluene is used together with 1.5 equivalents of mCPBA and 1 
equivalent of trifluoroacetic acid to give spirocyclisation to lactones 138 in 6 6 -  
91% yield (Scheme 4.10) . 17
OH
R
137
5 mol %, 4-M eC 6H4I 
1.5 equiv mCPBA  
1 equiv CF3C 0 2H
CH2C12. RT 
(9  exam ples, 
66-91%  yield)
Scheme 4.10: Spirocyclization o f phenol derivatives 137 with a catalytic amount 
of 4-iodotoluene.
An established reaction involving hypervalent iodine reagents is the a- 
oxygenation of carbonyl compounds. Ochiai et al. reported the first catalytic a- 
acetoxylation of ketones, where (diacetoxyiodo)benzene acts as the catalytic
to
oxidant of ketones with wCPBA as the terminal oxidant. To give the a- 
acetoxylated ketones, two additional reagents were required. Firstly, 3 equivalents 
of boron trifluoride diethyl etherate (BF3 -O Et2) were added to induce enolization 
o f the ketone. No enolization was observed in the absence of the Lewis acid. 
Secondly, 5 equivalents o f water were essential for the reaction to proceed, as 
without the addition o f water, the a-oxidation was slow with over 95% of the 
ketone recovered. The reaction was carried out in acetic acid to give the a- 
acetoxylated ketones in moderate yields (43-63%). A proposed catalytic cycle for 
this reaction is shown in Scheme 4.11. Without the iodoarene, no product was 
observed. This confirmed that the iodoarene was essential for the a-oxidation of 
the ketone. Also, the use o f 10 mol% iodoarene was necessary to afford the 
desired product. Using only 5 mol% significantly slowed down the reaction, 
allowing the formation o f the Baeyer-Villiger product in 38% yield.
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O
Ar'
O
A Me
BF3 (O Et)2
A c
Phl(III)
wCPBA
mCBA
Scheme 4.11: a-Acetoxylation o f ketones using catalytic quantities of 
hypervalent iodine compounds.
As an extension o f this reaction, Togo et al. used /?-toluenesulphonic acid 
in acetonitrile, instead o f acetic acid, to synthesise a range of a-oxytosylated 
ketones (Scheme 4.12) . 19
Scheme 4.12: Arl-catalysed a-oxytosylation of acetophenone 139 with wCPBA 
and pTsOH-ThO.
They found that the use o f boron trifluoride diethyl etherate was not 
necessary to generate the enol exclusively, as the [hydroxy(tosyloxy)iodo]benzene 
(prepared in situ) can react with the small amount of enol tautomer present to 
provide the a-oxytosylated ketone 140. Additionally, water was also not 
necessary as the reaction proceeds in acetonitrile. The yields obtained in these 
reactions were very good, ranging from 52-89%. Their proposed catalytic cycle is 
shown in Scheme 4.13.
pT sO H  H20 ( l . l  eq)
o
Phi (1 0  mol% ) 
/wCPBA (1.1 eq) O
139 140
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mCPBA.
mCBA
Phi
OH
P h— I I
OTs
OTs
OH O
Scheme 4.13: Proposed reaction pathway for Phi-catalysed a-oxytosylation of 
ketones.
After completion o f this work, Kita et al. published work on a new type of 
iodoarene catalyst that had a rigid spirobiindane backbone 141. They have shown 
that the rigidity maintains the chiral environment around the iodine(III) atom, and 
it is this that results in high asymmetric induction. They have succeeded in 
synthesising a range o f chiral a-hydroxy ketones by oxidising alkyl naphthol 
derivatives using catalytic quantities o f the iodoarene 141, as shown in Scheme 
4.14. The a-hydroxy ketones 143 have been isolated in yields up to 8 6 % and up to 
8 6 % ee, at 0°C .20
141
0.15 equiv. (R)
-►
8 6%, 86% ee BnBn
CH2C12, 0°C
142 3 h 143
Scheme 4.14: Catalytic dearomatisation o f phenols using spirobiindane iodoarene 
141.
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Subsequently, the use o f hypervalent iodine compounds in catalytic 
reactions represents a very exciting prospect indeed. As discussed in Chapter 
Three, many o f the chiral hypervalent compounds whose synthesis has been 
attempted, could not be investigated due to the difficulties encountered in the 
oxidation. Those that were oxidised to the diacetoxy or trifluoroacetoxy arene, 
failed to yield the corresponding [hydroxy(tosyloxy)iodo]arenes through ligand 
exchange. This step essentially reduced the hypervalent species to its non- 
hypervalent precursor. However, the advent of catalytic reactions provided us 
with the opportunity to circumvent this problem. If the hypervalent species could 
be prepared in situ allowing the electrophilic addition to occur in this one pot 
reaction, isolation o f the hypervalent compound would not be necessary. The 
following sections report the results found using the enantiopure iodine 
compounds in catalytic reactions.
4.3.1 Catalytic a-Acetoxylation of Ketones with Chiral Iodine 
Reagents
The synthesis o f the hypervalent precursor shown in Figure 4.3, was 
carried out over 5 steps (where n = 1) and 3 steps (where n = 2).
Figure 4.3: Novel chiral hypervalent precursor.
All of the precursors were obtained in excellent yields from the 
corresponding chiral alcohols. The shorter chain iodoarene precursors (n = 1) 
were synthesised in yields ranging between 55-96%, and the longer chain 
precursors (n = 2) were isolated between 58-96% yield.
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As the stoichiometric reactions using these compounds were severely
1 o
limited, the novel catalytic a-acetoxylation reaction developed by Ochiai offered 
a possible route to utilize the unique properties of the unisolable hypervalent 
iodine species. The generation o f any a-acetoxylated product would serve as 
proof that these compounds were being oxidised to the hypervalent state. With an 
array of enantiopure hypervalent iodine precursors already prepared, this was an 
excellent opportunity to investigate their synthetic utility.
4.3.1.1 Reactivity of Pseudo 6-Membered Chiral Iodanes
As described in Chapter Three, a wide range of different hypervalent 
precursors had been prepared. Our primary focus was to determine whether any 
hypervalent product could be formed within a catalytic cycle. Initial reactions 
were performed by reacting propiophenone 46 to a catalytic amount (10 mol%) of 
chiral iodoarene, dry wCPBA (1.4 equiv) in acetic acid, BF3 'O Et2 (3 equiv) and 
water (5 equiv) at room temperature under argon. Yields of 1 -phenyl-oxo-propan- 
2-acetate 144 synthesised from iodoarene precursors as shown in Scheme 4.15 are 
shown in Table 4.3.
0 ^d2
0.1 eq
+ m CPBA
1.4 eq OAc
144
+ Phi
Scheme 4.15: Arl-catalysed a-acetoxylation of propiophenone 46 with mCPBA, 
BF3 'OEt2 and water.
The results obtained in the catalytic reaction suggest that these aryl iodides 
were oxidised to the hypervalent state. If the iodoarene was omitted from the 
reaction mixture, no a-acetoxylated product was observed. Even though the yields 
were only modest, this presented an important result. To determine whether any
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transfer o f chiral information had occurred, the enantiomeric excess of the 
acetoxylated product 144 was determined by HPLC. As expected, the traces 
showed that the racemic product had in been synthesised. This was not surprising, 
as the selectivity observed with the stoichiometric a-oxytosylation reactions occur 
because the oxygen o f the chiral side chain coordinates to the iodine atom, 
effectively replacing the oxygen o f the tosylate moiety as shown in Figure 4.4.
►=-0
Figure 4.4: A [hydroxy(tosyloxy)iodo]arene and a (diacetoxy)iodoarene.
This is not the case with diacetoxy iodoarenes. 10 Here, the iodine is 
hypervalently bound to two acetoxy ligands where the carbonyl oxygen’s 
coordinate the iodine atom. This decreases the interaction o f the oxygen of the 
chiral side chain from the ensuing reaction, resulting in the racemic product 
observed.
Reagent R 1 R2 Yield of 144: %
58 Me Me 53
59 Me Et 45
60 Me Bn 46
61 Me COCF3 0
61 Me lBu 1 2
69 Ph Me 41
70 Ph Et 37
71 Ph Bn 29
Table 4.3: Catalytic a-acetoxylation of propiophenone 46.
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4.3.1.2 Reactivity of Pseudo 7-Membered Chiral Iodanes
In Chapter Three the preparation of a range of hypervalent iodine 
precursors based around a pseudo 7-membered chiral ring structure was also 
discussed. As observed with the psuedo 6 -membered range of iodoarenes, this 
type of hypervalent precursor also encounted problems when attempting to 
prepare hypervalent derivatives. The results in Table 4.4 show the yield of 1- 
phenyl-oxo-propan-2-acetate 144 when this type o f chiral hypervalent precursor 
was used within the catalytic a-acetoxylation reaction (Scheme 4.16).
/R 2o
OAc
+■ m CPBA  ► II I I + Phi
e£*
0-1 eq 2) H20  5 eq 144
Scheme 4.16: Arl-catalysed a-acetoxylation of propiophenone 46 with mCPBA, 
BF3 'OEt2 and water.
Reagent R 1 R2 Yield of 144: %
88 Me Me 55
89 Me Et 50
90 Me Bn 39
91 Me COCF3 0
92 Me lBu 15
103 Ph Me 57
104 Ph Et 45
105 Ph Bn 44
115 lBu Me 30
116 lBu Et 32
117 'Bu Bn 27
Table 4.4: Catalytic a-acetoxylation of propiophenone 46.
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Encouragingly, the results indicated that a hypervalent species was being 
produced in the majority o f the examples. The only precursor not to give any 1- 
phenyl-oxo-propan-2-acetate 144 was chiral reagent 91 which had a 
trifluoroacetate moiety attached to the oxygen of the chiral carbon (Figure 4.6). In 
this case the iodine(I) precursor was not recovered and a decomposition product 
was formed.
91
Figure 4.5: The unsuccessful trifluoroacetoxy iodoarene 91.
Again, the important factor is the generation of the a-acetoxylated product 
and not the modest yields. The results from this reaction did not yield any 
enantiomerically enriched ketone, but it served as an indicator to the proposed 
generation of a hypervalent iodine species.
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4.3.1.3 Reactivity of Chiral Sugar Based Iodoarenes
During 2005, several chiral sugar based hypervalent precursors were 
prepared by Dr Christian Becker (Figure 4.6) . 21 Becker synthesized compounds 
145-151 through the introduction of an aryl iodide moiety onto a chiral sugar 
backbone.
146145
AcOA cO
OAcO A c
147 148
HOHO
OHOH
149 150
BnOBnO
OBnO Bn
O M e
1 /O M e
151
Figure 4.6: Chiral sugar derived hypervalent precursors 145-151.
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0.1 eq
t w C PB A
1.4 eq OAc
144
A cO H , r.t., 24h
+ Phi
Scheme 4.17: Sugar based iodoarene-catalysed a-acetoxylation of 
propiophenone 46 with mCPBA, BF3 'OEt2 and water.
The yields of the iodine(I) precursor compounds were good, but oxidation 
to the hypervalent state proved elusive. Several oxidative methods were examined 
with these chiral iodoarenes, but no hypervalent products were observed. 
Following on from the successful catalytic reactions, it was decided to use these 
chiral iodoarenes in the a-acetoxylation o f propiophenone (Table 4.5).
Chiral sugar reagent Yield of 144: %
145 5
146 15
147 4
148 5
149 9
150 46
151 0
Table 4.5: Catalytic a-acetoxylation o f propiophenone 46 using chiral sugar
based iodoarenes 145-151.
The success o f these unusual chiral compounds was mixed. The majority 
of them produced modest yields o f the a-acetoxylated product 144, with 150 
affording 46% of a-functionalised propiophenone. The only derivative that failed 
to produce any product was compound 151. This compound differs slightly in that 
the iodoaryl group was not attached to an acetal but a single benzylic oxygen
92
Chapter Four: Reactivity o f  Hypervalent Iodine Compounds
atom. The free rotation available here could possibly be interfering with the 
oxidation process.
4.3.1.4 Reactivity of Chiral Ether Iodoarenes
Another avenue o f chiral hypervalent reagents pursued in the Wirth group 
is shown below (Figure 4.7).
R M e - 152 
Et - 153 
Bn - 154
Figure 4.7: Ether based chiral hypervalent iodine compounds 152-154.
This type of reagent was devised in collaboration between Dr French and 
Professor Wirth during Dr French’s sabbatical year in Cardiff. The synthesis of 
the chiral hypervalent precursor was realized in only 2  steps.
OH
155
O
pF
K2CO3
DM F, 60°C
156
Ph
OH
157
NaH, RI or RBr
DMF, 0°C
R =  M e - 152 (92% ) 
Et - 153 (81% ) 
Bn - 154 (74% )
Scheme 4.18: Two-step synthesis o f chiral ether iodoarenes 152-154 from 2- 
iodophenol 155 and (*S)-phenyloxirane 156.
The synthesis begins with a chiral epoxide opening using potassium 
carbonate in dimethyl formamide and the phenol 155. Subsequent alkylation with
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an alkyliodide or alkylbromide gave the chiral aryl iodides 152-154 (Scheme 
4.18).
o-
0.1 eq
OR
+ m CPBA  
1.4 eq OAc
144
+ Phi
Scheme 4.19: Chiral ether iodoarene-catalysed a-acetoxylation of 
propiophenone 46 with raCPBA, BF3 'OEt2 and water.
With the ongoing problems associated with oxidation of these chiral 
reagents, these ethers represented ideal candidates to apply within the catalytic 
reaction (Scheme 4.19). The results obtained are outlined in Table 4.6.
Chiral ether reagent Yield of 144: %
152 55
153 19
154 25
Table 4.6: Catalytic a-acetoxylation o f propiophenone 46 using chiral ether
iodoarenes 152-154.
While the yields o f the acetoxylated product were only modest (19-55%), 
it was clear that these ether containing iodoarenes were active catalysts and were 
being oxidised to the hypervalent state. This was again good news and further 
research with this type o f iodoarene is ongoing.
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4.3.2 Catalytic a-Oxytosylation of Ketones with Chiral Iodine 
Reagents
The relative success in obtaining the a-acetoxylated ketones provided 
good evidence towards the formation of a hypervalent species. A natural 
progression from this was to find a way o f using these reagents. The logical step 
was to try and prepare the [hydroxy(tosyloxy)iodo]arene in the one-pot catalytic 
reaction. Further research led onto work by Togo et a l}9 As mentioned 
previously, they used a stoichiometric quantity of //TsOHFhO and awCPBA with 
1 0  mol% of the hypervalent precursor in acetonitrile to generate the a- 
oxytosylated ketone (Scheme 4.12). Most notably in this case was the omission of 
the additives borontrifluoride diethyl etherate and water. The 
[hydroxy(tosyloxy)iodo]arene can react sufficiently well with the enol form of the 
ketone in acetonitrile to provide the a-oxytosylated ketone.
Initial reactions were performed with several iodoarenes, which were
•  'J'Xoriginally synthesised by Hirt, a previous researcher in the Wirth group. These 
iodoarenes were chosen as they could be oxidised in sufficient quantities to enable 
studies of the stoichiometric reaction with propiophenone. The only difference 
between the stoichiometric and catalytic reaction was the temperature. From early 
studies on the stoichiometric process, it was determined that the optimum 
temperature for the a-oxytosylation reaction was 0°C, as this temperature gave 
the highest enantioselectivity. Catalytic studies at this temperature revealed that 
the reaction proceeded very slowly and these results were consistent with those of 
Togo. 19 As the ligand exchange was slow at this temperature, these results 
suggested that the rate determining step of the catalytic cycle was the oxidation to 
the hypervalent iodine(III) state. With this in mind we opted to perform the 
reactions at room temperature, allowing them to run for up to two days to ensure 
maximum conversion.24
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10 mol% Ar*I, 1.5 eq mCPBA  
 1
1.1 eq /?T sO H H 20 ,  M eCN, r.t., 48 h
Scheme 4.20: Catalytic a-oxytosylation reaction with a range of enantiopure 
iodoarenes.
Reagent23 Reaction type Temp.
°C
Yield of 
126:%
ee of 126:
%
(*S)-158
OM ecc Stoichiometric
Catalytic
0
25
70
6 8
15 (5) 
1 2  (S)
OM e
Stoichiometric 0 65 28 (S)
(S)-159
U L ,
Catalytic 25 59 27 (S)
OMe
Y Y ^
Stoichiometric 0 57 29 (S)
(£)-160
Y n
OBn Catalytic 25 50 25 (S)
OM e
Y Y ^
Stoichiometric 0 1 0 11(5)
(iS)-161
T ' 1
O'Bu Catalytic 25 9 3(5)
Table 4.7: Comparison o f results from stoichiometric and catalytic a-
oxytosylation o f propiophenone 46 in dichloromethane.
The results obtained at room temperature from the catalytic reaction show 
the expected relationship to those found at 0°C in the stoichiometric reaction
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when performed in dichloromethane (Table 4.7). In most cases both isolated 
yields and levels o f asymmetric induction were similar. This catalytic method 
therefore represents a significant improvement on previous results with the group.
4.3.2.1 Reactivity of Novel Chiral Hypervalent Precursors
The catalytic a-oxytosylation reaction allowed us to examine the 
effectiveness of our novel hypervalent precursors, which up until now had 
remained redundant. The reactions were performed by treating 0.5 mmol of 
propiophenone in acetonitrile with 10 mol% iodoarene, 1.5 equivalents of 
commercial /wCPBA (dried in a desicator for 24 hours) as the stoichiometric 
oxidant and 1.1 equivalents o f //TsOH-ThO as the tosylate nucleophile (Scheme 
4.21). The reaction was performed at room temperature to afford either (R)-41 or 
(iS)-126 in yields between 51-76%  (Table 4.8).
10 mol%  Ar*I, 1.5 eq mCPBA 1
1.1 eq /? T s0 H  H 20 ,  M eCN , r.t., 48 h
46
Scheme 4.21: Catalytic a-oxytosylation reaction with a range of enantiopure 
iodoarenes.
In all cases the tosylated propiophenone product was observed. The yields 
of l-phenyl-oxo-2 -tosyloxypropane were good, but the levels of asymmetric 
induction from these extended chiral iodoarenes was poor. To improve the 
transfer of chiral information the temperature could be lowered to 0°C. However,
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as seen in the stoichiometric reactions the reaction rate reduces, therefore, this 
opportunity was not examined.
Chiral iodoarene Number R1 R2 Yield of 
Product: %
ee %
(5)-58 Me Me 76 3 (5)126
(5)-59 Me Et 74 2 (5)126
fY Y R' (5)-60 Me Bn 74 2 (5)-126
OR2 (5)-69 Ph Me 64 5 (5)126
(5)-70 Ph Et 54 3 (5)126
(l?)-77 'Pr Me 58 3 (10-47
(5)-88 Me Me 6 6 2 (5)-126
(5)-89 Me Et 59 1 (5)-126
OR2Y (5)-90 Me Bn 51 2 (5 )126
(5)-92 Me lBu 57 2 (5)126
(5)-103 Ph Me 70 9 (5)126
(1?)-115 lBu Me 56 3 (10-47
(10-116 *Bu Et 55 1 (10-47
Table 4.8: Catalytic a-oxytosylation o f propiophenone 46 using novel chiral
hypervalent precursors.
The yields observed in the catalytic a-oxytosylation of propiophenone 
were very good, but the enantioselectivities were low. Reagents 69 and 103 with a 
phenyl moiety in the terminal position o f the chain R 1 gave the highest
'j
selectivities, of 5% and 9% respectively. A methyl group in the R position 
appears to have a greater influence that either an ethyl or benzyl moiety. The latter 
pattern shows good correlation with earlier work in the Wirth group. 10
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4.3.2.2 Reactivity of Alternate Novel Chiral Hypervalent 
Precursors
The range o f aryl iodides prepared by the Wirth group that also 
encountered oxidation problems in the preparation of hypervalent iodine reagents 
were also examined in the catalytic a-oxytosylation trials (Figure 4.8).
146
AcO
O A c 151
O
O 149 O
BnO
0
O
OBn
OMe
O.
O 
BnO OBn
O M e
OMe
(5)-152
O
(5 )163
O M e
(+)-164
Figure 4.8: Alternate chiral hypervalent precursors examined in the catalytic
a-oxytosylation o f propiophenone 46.
The chiral sugar based iodoarenes synthesized by Becker, the chiral ether 
based iodoarenes derived from styrene epoxide developed by French and several
other iodoarenes were tested (Scheme 4.22). 21,22
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10 mol% Ar*I, 1.5 eq mCPBA
1.1 eq /?TsOH-H20 ,  M eCN, r.t., 48 h
Scheme 4.22: Catalytic a-oxytosylation reaction with a range of enantiopure 
iodoarenes.
Each one o f the chiral precursors was subjected to the same reaction 
conditions as those described section 4.3.2.1 and the results obtained are shown in 
Table 4.9. The chiral sugar based iodoarenes showed poor product yields even 
though they were left to react for an extended period (~90 hours) and very little 
transfer of chiral information resulted, as shown by the low levels of 
enantioselectivity obtained. This was possibly due to the distance of the iodine 
atom from the chiral sugar moiety.
Reagent Yield of Product: % ee %
145 1 0 1 (5)-126
146 17 0
147 11 2  (5)-126
149 5 1 (5)-126
151 19 1 (70-47
(5 )152 75 25 (R)-47
(5)163 91 3 (tf)-47
(+)-164 75 1 (7?)-47
Table 4.9: Catalytic a-oxytosylation of propiophenone using alternative chiral
hypervalent reagents.
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Surprisingly, the chiral ether iodoarene derived from styrene oxide (S)-152 
resulted in excellent conversion and modest enantioselectivity of (/?)-l-phenyl- 
oxo-2-tosyloxypropane (R)-41. The product was isolated in 75% yield and 25% 
ee. This particular result is promising as the hypervalent precursor was 
synthesized in only two steps. The iodoarene derived from propylene oxide (S)- 
163 gave a good yield o f the tosylated product but resulted poor enantioselectivity 
within the product. The difference between these results can be attributed to the 
terminal group on each o f the chiral chains. The phenyl group is far larger than the 
methyl group, which could aid directing the nucleophile, but it is also possible 
that there was some degree o f n -stacking o f the phenyl rings. This would lead to 
increased conformational rigidity and higher enantioinduction. Finally, the 
iodoparacyclophane derivative (+)-164 gave very good yields of tosylated 
product, but with no discemable selectivity.
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4.4 Conclusion
In this Chapter we have investigated the reactivity of the next generation 
‘Wirth chiral reagent’. Their potential use is widespread with environmental 
benefits over their heavy metal alternatives. As seen in Chapter Three, many of 
these hypervalent precursors will not oxidise to a stable (diacetoxy) or 
bis(trifluoroacetoxy)iodoarene. This o f course is a very big issue. Until now, 
stoichiometric quantities o f the hypervalent compound had been required to afford 
new stereogenic centres. The application of chiral reagents 63 and 93 in the 
dioxytosylation of styrene at -30°C , afforded 1,2-bis(tosyloxy)phenylethane in 14 
and 11% ee respectively. These ee’s are lower than the result obtained using the 
smaller chained ‘Wirth’ type iodoarene 124 (15% ee). With each carbon that was 
added to increase the chain length comes a greater degree of free rotation about 
the carbon-carbon bonds. The interaction o f the oxygen atom on the chiral chain 
with the iodine atom therefore decreases as the chain increases. This results in a 
decrease in enantioselectivity o f the a-oxytosylated propiophenone product 126.
Although the results were disappointing, the replacement of the terminal 
methyl group with a phenyl group increased the selectivity obtained within the 
product. This is shown in the results obtained from reagents 106 (16% ee) and 107 
(14% ee). Whether this is due to the greater size or because there is an element of 
7i-stacking, involved between the two aromatic rings, will only be determined 
through further investigation.
With the advent o f a catalytic acetoxylation and more importantly the 
catalytic a-oxytosylation reactions, we continue to have an avenue to test the 
‘Wirth’ type reagents. These reactions have allowed us to observe the potential of 
these reagents and study their asymmetric induction with in ketone 
functionalisation. Further work is necessary to develop reagents that reduce the 
flexibility o f the chiral chain, to increase the transfer o f chiral information.
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Chapter 5
5 Oxidation to the Hypervalent state
5.1 Introduction
In this chapter, the oxidation o f iodoarenes will be reported. After a brief 
overview of the literature o f known procedures for the oxidation of iodoarenes to 
X -iodanes and X -iodanes, the new methodology developed to prepare 
[bis(trifluoroacetoxy)iodo]arenes will be discussed.
Following Willgerodt’s work in the late part of the 19th century, the 
synthetic organic chemist has developed a multitude of hypervalent iodine 
compounds. 1 By the mid 1950’s they numbered 426, as catalogued by Beringer 
and Gindler.2 Today, there are too many hypervalent iodine compounds to 
document in full but the majority o f them belong to well-defined families.
Methods for the preparation o f hypervalent iodine reagents that have been 
developed vary considerably but there are several reliable methods that are 
consistently used. A publication by Varvoglis in 1992 listed an extensive range 
of preparative methods for individual compounds and another in 1997 gave more 
selective methods o f preparing these compounds.
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The general approach for the preparation of the most common hypervalent 
iodine compounds involves initial oxidation of iodine(I) to iodine(III) or (V). This 
requires the correct choice o f strongly electrophilic reagent as well as conditions 
which will lead to the formation of either one, for iodine(III), or two, for 
iodine(V) hypervalent bonds.
It is possible, in principle, to oxidise both aryl iodides and alkyl iodides, 
although the products from alkyl iodides are considerably more unstable than their 
aryl counterparts. O f practical importance are hypervalent iodine compounds with 
halides (chloride, fluoride) and acetoxy or trifluoroacetoxy groups as ligands.
The following sections present the most common synthetic methods for 
preparation of hypervalent iodine compounds. Sectionalised into the type of 
ligands attached to the iodine.
5.2 Iodanes with One Iodine-Carbon Covalent Bond
Iodanes with on iodine-carbon covalent bond includes 
(dichloroiodo)arenes and (difluoroiodo)arenes along with compounds that contain 
iodine-oxygen bonds, for example, (diacetoxy)iodobenzene 6 , Koser reagent 15, 
Dess-Martin periodinane 29, iodosobenzene 7 and o-iodoxybenzoic acid 24.
The conditions required for the initial oxidation of an iodoarene to the 
hypervalent state, usually requires a powerful oxidant. However, many 
hypervalent iodoarenes are prepared through ligand exchange reactions. The 
conditions in these reactions are particularly mild, since no or little heating is 
required, protection from daylight is not necessary, and the use of an inert 
atmosphere is rarely mandatory.
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5.2.1 Iodanes with Iodine-Chlorine hypervalent bonds
Willgerodt prepared the most useful iodanes with iodine-chlorine 
hypervalent bonds in 1886.4 The method, which is still used, relies upon the direct 
combination of elemental chlorine with the corresponding iodide (Scheme 5.1). 
The usual procedure is to dissolve the iodoarene 2 in a suitable solvent, preferably 
chloroform or dichloromethane, and passing chlorine gas through this solution at 
0°C:
Scheme 5.1: Willgerodt’s synthesis o f (dichloroiodo)benzene 3.
This method has been applied to the large-scale preparation o f PhlC^ 
where it was obtained in 94% yield starting from 20 kg of iodobenzene.5 In order 
to avoid the use of elemental chlorine, its generation in situ can be effected by 
oxidation with hydrochloric acid and sodium perborate tetrahydrate in acetonitrile 
or tetrachloromethane (possible carcinogen, largely removed from educational and 
industrial laboratories) at room temperature. Although most aliphatic analogues 
are unstable, (dichloroiodo)perfluoroalkanes are stable. In order to prepare such 
compounds only chlorine is necessary without any solvent and the reaction takes 
place at low or room temperature .6 A more recent publication describes the 
oxidation of iodoarenes without the inconvenient use of gaseous chlorine. It was 
shown that the use o f urea-hydrogen peroxide adduct (UHP), which is a stable, 
inexpensive and safely handled oxidant, and 36% hydrochloric acid resulted in the 
effective formation o f (dichloroiodo)arenes from iodoarenes (Scheme 5.2) with 
yields ranging from 64-98% .7
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1) UHP, 85°C, 15 min /
2) conc. HC1 36% \ — /  ^
87%
3
Scheme 5.2: Preparation o f (dichloroiodo)benzene 3 using UHP and HC1.
5.2.2 Iodanes with Iodine-Fluorine Hypervalent Bonds
The direct fluorination o f iodoarenes and iodoalkanes is possible with 
either diluted elemental fluorine or xenon difluoride, the latter being rather 
expensive. The most common method for the preparation of useful ArIF2 168 is 
through the Carpenter method, which involves two steps.8 Scheme 5.3 shows the 
oxidation of an iodide with elemental chlorine followed by ligand exchange of the 
resulting dichloride 167 with hydrofluoric acid in the presence of mercuric oxide.9
cu
c h 2c i2, o°c
Cl 40% HF
HgO, r.t.
166
85%
167
FI
95%
168
Scheme 5.3: Carpenter method for the preparation of (difluoroiodo)toluene 
(DFIT - 168).
Fluorination o f iodobenzene 2, pentafluoroiodobenzene and 
heptafluoroiodopropane with an excess o f xenon difluoride or chlorine trifluoride 
can lead directly to the corresponding tetrafluoroiodo compounds. 10
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5.2.3 Iodanes with Iodine-Oxygen Bonds
[Bis(acyloxy)iodo]arenes are important compounds that can either be 
prepared directly from iodoarenes and peroxyacids or by ligand exchange 
reactions.
The first method is suitable mainly for diacetoxy-derivatives, which are 
readily formed, by oxidation o f iodoarenes with hydrogen peroxide/acetic 
acid/acetic anhydride.
o AcOH, 40 °C
80%
Scheme 5.4: McKillop and Kemp method for the preparation of 
(diacetoxy)iodobenzene 6 .
(Diacetoxyiodo)benzene 6  was first synthesised by Willgerodt in 1892 by 
dissolving iodosylbenzene 7 in acetic acid . 11 Today, there are many direct 
methods to access this useful reagent. These include methods where alternative 
oxidising agents are used. McKillop and Kemp reported sodium perborate 
tetrahydrate in acetic acid12 (Scheme 5.4) and Skulski reported sodium perborate
I ^tetrahydrate in acetic anhydride. The use of sodium periodate/sodium 
acetate/acetic anhydride and chromium trioxide/acetic acid/acetic 
anhydride/sulphuric acid, also provides satisfactory results. 14 The standard method 
for the preparation of 6  is the direct oxidation of the iodide using either 40% 
peracetic acid or by peracetic acid formed in situ from 30% hydrogen peroxide 
and acetic anhydride at 40°C.15 Just 1 equivalent of peracetic acid is necessary for 
the oxidation of the iodine in the presence o f acetic acid. With this method, the 
temperature must be kept at 40°C as below this, the oxidation does not occur and 
at higher temperature and with an excess of peracetic acid, over-oxidation to 
ArI0 2  occurs. Another well used method is the use of twCPBA in a 1:1 mixture of 
dichloromethane and acetic acid . 16
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The direct approach can also be applied to some bis(trifluoracetoxy)iodo 
analogues such as [bis(trifluoroacetoxy)iodo]pentafluorobenzene 174 and other 
[bis(acyloxy)iodo]arenes from iodoarenes bearing strong electron withdrawing 
groups. The reaction rate o f electron poor substrates can be very low. In these 
cases peroxytrifluoroacetic acid can be used (Scheme 5.5). The use of this peracid 
is limited, as its preparation requires the combination of trifluoroacetic anhydride 
and 80% hydrogen peroxide, which is dangerous and no longer commercially
17available.
Scheme 5.5: Preparation o f [bis(trifluoroacetoxy)iodo]benzene 10 with 80% 
H20 2 and (CF3C 0 )20 .
Very recently, the use o f potassium persulfate with trifluoroacetic acid 
anhydride was reported by Kitamura et al. in an efficient synthesis of
The alternate preparation o f [bis(acyloxy)iodo]arenes is an indirect method 
that involves ligand exchange, usually between (diacetoxyiodo)benzene 6  and a 
carboxylic acid as shown in Scheme 5.6. The reaction is most effective when 
performed in mildly heated dichlorobenzene under reduced pressure, followed by 
azeotropic distillation to remove the acetic acid. This straightforward approach is 
suitable for the preparation o f several [bis(acyloxy)iodo]arenes including 
dibenzoxy derivatives and also 1 -adamantylcarboxy derivatives that are formed in 
high yields. 19,20 In order to prepare [bis(trifluoroacetoxy)iodo]benzene 10 itself, it
is enough to simply dissolve (diacetoxyiodo)benzene 6  in trifluoroacetic acid and
21evaporate to a small volume.
(CF3C 0 )20 ,  -60°C
? F3
77% C F 3
2 10
1 8[bis(trifluoroacetoxy)iodo]arenes.
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6 10
Scheme 5.6: Ligand exchange method of preparing 
[bis(trifluoroacetoxy)iodo]benzene 1 0 .
5.2.4 Iodosyl Compounds
Although iodosylbenzene 7 is polymeric {-(Ph)I-O-}, it is usually written 
as the monomeric compound PhlO. Its standard preparation is shown in Scheme 
5.7 which involves the alkaline hydrolysis o f either PI1ICI2 3 or PhI(OAc)2 6 , with 
the latter the most convenient.
O
1 = 0
Aqueous NaOH
,0
7 5 %
6
Scheme 5.7: Preparation o f iodosylbenzene 7 from (diacetoxy)iodobenzene 6.
Direct oxidation to the iodyl compound is somewhat more difficult. The 
use of powerful oxidants to obtain the hypervalent product directly oxidises the 
iodine (Scheme 5.8) to the aryl-A,5-iodane to give the iodyl compound 169.22
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f ~ \ _  ( h o c i/h 2o /c h 2c i2
\  /  1
B U 4 N H S O 4  (c a t)  \ = /  ^
169
Scheme 5.8: Direct preparation o f Iodylbenzene 169.
5.2.5 Iodanes with Two Different Ligands
Aryl-A, -iodanes that contain two different ligands in the hypervalent bond, 
can be formed indirectly by ligand exchange reactions. As previously mentioned 
in Chapter One, Koser’s reagent or [hydroxy(tosyloxy)iodo]benzene 15 is 
prepared by the addition o f p-toluenesulphonic acid monohydrate to 
(diacetoxyiodo)benzene 6  in either acetonitrile or dichloromethane (Scheme 
5.9) . 23
6
Ts0 H-Hv °  f \ J OTsII
M eC N , rt \ = /  ^
93%
15
Scheme 5.9: Preparation o f [hydroxy(tosyloxy)iodo]benzene 15.
Wirth and Yusubov have developed an alternative method (Scheme 5.10) 
for the preparation o f HITB 15.24 Because of the continued need for efficient 
transformations, they developed a solvent-free synthesis.
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N o solvent /
/>Ts0 H -H 20   ► (/ — i
OTs
Pestle & Mortar N ^  qj_[
93%
15
Scheme 5.10: Solvent free synthesis o f HTIB 15.
Solvent-free reactions have many advantages, and some important aspects
' J C
are reduced pollution, lower cost and the simplicity of the processes involved. 
Because many organic solvents are ecologically harmful, strategies for their 
minimised usage and developments toward benign chemical technologies are 
highly sought after. Because many hypervalent iodine reagents have low 
solubility’s in the majority o f organic solvents, the development of solvent-free 
reactions is a big step forward and should lead to an increased use of this 
chemistry. Only iodine(III) compounds should be considered for these reactions, 
because some iodine(V) compounds are known to be shock and pressure 
sensitive.27
5.3 Direct Oxidation to [Hydroxy(tosyloxy)iodo]benzene
Aryl-A,3-iodanes with two different ligands attached to the iodine atom, are 
prepared from the iodoarene in 2  steps; initial oxidation to the hypervalent iodine 
compound, followed by a ligand exchange reaction.
The first step is the oxidation of the iodoarene and requires a peracid, 
which will nominally generate a (diacetoxyiodo)arene. It is known that it is
28 29possible to access aryl sulphonic peracids. ’ The direct generation of a 
[hydroxy(tosyloxy)iodo]arene would prove beneficial to the hypervalent and 
synthetic chemist alike and it was decided to apply these aryl sulphonic peracids 
(Figure 5.1) to aryl iodides, to investigate whether they were able to oxidise the
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iodoarenes, to directly generate the corresponding aryl-A?-iodane. Their general 
structure is reportedly:
F
Figure 5.1: An aryl sulphonic peracid.
The primary use of the sulphonic peracid has been to epoxidise alkenes. 
They are prepared in situ as shown by Schultz et al. who prepared the sulphonic 
peracid 171 by substitution of aryl sulphonyl imidazoles 170 with 30% hydrogen 
peroxide (Scheme 5.11) . 28
Scheme 5.11: Preparation o f an Aryl Sulphonic Peracid 171.
Although the sulphonic peracids have not been isolated, it is proposed that
H20 2( 0 H )
170 171
they are the intermediates (Scheme 5.12) in the epoxidation o f alkanes.
Sulphonyl im idazole,
25°C , M eCN
57%
172 173
Scheme 5.12: Epoxidation o f cyclohexane 172 with an in situ generated 
sulphonic peracid.
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Following from Chapter Three, where we encountered significant 
problems in with the oxidation of chiral iodoarenes. A direct method to access the 
desired [hydroxy(tosyloxy)iodo]arene from a sulphonic peracid may lead to a 1 
step procedure. A series o f experiments were conducted, to investigate the 
oxidative potential o f a sulphonic peracid towards the iodoarenes. This method 
was performed primarily using iodobenzene 2 as a test substrate (Scheme 5.13).
H20 2, NaOH  
M eCN
2 174 15
Scheme 5.13: Attempted oxidation o f iodobenzene 2 with the sulphonic peracid 
precursor 174.
Oxidation reactions o f iodobenzene 2 were performed to obtain 
[hydroxy(tosyloxy)iodo]benzene directly. Unfortunately, this method of oxidising 
iodobenzene proved to be problematic. The reactions ran for up to three days, over 
a range of temperatures from 0°C to 80°C, but at no point was the desired product 
15 observed. It was decided to apply this method to alternate iodoarenes with 
differing electronic properties; electron donating and withdrawing groups were 
employed however, in each case no oxidation was observed.
An alternative approach to that o f the sulphonic peracid, was the in situ 
generation of a sulphonyl peroxy intermediate (Scheme 5.14). This can be 
achieved from the reaction between 2-nitrobenzenesulphonyl chloride 175 and
TOpotassium superoxide at -15°C  (Scheme 5.14). To date, this peroxy intermediate
• « T1has been used to oxidise selenides to selenoxides in excellent yields.
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- s - c i
o
MeCN, -15°'
K 02 ■s—o -cr
OTs
OHN 0 2 n o 2
175 176 15
Scheme 5.14: Oxidation attempt with KO2 generation of 2-nitrobenzenesulphonyl
Unfortunately, this method also proved unsuccessful in the production of 
the [hydroxy(tosyloxy)iodo]benzene. As with the previous method, several 
different iodoarenes were investigated with the recovery of the starting iodoarene 
in each case.
5.4 A New Direct Synthesis of
[Bis(trifluoroacetoxy)iodo]arenes
As discussed above, there are several published methods for the synthesis 
of [bis(trifluoroacetoxy)iodo]arenes . These reagents can either be prepared by an 
indirect route, usually by a ligand exchange reaction on an already oxidized 
iodine(III) compound, or by direct oxidation from aryl iodide precursor molecules 
(Scheme 5.15).
The most commonly used procedure is a ligand exchange reaction using
9 1(diacetoxy)iodobenzene 6  and trifluoroacetic acid. The success of this method is 
related to the electronic properties o f the (diacetoxyiodo)arene; the reaction rate of 
electron poor substrates can be very low. Other indirect methods include the
32reaction o f (dichloroiodo)arenes with silver trifluoroacetate or the reaction of
33iodosylarenes with trimethysilyl trifluoroacetate. ‘
peroxy intermediate 176.
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A cO H /H 20 2/CF3COOH, 
-6 0 °C  to r.t
2
Scheme 5.15: Routes to [bis(trifluoroacetoxy)iodo]benzene 10.
The direct oxidation o f iodoarenes is still a more convenient method, 
although the choice o f oxidants has to take into account the structure and the 
electronic properties o f the iodoarene. Deactivated iodoarenes can be oxidised by 
either fuming nitric acid34 or sodium percarbonate35 together with trifluoroacetic 
anhydride. As shown in Section 5.2.3, the direct synthesis of 
[bis(trifluoroacetoxy)iodo]arenes is realised through the use of trifluoroacetic 
anhydride and 80% hydrogen peroxide. However, this method is problematic as 
80% H2O2 is no longer commercially available. Even though 80% H2O2 can be 
prepared in the laboratory, a much safer alternative is available to the synthetic 
chemist. The urea-hydrogen peroxide adduct (OC(NH2)2 H2O2, UHP) is a cheap, 
commercially available white crystalline solid, which has good stability at room 
temperature, a high H2O2 content (36.2%) and has good solubility in organic 
solvents. UHP has been known since 1906, and its applications in organic and 
analytical chemistry, as well as industry, are quickly widening. More recently, 
Skulski has used it in the solvent-free synthesis o f (dichloroiodo)arenes.7
To overcome the lack o f availability of 80% hydrogen peroxide, we 
developed two methods to directly afford [bis(trifluoroacetoxy)iodo]arenes.38 
These were based around the in situ generation of trifluoroperacetic acid, as a 
variation of the procedure reported by Zhdankin and Stang. 17
117
Chapter Five: Oxidation to the hypervalent State
5.4.1 Method A
The solubility o f hydrogen peroxide is considerably higher in organic 
solvents than in water.39 Consequently, urea can be removed from solutions of 
commercially available urea-hydrogen peroxide adduct in organic solvents by 
extraction with water. The remaining solution of hydrogen peroxide in an organic 
solvent can then, after drying, react with trifluoroacetic anhydride to generate 
trifluoroperacetic acid (Scheme 5.16).
o o
X  Xoc(N H 2)2- h 2o 2 o
+ A,
H20  - 4 0  °C, 30  m in F3C O H
-4 0  °C 
to 
r.t.
r v ,
10 CF
Scheme 5.16: Removal o f urea before reaction.
If this reaction is performed in the presence of an aryl iodide, the 
corresponding hypervalent [bis(trifluoroacetoxy)iodo]arenes are obtained in good 
yields as shown in Table 5.1 and as described in the general procedure GP14.
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Product
177
178
179
180
181 o c o c f3
Method Yield (%)
65
95
90
81
50
determined by H NMR.
Table 5.1: Synthesis o f (trifluoroacetoxy) 181 and
[bis(trifluoroacetoxy)iodo]arenes 177-180 using Method A.
5.4.2 Method B
A mixture of the urea-hydrogen peroxide adduct and trifluoroacetic 
anhydride can be used directly for the generation o f trifluoroperacetic acid. In the 
presence of an iodoarene, the hypervalent iodine species (Table 5.2) are 
generated, but the urea has to be removed after the reaction (GP75). This protocol 
(Scheme 5.17) is therefore only suitable for hypervalent iodine compounds that 
tolerate aqueous work-up.
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Scheme 5.17: Removal o f urea after reaction.
Product Method Yield (%)
182
'CN
183
Table 5.2: Synthesis o f [bis(trifluoroacetoxy)iodo]arenes using Method B.
In both Methods, A and B, the temperature of the reaction was lowered to 
around -40°C in order for the trifluoroperacetic acid to form. At room 
temperature or even at 0°C, we observed no peracid formation and subsequently 
no oxidation. We performed several low-temperature *H NMR studies using a 
hydrogen peroxide-trifluoroacetic anhydride mixture to determine the temperature 
at which the trifluoroperacetic acid formed. The initial reaction temperature was 
-60°C, and the reaction repeated at 10°C intervals. The first signs of oxidation of 
the iodoarene were observed at -30°C. It was at this temperature that we began to
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see the appearance o f the new aromatic peaks, characteristic of the hypervalent 
iodine species, downfield of the non-hypervalent iodine species.
As discussed in Chapter 3, many of the new chiral iodoarenes that were 
based upon the extended chiral side chain, failed to undergo oxidation to the 
hypervalent species. This novel method was applied to several of these 
compounds (Table 5.3), to determine whether the [bis(trifluoroacetoxy)iodo] 
arenes were as unstable as their diacetoxy analogues.
Chiral iodoarene Reagent R1 R2 Product Yield %
(5)-58 Me Me (5)-66 6
OR2
(5)-69 Ph Me (5)-74 2
(5)-88 Me Me (5)-96 2 1
O R2
(5)-89 Me Et (5)-97 15
(5)-90 Me Bn (5)-98 6
(5)-103 Ph Me (5)109 59
(5)-104 Ph Et (5)110 17
(JQ-115 lBu Me (tf) - 1 2 0 2
Table 5.3: Synthesis o f chiral [bis(trifluoroacetoxy)iodo]arenes using
Method B.
The results shown in Table 5.3, once again highlight the problems 
associated with the oxidation of the next generation chiral iodides prepared 
previously. The only reagents that were stable enough to obtain in sufficient 
quantities to allow further investigation were 96, 97, 109 and 110. As discussed in 
Chapter Three, the oxidation o f 109 and 110 may be attributed to the additional 
phenyl ring attached to the chiral carbon of the side chain.
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5.5 Conclusion
In this Chapter a novel alternative oxidative synthetic procedure for the 
synthesis o f [bis(trifluoroacetoxy)iodo]arenes, has been described. Until now, the 
primary method for the synthesis of these hypervalent iodine compounds was by 
the use of hazardous 80% hydrogen peroxide. This novel method offers the 
following advantages:
• It avoids the use o f the commercially unavailable and hazardous 80% 
hydrogen peroxide.
• It is applicable to iodoarenes which contain electron donating or electron 
withdrawing substituents.
• It represents a high yielding direct synthesis of these useful compounds.
• It allows the synthesis of hypervalent iodine compounds at low 
temperatures.
For this last point, the oxidation of the iodoarenes at low temperatures 
allowed us to oxidise iodoarenes that would not oxidise using conventional 
methods or those which are unstable at higher temperatures. When this method 
was applied to the chiral iodoarenes that we were unable to oxidise by 
conventional methods, some success was observed. The chiral iodoarenes that 
have the longer chiral side chains are the most stable, and as with the majority of 
these next generation compounds, stability was still an issue. Due to time 
constraints, the reactivity o f these chiral hypervalent iodine reagents were not 
investigated.
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Chapter 6
6 Conclusion and Future Directions
6.1 Conclusion
Chiral hypervalent iodine compounds are very extraordinary molecules. 
They have potential use both in academia and in industry. Their chemistry may 
allow them to one-day replace toxic heavy metals in synthesis. With 
environmental alternatives more sought after then ever, these chiral iodine(III) and 
(V) compounds definitely have a bright future ahead.
The research carried out within this thesis can be summarised as follows:
• Synthesis of chiral iodine(lll) compounds
• Oxidation o f iodine(I) to iodine(III)
• Reactivity o f chiral iodine(III) compounds
The synthesis o f chiral iodine(III) compounds revealed many problems 
associated with oxidation. It became clear that the increasing length of the chiral 
chain ortho to the iodine atom on the benzene ring was affecting the oxidation of 
the iodine(I) to the iodine(III) state. These results are consistent with the work of 
Shenjie et al} They discovered that an alkyl chain ortho to an iodine increased in 
length, the oxidation o f the iodine(I) became more difficult. With these problems 
arising, only seven iodine(III) compounds were isolated (Figure 6.1).
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I(OAc)2 I(OAc)2
I(OAc)2 I(OAc)2
I(OAc)2 I(OCOCF3)2I(OAc)2
106 107 109
Figure 6.1: Aryl iodides isolated in stoichiometrically useful quantities.
The problems associated with oxidation were apparent using the majority of 
established oxidation methods. Sodium perborate and peracetic acid 
predominantly afforded little or no product. The known method to directly access 
[bis(trifluoroacetoxy)iodo]arenes is oxidation using trifluoroperacetic acid. This
method is very difficult and dangerous, as it requires the use of 80% hydrogen
• 2  •peroxide (no longer commercially available). Therefore, an alternative method
was devised to resolve this problem. Through the use of urea hydrogen peroxide 
(34% H2O2), and trifluoroacetic anhydride in dichloromethane, the corresponding 
[bis(trifluoroacetoxy)iodo]arenes were generated in very good yields. This 
method was effective for iodoarenes that contain either electron donating or 
electron withdrawing substituents.
The chiral hypervalent iodine(III) compounds developed in the Wirth group 
have been used in the functionalisation of alkenes and ketones. They are required 
in stoichiometric quantities to perform these transformations and with the 
oxidation problems associated with these reagents they are limited in their 
synthetic utility. Recent advances in the area provided an outlet for us to evaluate 
our range of aryl iodides .4 With these catalytic cycles available, we were able to
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test our chiral iodine(I) compounds and observe use in catalytic oxidation 
processes. 5
It was found that an increase in chain length resulted in a decrease in the 
transfer of chiral information to the substrate. By comparing chiral reagents 
prepared previously within the Wirth group to the ones prepared within this work 
we observed a downward trend in enantiomeric excesses of the products. The 
more successful chiral iodine(III) reagents had the chiral centre in a benzylic 
position and this appears to be the most effective position for asymmetric 
induction. Further work had begun in synthesising chiral iodine reagents with two 
chiral centres, one in the benzylic position and a second at the next carbon in the 
chiral chain.
6.2 Future Work
The addition o f a second chiral centre in the chain may increase the 
transfer of chiral information to the substrate. A series of experiments were 
underway toward the end o f the research but unfortunately they currently remain 
unfinished. This section will outline the ideas and show the current position of the 
research.
6.2.1 6-Membered Chiral Iodoarenes with Two Chiral Centres
The addition o f a second chiral centre in the benzylic position may 
improve the enantioinducing power o f these reagents. Figure 6.1 shows how the 
introduction of another stereocentre may help to increase the steric shielding of 
the syn-face of the intermediate and direct the tosylate nucleophile toward the re­
face of the alkene.
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Me I— OHMe-
OTs
184
Figure 6.1: Increased steric shielding o f sjw-face in the proposed intermediate
184.
Two routes A and B to the next generation chiral iodine(III) compounds 
were explored. The first synthesis is outlined in Scheme 6.1. To include a second 
chiral centre, this synthesis would involve extra steps. It began with a reduction of 
3-methoxyacetophenone 185 to give l-(3-methoxyphenyl)ethanol 186 in 95% 
yield. The iodine was then introduced into the ring by ort/zo-lithiation in 24% 
yield.6 The alcohol was oxidised back to the carbonyl using PCC (96%) to give 
187, and the side chain homologated using
(methoxymethyl)triphenylphosphonium chloride to afford the 2 -iodo-l-methoxy- 
3-(2-methoxyprop-l-en)benzene 188 in 84% yield. The methoxy group of the 
ether was cleaved through acid hydrolysis (71%). This was achieved by stirring 
189 in the dark with concentrated formic acid, to give acetaldehyde 190 in 71% 
yield. 7 The concurrent steps were never realised due to time constraints, but the 
groundwork has been laid for a future researcher.
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N aB H 4
A, Ethanol 
95%
HCOOH
71%
OMe
R'-M gCl
OH
OMe
Resolution, 
NaH , R2I
n-BuLi, I2 
 ►
0°C to r.t. 
Hexane/diethyl ether
24%
OMe
OMe LDA,
Cl+ Ph3P-CH2OMe ----------------
84%
[Ox]
O M e
PCC
CH2C12
96%
TsOH«H20
HO OTs
Scheme 6.1: Synthesis A -  Route to 6 -membered chiral iodine(III) compounds
with two chiral centres.
The second synthesis is much shorter, although work will have to be done 
to improve the yields in some steps. The synthesis is outlined in Scheme 6.2. To 
reduce synthesis time, the chosen starting material was (2 -iodophenyl)acetonitrile 
191, which is commercially available. The benzylic position was alkylated 
through deprotonation using LDA in dry THF to produce the alkylated products 
yields from 77 to 87%. It could be at this point that separation via HPLC could be 
applied to separate the enantiomers o f 192-194, or alternatively at the
129
Chapter Six: Conclusion and Future Directions
acetaldehyde stage. The subsequent 2-(2-iodophenyl)alkylnitriles can be reduced 
to the corresponding acetaldehydes through a DIBAL reduction to give 195-197. 
The yields for this step are currently poor, ranging between 11 and 20%. The next 
step would be the Grignard addition and from here on this synthesis mirrors that 
of Route A.
N
nBuLi,
D iisopropylam ine
R 'X
 ►
THF
DIBAL
Toluene
191 R1 = M e= 192 =  87%  
Et = 193 =  77%  
Bn = 194  =  84%
(Vyr
OR’
I(R4)2
[Ox]
pTsOH*H20
O M e
R 1 = M e= 195 = 20% 
Et =  196 = 11% 
Bn = 1 9 7 =  14%
Resolution, 
NaH, R3!
R2MgBr
OH
OMe
HO OTs
Scheme 6.2: Synthesis B -  Route to 6 -memerbed chiral iodine(III) compounds 
with two chiral centres.
The second synthesis contains fewer steps and it allows more flexibility in 
choosing which alkyl or aryl moiety to attach at the benzylic position. Whether 
this type of chiral iodoarene will improve on the selectivity previously observed in 
the functionalisation o f alkenes and ketones, remains to be seen.
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Chapter 7
7 Experimental
7.1 General Methods
Most reactions were carried out using standard borosilicate glassware of 
the relevant size. Inert reactions conditions are applied by vacuum dried or oven 
dried (120°C) apparatus under argon atmosphere. Experiments requiring a precise 
temperature were performed using either a hot plate with temperature probes in 
silicon oil or through the use o f a cooling machine, Lauda RK 8  LP using 
methanol as the solvent. Reactions that needed a temperature of-78°C were 
carried out using a cooling bath with dry ice and acetone.
Solvents were removed using a Btichi R-124 rotary evaporator (final 
vacuum -15 mbar). Further drying was achieved through high vacuum at ca. 0.05 
mbar. Vacuum distillations were performed using a Biichi GKR-50 Kugelrohr 
distillation apparatus.
Non-sensitive reactions were performed open to air or in loosely stoppered 
vessels. All reactions were continually agitated with magnetic stirring unless 
otherwise stated.
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7.1.1 Solvent Treatment
THF and diethyl ether were freshly distilled from sodium/benzophenone 
under inert gas atmosphere o f N2 . Diisopropylamine and dichloromethane were 
distilled from KOH and CaF^ respectively, under anhydrous conditions. All other 
high purity solvents used were bought from Aldrich, Alfa Aeser, Fluka or Acros 
in septum bottles and handled under argon. Solvents for chromatography and 
work up were distilled, and all other solvents were used as purchased.
7.2 Spectroscopic Analysis
7.2.1 NMR-Spectroscopy
Bruker DPX 500 (500 MHz), Bruker DPX 400 (400 MHz), Bruker DPX 
250 (250 MHz). The chemical shifts 8  are given in ppm relative to an internal 
standard. Deuterated chloroform solutions containing tetramethylsilane were used 
to perform the analysis. Additionally, the peak of the deuterated solvent is used as 
an internal reference: CDCI3 at 8  = 7.26 ppm, MeOD at 8  = 3.30 ppm, DMSO at 8  
= 2.50 ppm. All coupling constant J  are reported in Hertz (Hz). The multiplicity 
of the signals are abbreviated as follows: s = singlet, d = doublet, t = triplet, q = 
quadruplet, quin = quintuplet, sep = septet, m = unresolved multiplet, br = broad, 
Aromatic signals not specifically assigned at one particular position have been 
labelled ‘arom’.
7.2.2 13C NMR-Spectroscopy
Bruker DPX 500 (125 MHz), Bruker DPX 400 (100.6 MHz) or Bruker 
DPX 250 (62.5 MHz). The chemical shifts 8  are given in ppm relative to the 
solvent signals of deuterated chloroform: CDCI3 at 8  = 77.0 ppm, MeOD at 8  =
49.0 ppm, DMSO at 8  = 39.5 ppm.
133
Chapter Seven: Experimental
7.2.3 Mass Spectrometry
Mass spectrometric analyses were performed either by atmospheric 
pressure chemical ionisation technique, voltage applied corona discharge pin 
(APCI) or by voltage on a tip (ES).
• Fisons VG platform II. The analyses were performed in the mass 
spectrometry laboratory o f the Chemistry Department, Cardiff University. 
Ions were generated by atmospheric pressure chemical ionisation (APCI).
• GC-MS (column BD-5MS). If not otherwise specified, the following 
temperatures were used: from 70 to 200 C for 40 minutes. In this case, 
electron ionisation (El) was used as an ionisation method.
In both cases, the masses o f fragments are given in atomic mass unit per 
elementary charge (m/z). The intensity relative to the strongest signal (molecular 
peak) is quoted in parenthesis (in%)
Accurate high-resolution mass spectral data were recorded at either the 
National Mass Spectrometry Service Centre at the University of Swansea, or at 
the Mass Spectrometry Laboratory at Cardiff University.
The molecular formulae are given in molecular ion [M]+, molecular ion + 
hydrogen [M+H]+, molecular ion -  hydrogen [M-H]+, molecular ion + 
ammonium ion [M+NIU]* or molecular ion + sodium ion [M+Na]+.
7.2.4 Gas Chromatography-Mass Spectroscopy
Varian Saturn 3400 GC/MS with column DB-5MS, 30 m. Ions were 
generated by El and detected in a Varian Ultralace ion trap.
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7.2.5 IR Spectroscopy
All compounds were analysed on a Perkin-Elmer 1600 FTIR- 
spectrometer. The wave numbers are reported in cm'1. Liquid samples were 
measured as liquid film. Solid samples were analysed as a film in nujol mull.
7.2.6 Melting Points
Melting points were measured in an open capillary tube with a Mel-temp 
II instrument and are uncorrected.
7.2.7 Optical Rotation
Optical activity was measured using a LTs. AA-1000 Polarimeter. The 
samples were measured at 589 nm of wavelength at ambient temperatures. The 
sample concentration is quoted in g/ 1 0 0  ml.
7.3 Chromatographic Methods
7.3.1 Thin Layer Chromatography
Thin layer chromatography was performed with Merck Kieselgel 60 F254 
pre-coated aluminium backed plates. Visualisation was achieved by UV- 
fluorescence or after dipping in one of the following solutions:
1. 1 g potassium permanganate, 7 g potassium carbonate, 2 ml of a 5% 
solution o f sodium hydroxide in 1 0 0  ml of deionised water.
2. 1 g cerium(IV) sulphate-tetrahydrate, 2.5 g ammonium heptamolybdate 
tetrahydrate, 10 ml concentrated sulphuric acid in 90 ml of water.
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7.3.2 Flash Chromatography
Fischer silica gel 60 (30-70 mesh). The solvent ratios are quoted in volume 
percentage.
7.3.3 High Performance Liquid Chromatography
1. Merck-Hitachi L-6200 gradient pump with Merck-Hitachi L-4200 UV- 
vis detector, Merck-Hitachi L-2500 integrator.
2. Shimadzu LC-10AT-VP solvent delivery system, Shimadzu SPD- 
M10A-P DAD detector, Shimadzu SCL-10A-VP controller, operated 
by Shimadzu Class VP software.
Analytical chiral columns used: OB, OB-H, OD, OD-H from Daicel Chemical 
Industries, column length 25 cm, column diameter 0.46 cm.
Preparative column used: OD from Daicel Chemical Industries, column length 
25 cm, column diameter 2 cm.
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7.4 General Procedures
7.4.1 General Procedure for the Oxidation of 1° and 2°-
Alcohols using Pyridinium Chlorochromate (GP1)
The alcohol (21.4 mmol, 1.0 eq) in dichloromethane (15 ml) was added 
drop wise to a stirred solution o f pyridinium chlorochromate (32.1 mmol, 1.5 eq) 
in dichloromethane (50 ml) at 0°C. The solution was allowed to warm to room 
temperature and stirred vigorously for 24 hours. Diethyl ether was added (25 ml), 
and the mixture filtered through a column of Celite® over silica gel. Elution of the 
product with additional ether and evaporation of solvent under reduced pressure 
yielded the desired product.
7.4.2 General Procedure for the Wittig Reaction (GP2)
A solution o f «BuLi (31.7 mmol, 1.6 eq of a 2.5 M solution in hexanes) 
and diisopropylamine (31.7 mmol, 1.6 eq) in dry THF (10 ml) was added 
dropwise over 5 minutes to a stirred suspension of 
(methoxymethyl)triphenylphosphonium chloride (20.8 mmol, 1.1 eq) in dry THF 
(15 ml) at -10°C under an inert atmosphere of argon. The solution was allowed to 
warm to room temperature and after 30 minutes, the aldehyde (19.8 mmol, 1.0 eq) 
in dry THF was added drop wise over 5 minutes. The solution was stirred for 15 
hours, quenched with saturated aqueous ammonium chloride solution (2 x 1 0  ml), 
the organic layer was decanted and the aqueous layer extracted with diethyl ether 
( 2 x 1 5  ml). The combined organic fractions were washed with brine (10 ml), 
dried over magnesium sulphate and the solvent removed under reduced pressure 
to yield the crude product. Purification was performed using column 
chromatography to give the desired product.
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7.4.3 General procedure for acidic hydrolysis of vinyl
ethers (GP3)
Formic acid (80.0 mmol, 17.4 eq) was added to a pale yellow solution of 
(£)- and (Z)-vinyl ether isomers (4.6 mmol, 1.0 eq). Upon addition the solution 
immediately deepened to a bright yellow colour. The reaction was stirred at room 
temperature in a foil-covered vessel. After 64 hours the solution was quenched 
with water (15 ml) and the layers allowed to separate. The organic layer was 
decanted and the aqueous layer extracted with dichloromethane ( 3 x 5  ml). The 
combined organic fractions were washed with saturated sodium hydrogen 
carbonate ( 2 x 5  ml), brine ( 2 x 5  ml), dried with MgS0 4  and the solvent was 
removed under reduced pressure. The oil produced required no further 
purification.
7.4.4 General procedure for the Grignard reaction (GP4)
A solution o f an alkyl magnesium halide (2.24 mmol, 1.0 eq) in dry 
diethyl ether (5 ml) was added drop wise over 5 minutes, to a solution of an 
iodoaryl acetaldehyde (2.24 mmol, 1.0 eq) in dry diethyl ether under an argon 
atmosphere at -10°C. After 1.5 hours, ammonium chloride (1 x 10 ml) was added 
to the stirred solution. The aqueous phase was extracted with dichloromethane (2 
x 5 ml) and the organic layers combined and dried over magnesium sulphate. The 
solvent was removed under reduced pressure and purification was performed by 
column chromatography, to yield the desired compound.
7.2.5 General procedure for the alkylation of alcohols
(GP5)
Sodium hydride (2.22 mmol, 3.0 eq, 55— 65% in oil) was washed with 
pentane ( 4 x 3  ml) and then suspended in dimethylformamide (12 ml). After 
cooling to 0°C, a solution o f the alcohol (0.74 mmol, 1.0 eq) in
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dimethylformamide (2 ml) was added. After stirring for 15 minutes at room 
temperature, the mixture was cooled to 0°C and the alkyl iodide (0.74 mmol, 1.0 
eq) was added. After a further 3 hours at room temperature, water was carefully 
added. The resulting mixture was extracted with /-butyl methyl ether ( 2 x 5  ml), 
and the combined organic phases were washed with brine ( 3 x 5  ml), dried over 
MgSC>4 and filtered and concentrated under reduced pressure. Purification was 
performed using column chromatography to give the desired product.
7.4.6 General procedure for the trifluoroacetoxylation of 
alcohols (GP6)
Trifluoroacetic anhydride (1.04 mmol, 1.2 eq) was carefully added to a 
stirred solution of an alcohol (0.87 mmol, 1.0 eq) and triethylamine (1.04 mmol, 
1.2 eq) in dichloromethane (10 ml) at 0°C. After 30 minutes the solvent was 
removed under reduced pressure and the product was purified by column 
chromatography.
7.4.7 General procedure for the preparation of t-butyl 
ethers from tertiary butanol (GP7)
Concentrated sulphuric acid (0.43 mmol, 1.0 eq) was added to a vigorously stirred 
suspension of anhydrous MgSC>4 (1.72 mmol, 4.0 eq) in cyclohexane (4 ml). The 
mixture was stirred for 15 minutes and a solution of /-butanol (2.15 mmol, 5.0 eq) 
and the alcohol (0.43 mmol, 1.0 eq) in cyclohexane (2 ml) was then added. The 
mixture was stoppered and stirred for a further 18 hours at 25°C. The reaction 
mixture was then quenched with 5% sodium bicarbonate solution (5 ml) and 
stirred until all the magnesium sulphate had dissolved. The organic phase was 
separated and washed with brine ( 2 x 5  ml), The combined organic fractions were 
dried over MgSC>4, filtered and concentrated under reduced pressure. Purification 
was performed using column chromatography to give the desired product.
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7.4.8 General procedure for the homologation of the carbon
side chain (GP8)
A mixture o f 2-iodobenzyl chloride (11.9 mmol, 1.0 eq), the symmetrical 
1,3-dione (13.1 mmol, 1.1 eq) and potassium carbonate (12.5 mmol, 1.05 eq) in 
ethanol (30 ml) was re fluxed for 24 hours. The solvent was removed under 
reduced pressure and the residue partitioned between ether (50 ml) and water (15 
ml). The organic layer was dried with magnesium sulphate and concentrated 
under reduced pressure to yield the crude product. Purification was performed 
using column chromatography to give the desired product.
7.4.9 General procedure for the asymmetric reduction of
ketones (GP9)
A solution of the propanone or butanone derivative (11.9 mmol, 1.0 eq) in 
dry THF (5 ml) was added to a solution o f (-)-^-chlorodiisopinocampheylborane 
(13.1 mmol, 1.1 eq) in dry THF (25 ml) under an inert argon atmosphere at -  
25°C. After 15-25 hours, the reaction was warmed up to room temperature and 
the solvent was removed under reduced pressure. The residue was dissolved in 
diethyl ether (25 ml) and vigorously stirred. To this stirred solution was added 
diethanolamine (26.2 mmol, 2.2 eq). After stirring at room temperature for a 
further 2 hours, the suspension was filtered through Celite® and washed with 
diethyl ether (5 x 10 ml). The solvent was removed under reduced pressure, 
purified by column chromatography to yield the desired product.
7.4.10 General procedure for the reduction of ketones 
(GP10)
The propanone or butanone derivative (7.30 mmol, 1.0 eq) was added drop 
wise over 2 minutes to a stirred suspension of sodium borohydride (NaBH^ (4.02
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mmol, 0.55 eq) in ethanol (10 ml) under argon at room temperature. The resulting 
solution was heated to reflux with stirring. After 3 hours, the solution was 
removed from the oil bath, allowed to cool to room temperature, and quenched 
with water (10 ml) and acetic acid (3 ml). The resulting mixture was concentrated 
under reduced pressure, and the residue partitioned between ether ( 1 0  ml) and 
water (10 ml). The aqueous layer was extracted with ether ( 4 x 1 0  ml), the organic 
fractions combined, dried over MgSC>4 and the solvent removed under reduced 
pressure. Purification was performed using column chromatography to give the 
desired product.
7.4.11 General procedure for the oxidation of iodoarenes 
with sodium perborate tetrahydrate 1 (GPU)
Sodium perborate tetrahydrate (3.10 mmol, 10 eq) was added portion wise 
to a solution of the iodoarene (0.31 mmol, 1.0 eq) in glacial acetic acid (5 ml), at 
40°C. The conversion was monitored by TLC analysis. After completion of the 
reaction, the solution was concentrated to half its volume by removal of acetic 
acid by evaporation under reduced pressure. The mixture was diluted with a small 
volume of water (5 ml) and quickly extracted with chloroform (2 x 10 ml). The 
combined extracts were washed with brine ( 2 x 1 0  ml), dried with MgSC>4 and the 
solvent was removed under reduced pressure to yield the crude product. The 
(diacetoxyiodo)arene derivatives could be purified either by recrystallisation from 
acetic acid/pentane or by flash TLC. Some of the products were found to be 
unstable and therefore characterized only by NMR spectroscopy.
7.4.12 General procedure for the oxidation of iodoarenes 
with commercially available peracetic acid 2 (GP12)
Peracetic acid (0.39 mmol, 0.88 ml of a 30% solution in acetic acid, 1.75 
eq) was added drop wise over two minutes to a flask containing the iodoarene 
(0.22 mmol, 1.0 eq) in acetic acid (5 ml) at 40°C under argon. After stirring for 24
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hours, dichloromethane (5 ml) was added to the reaction mixture followed by 
chloroform (5 ml). Water (3 ml) was added to the solution and the organic phase 
separated. The aqueous phase was extracted further with chloroform ( 3 x 5  ml) 
and the organic phases combined. The organic phase was dried with MgSCU and 
the solvent removed under vacuum, to yield the crude product. The 
(diacetoxyiodo)arene derivatives could be purified either by recrystallisation from 
acetic acid/pentane or by flash TLC. Some of the products were found to be 
unstable and therefore characterized only by NMR spectroscopy.
7.4.13 General procedure for the oxidation of iodoarenes 
with an in situ  generation of peracetic acid 2 (GP13)
Peracetic acid was prepared by stirring a solution of acetic anhydride ( 6  
ml) and hydrogen peroxide (1.6 ml o f a 30% solution in water) for 4 hours at 
exactly 40°C. The iodoarene (1.0 mmol, 1.0 eq) was added to the reaction 
mixture and stirred for up to 24 hours. Dichloromethane (5 ml) was added to the 
reaction mixture followed by chloroform (15 ml). Water (5 ml) was added to the 
solution and the organic phase separated. The aqueous phase was extracted further 
with chloroform ( 3 x 1 0  ml) and the organic phases combined. The organic phase 
was dried with MgSCL and the solvent removed under vacuum, to yield a white 
solid. The (diacetoxyiodo)arene derivatives could be purified either by 
recrystallisation from acetic acid/pentane or by flash TLC. Some of the products 
were found to be unstable and therefore characterized only by NMR spectroscopy.
7.4.14 General procedure for the oxidation of iodoarenes 
with trifluoroperactic acid - method A 3 (GP14)
Urea hydrogen peroxide (2.28 mmol, 2.5 eq) was dissolved in a minimum 
quantity of deionised water (0.5 ml) and extracted with dichloromethane ( 3 x 6  
ml). The combined organic phases were dried over Na2S0 4  and filtered to give a 
solution of hydrogen peroxide in dichloromethane. This solution was cooled to -
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40°C and trifluoroacetic anhydride (9.10 mmol, 10 eq) was added drop wise. 
After 30 minutes, the iodoarene (0.91 mmol, 1.0 eq) was added to the solution and 
the reaction mixture left to stir for a further 7 hours at —40°C. The solution was 
warmed up to room temperature and stirred for 1 hour. The 
[bis(trifluoroacetoxy)iodo]arene derivatives could be purified by washing with 
pentane. The solvent was removed under reduced pressure to yield the 
corresponding [bis(trifluoroacetoxy)iodo]arene. Some of the products were found 
to be unstable and therefore characterized only by NMR spectroscopy.
7.4.15 General procedure for the oxidation of iodoarenes 
with trifluoroperactic acid -  method B 3 (GP15)
Trifluoroacetic anhydride (25.0 mmol, 10.0 eq) was added drop wise to a 
stirred solution of urea hydrogen peroxide (6.25 mmol, 2.5 eq) in dichloromethane 
at -40°C. After 30 minutes, the appropriate iodoarene (2.5 mmol, 1.0 eq) was 
added, and the resulting solution stirred for 7 hours at -40°C. The solution was 
warmed to room temperature and stirred for 1 hour. The solution was quickly 
washed with a small quantity o f water, the organic phase separated, dried over 
MgSC>4 and the solvent removed under reduced pressure to yield crude product. 
The [bis(trifluoroacetoxy)iodo]arene derivatives could be purified by washing 
with pentane. Some o f the products were found to be unstable and therefore 
characterized only by NMR spectroscopy.
7.4.16 General procedure for the oxidation of iodoarenes 
with m-CPBA (GP16)
The iodoarene (1.0 mmol, 1.0 eq) was added to a stirred solution of acetic 
acid (4 ml), and mCPBA (1.05 mmol, 1.05 eq), in dichloromethane (3 ml) at room 
temperature under a nitrogen atmosphere. The mixture was stirred for up to 24 
hours, while the reaction was monitored by TLC. The solution was quenched with 
a small quantity o f water ( 2  ml), the aqueous phase was washed with chloroform
143
Chapter Seven: Experimental
( 2 x 5  ml) the organic phase combined, dried over MgS(>4 and the solvent 
removed under reduced pressure to yield a white solid. The (diacetoxyiodo)arene 
derivatives could be purified by recrystallisation from acetic acid/pentane.
7.4.17 General procedure for the oxidation of iodoarenes 
with Koser reagent4 (GP17)
A solution of the iodoarene (1.0 mmol, 1.0 eq) in dichloromethane (10 ml) 
was mixed with Koser reagent (1.2 mmol, 1.2 eq) at room temperature for up to 
72 hours. The progress was monitored by TLC and NMR. The solvent was 
removed under reduced pressure and the crude solid analysed.
7.4.18 General procedure for the oxidation of iodoarenes 
with Chromium (VI) oxide 5 (GP18)
Powdered chromium trioxide (0.30 mmol, 1.0 eq) was slowly added to a 
stirred solution of glacial acetic acid (0.2 ml) and acetic anhydride (0.1 ml). The 
temperature was then raised to 40°C for 1 hour. The deep orange solution was 
cooled down to 10°C and the iodoarene (0.45 mmol, 1.5 eq) added drop wise. The 
temperature was raised to 40°C. At this temperature, concentrated sulphuric acid 
(0.06 ml) was added to the reaction mixture and the resulting solution stirred at 
40°C. After 1 hour the reaction was cooled to 0°C and 20% aqueous ammonium 
acetate solution (5 ml) was added to the deep-green mixture. The flask was stored 
at 4°C for 2 hours the resulting precipitate was filtered with cold acetic acid ( 2 x 5  
ml). The crude product was then purified by recrystallisation from acetic 
acid/pentane.
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7.4.19 General procedure for the preparation of 
[hyd roxy(tosyloxy)iodo] arenes (GP19)
The (diacetoxyiodo)benzene derivative was dissolved in acetonitrile (~0.9 
mol). To this solution exactly 1 equivalent of />-toluenesulphonic acid 
monohydrate in acetonitrile (0.4 mol) was added. After the solution was stirred for 
1 hour the solvent was removed under reduced pressure.
7.4.20 General procedure for the dioxytosylation of styrene 
(GP20)
The chiral hypervalent iodine compound (0.5 mmol, 1.0 eq) and p- 
toluenesulphonic acid monohydrate (1.2 mmol, 2.4 eq) were dissolved in 
dichloromethane (3 ml). Styrene (0.5 mmol, 1.0 eq) was added at temperatures 
between -30°C-25°C. The solution was stirred at this temperature for 4-24 
hours. After filtration through silica gel the solvent was removed under reduced 
pressure and the residue purified by flash chromatography on silica gel.
7.4.21 General procedure for the catalytic a-oxytosylation of 
propiophenone (GP21)
A solution of propiophenone (1.0 mmol, 1.0 eq) in acetonitrile (1 ml) was 
added to a solution of iodoarene (0.1 mmol, 0.1 eq), / 7-toluenesulphonic acid 
monohydrate (1.5 mmol, 1.5 eq) and wCPBA (1.5 mmol 77% wet, 1.5 eq) in 
acetonitrile (2 ml) at room temperature. The resulting solution was stirred for 60 
hours, then quenched by addition o f saturated aqueous sodium thiosulphate (5 ml) 
and saturated aqueous sodium carbonate (5 ml). The mixture was extracted with 
ethyl acetate ( 3 x 5  ml), the combined organic layers were washed with brine ( 1 0  
ml), dried over Na2SC>4 , filtered and concentrated under reduced pressure. The 
residue was purified by flash column chromatography to yield the desired product.
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7.4.22 General procedure for the catalytic a-acetoxylation of 
propiophenone (GP22)
A solution o f propiophenone (1.0 mmol, 1.0 eq) in acetic acid (1 ml) was 
added to a solution o f iodoarene (0.10 mmol, 0.1 eq) and m-CPBA (1.5 mmol 
77% wet, 1.5 eq) in acetic acid (2 ml) at room temperature. Boron trifluoride 
diethyl etherate (1.5 mmol, 1.5 eq) and water (2.5 mmol, 2.5 eq) was added and 
the resulting solution stirred for 24 hours, then quenched by addition of saturated 
aqueous sodium thiosulphate (5 ml) and saturated aqueous sodium carbonate (5 
ml). The mixture was extracted with diethyl ether ( 3 x 5  ml) the combined organic 
layers were washed with brine (10 ml), dried over MgSC>4, filtered and 
concentrated under reduced pressure. The residue was purified by flash column 
chromatography yield the desired product.
7.4.23 General procedure for iodination via ortho-lithmtion 
of aromatic rings (GP23)
To a stirred solution o f the alcohol (10.0 mmol, 1.0 eq) in hexane/diethyl 
ether (4:1, 100 ml) at 0°C was added wBuLi (20 mmol, 2.0 eq of a 2.5 M solution 
in hexanes) dropwise over 20 minutes. Dry diethyl ether (10 ml) was added, the 
resulting solution warmed to room temperature and stirred for 4 hours. Iodine 
(10.0 mmol, 1.0 eq) in diethyl ether (30 ml) was added and the solution stirred for 
a further 30 minutes. The solution was quenched with aqueous 
ammonia/ammonium chloride solution (50 ml, pH ~8 ), and the aqueous phase 
extracted with diethyl ether (3 x 40 ml). The combined organic fractions were 
dried over MgSC>4 , filtered and concentrated under reduced pressure. The product 
was purified by column chromatography to give the desired product.
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7.4.24 General procedure for the alkylation of 2-
(iodophenyl)acetonitrile (GP24)
A solution o f 2-(iodophenyl)acetonitrile (10.0 mmol, 1.0 eq) in dry THF (2 
ml) was added to a previously prepared solution of «BuLi (10.0 mmol, 1.0 eq of a
2.5 M solution in hexanes) and diisopropylamine (10.0 mmol, 1.0 eq) in dry THF 
(3 ml) at -78°C under an inert atmosphere o f argon. The mixture was stirred for 
20 minutes and a solution o f the iodoalkane (10.5 mmol, 1.05 eq) in THF (2 ml) 
was added dropwise and the resulting solution allowed to warm to room 
temperature. The reaction mixture was quenched with saturated aqueous 
ammonium chloride (2 x 1 0  ml), the organic layer was decanted and the aqueous 
layer extracted with ether (2 x 10 ml). The combined organic fractions were 
washed with brine ( 2 x 1 0  ml), dried over MgSC>4, filtered and concentrated under 
reduced pressure. The product was purified by column chromatography to give 
the desired product.
7.2.25 General procedure for the reduction of the 2-
(iodophenyl)acetonitrile derivative using DIBAL 
(GP25)
DIBAL (41.2 mmol o f a 1M solution in toluene, 2.0 eq) was added to a 
stirred solution of 2 -(iodophenyl)acetonitrile derivative (2 0 . 6  mmol, 1 .0  eq) in dry 
toluene (10 ml) at -78°C  under an inert atmosphere of argon for 30 minutes. The 
resulting solution was allowed to warm up to room temperature and stirred for a 
further hour. The solution was hydrolysed with 5% sulphuric acid (10 ml) and the 
solution extracted with ethyl acetate ( 2 x 1 0  ml). The pH of the aqueous layer was 
raised to pH 4.5 using sodium hydroxide and further extracted with ethyl acetate 
( 3 x 1 0  ml). The combined organic fractions were washed with brine ( 2 x 1 0  ml), 
dried over MgSCL, filtered and concentrated under reduced pressure. The product 
was purified by column chromatography to give the desired product.
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7.2.26 General procedure for the a-functionalisation of 
propiophenone (GP26)
The chiral hypervalent iodine compound (0.5 mmol, 1.0 eq) and 
/7-toluenesulphonic acid monohydrate (0.6 mmol, 1.2 eq) were dissolved in 
dichloromethane (3 ml). Propiophenone (0.5 mmol, 1.0 eq) was added at 
temperatures between -30°C -25°C . The solution was stirred at this temperature 
for 4-24 hours. After filtration through silica gel, the solvent was removed under 
reduced pressure and the residue purified by flash chromatography on silica gel.
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7.5 Experimental Data
[Bis(trifluoroacetoxy)iodo] benzene6 - 10
I(OCOCF3)2
Synthesised according to GP15 with iodobenzene 2 (1.5 g, 7.35 mmol) in DCM (5 
ml) added to a previously prepared solution o f trifluoroacetic anhydride (13.4 g, 
63.78 mmol) and urea hydrogen peroxide (1.5 g, 15.95 mmol) in DCM (10 ml). 
Product was isolated by washing with pentane. Yield 96% (3.034 g, 7.058 mmol) 
of a white powder, mp = 120-122 °C. Spectroscopic data agrees with literature. 
lU NMR (CDC13, 500 MHz) 5H: 7.62 (2H, d, J =  8.0 Hz, //-arom), 7.74 (1H, t, J  =
8.0 Hz, H-arom), 8.20 (2H, d, J  = 8.0 Hz, //-arom); ,3C NMR, (CDCI3, 100 MHz) 
6 C: 112.8 (q, JCF = 290 Hz, COCF3, C-8 ), 122.8 (C-l), 132.0 (C-3 & 5), 133.7 (C- 
4), 135.1 (C -2& 6) 161.1 (q, J cf = 41 Hz, COCF3, C-l).
2-Iodobenzaldehyde7 - 51
Synthesised according to GP1 with 2-iodobenzyl alcohol 43 (5.0 g, 21.36 mmol) 
in dichloromethane (15 ml) stirred with pyridinium chlorochromate (9.91 g, 32.01 
mmol) in dichloromethane (50 ml) at 0°C. Yield 96% (4.73 g, 21.38 mmol), 
yellow solid, mp 34-35°C. Spectroscopic data consistent with literature. lH NMR, 
(CDCI3, 400 MHz) 5h: 7.34 (1H, dd, J =  7.4, 1.3 Hz, //-arom), 7.51 (1H, dd, J  =
7.4, 1.1 Hz, H-arom), 7.92 (1H, d, J =  7.9 Hz, //-arom) 8.00 (1H, d, J =  7.9 Hz, H- 
arom), 10.13 ( 1 H, s, C //0 ); l3C NMR, (CDCI3, 100.4 MHz) Sc : 101.2 (C-l),
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129.1 (C-4), 130.7 (C-3), 133.4 (C-2), 135.9 (C-5), 141.0 (C-6 ), 196.1 (C-7); IR 
(Nujol): vmax= C =0 1703 cm '1.
(£)-and (Z)-l-(2-Iodophenyl)-2-methoxyethene8 - 51 & 52
OM e 9
Synthesised according to GP2 with (methoxymethyl)triphenylphosphonium 
chloride (7.32 g, 21.35 mmol) in dry THF (10 ml), 2-iodobenzaldehyde 51 (4.50 
g, 19.40 mmol) stirred in the presence o f nBuLi (12.42 ml, 31.04 mmol of a 2.5 M 
solution in hexanes) and diisopropylamine (4.35 ml, 31.04 mmol) in dry THF (5 
ml). The resulting solution was columned using petroleum ether / diethyl ether 
(15:1). Yield 91% (1.50g, 5.77 mmol, {E)\{7)  = 1:1), as a pale yellow oil. 
Spectroscopic data consistent with literature. *H NMR, (CDCI3, 250 MHz) 8 h: 
3.77 (3H (.E) or (Z), s, C //3), 3.81 (3H (E) or (Z), s, CH3\  5.50 (1H, d, J =  9.4 Hz, 
(Z)-C//OCH3), 6.02 (1H, d , J  = 12.8 Hz, (E)-C//OCH3), 6.26 (1H, d , J =  1 2  Hz, 
(Z)-C//=CHOCH3), 6.86-6.90 (2H, m, (E) & (Z) H-5). 6.95 (1H, d J =  12.8 Hz, 
(E)-C//=CHOCH3), 7.27-7.38 (2H, m, (E) & (Z) H-5), 7.85 (2H, ddd, J =  7.9, 1.7,
1.5 Hz, (E) & (Z) H-3), 8.30 (2H, dd, J =  7.9, 1.4 Hz, (E) & (Z) H-6 ); 13C NMR, 
(CDCI3, 62.5MHz) 6 C: 56.6 ((E) OCH3), 60.9 ((Z) OCH3), 99.5 ((Z) C -l), 99.8 
((E) C-l), 109.1 ((Z) CHOCH3), 109.5 ((E) CHOCH3), 125.2, 127.4 x 2, 128.0,
128.4, 129.6 ((E) & (Z) C-3,4,5), 138.3 ((Z) C-2) 139.3 ((Z) C-6 ), 139.5 ((E) C-
2), 139.6 ((E) C-6 ), 149.1 ((Z) CH=CHOCH3), 150.6 ((E) CH=CHOCH3); MS 
(El): m/z (%) = 260 (65) [M]+ , 118  (100); HRMS for C9H 10IO: calcd. 259.9693, 
found 259.9690 [M+H]+. IR (Liquid film): vmax= 1094 (C-O), 1636 (C=C) cm '1.
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(2-iodophenyl) acetaldehyde8 - 54
Synthesised according to GP3 with l-(2-iodophenyl)-2-methoxyethene 51 & 52 
(1.20, 4.61 mmol) stirred in formic acid (3.70 ml, 80.38 mmol) in DCM (10 ml). 
Yield 97% (1.03 g, 4.19 mmol), as a pale yellow oil required no further 
purification. *H-NMR, (CDC13, 400 MHz) 5H: 3.80 (2H, s, ArCH2), 6.93 (1H, dd, 
J=  7.6, 7.5 Hz, H-arom), 7.14 (1H, d , J =  7.5 Hz, H-arom), 7.27 (1H, dd, J =  7.5,
7.5 Hz, H-arom), 7.80 (1H, d, J =  7.6 Hz, H-arom), 9.70 (1H, s, C //0 ); 13C NMR, 
(CDC13, 100.4 MHz) 6 C: 55.1 (CH2), 101.5 (C-l), 129.2 (C-4), 129.7 (C-3), 131.4 
(C-2), 136.6 (C-5), 140.1 (C-6 ), 201.4 (C-8 ) ; MS (El) m/z {%) = 245 (7) [M]+, 
217 (62), 119 (100); IR (Neat) : vmax = 3058, 2942, 2928, 1724, 1582, 1563, 1467, 
1436, 1261, 1156, 1014, 8 6 8 , 800, 750 cm*1.
(±  )-l-(2-Iodophenyl)propan-2-ol -  55
Synthesised according to GP4 with methylmagnesium iodide (372 mg, 2.24 
mmol) and (2-iodophenyl) acetaldehyde 54 (550 mg, 2.24 mmol) stirred in dry 
diethyl ether (5 ml). The product was columned using petroleum ether/diethyl 
ether (6:1). Yield 97% (568 mg, 2.18 mmol), as a pale yellow oil. HPLC 
conditions: Chiracel OD-H column, hexane/2-propanol, 98:2, 0.5 ml/min, 10 °C, 
tR = 22.9 min (-)-enantiomer, ts = 24.5 min (+)-enantiomer: *H-NMR, (CDCI3, 
250 MHz) 8 h: 1-34 (3H, d , J =  6.2 Hz, CHi), 1.55 (1H, br s, OH), 2.89-2.95 (2H, 
m, ArC//2), 4.10-4.22 (1H, m, CH), 6.96 (1H, ddd, J  = 7.9, 6.9, 2.2 Hz, H-arom), 
7.25-7.36 (2H, m, H-arom), 7.78 (1H, dd, J  = 7.9, 1.0 Hz, H-arom); 13C NMR, 
(CDCI3, 62.5 MHz) 8C: 23.0 (C-9), 49.9 (C-7), 67.7 (C-8 ), 101.2 (C-l), 128.4 (C-
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4), 128.4 (C-3), 130.9 (C-5), 139.8 (C-6 ), 141.4 (C-2); MS (ES+): m/z (%) = 280 
(5) [M+NH4]+, 262 (4), 218 (45), 105 (5), 91 ( 1 0 0 ), 45 (47); HRMS for 
C9H15INO: calcd. 280.0193, found 280.0195 [M+NH4]+; IR (Neat): vmax = 3399, 
2930, 1455, 1380, 1151, 1031 cm*1.
(5)-l-(2-IodophenyI)propan-2-ol -  56
Synthesised according to GP9 with 1-(2-iodophenyl)propan-2-one 57 (550 mg, 
2.235 mmol) added to a stirred solution of (-)-/?-chlorodiisopinocampheylborane 
(789 mg, 2.459 mmol) in dry THF (5 ml). Diethyl ether (10 ml) was added along 
with diethanolamine (517 mg, 4.918 mmol). The product was columned using 
petroleum ether/diethyl ether (6:1). Yield 67%, 34% ee (393 mg, 1.498 mmol), 
pale yellow oil. The enantiomers could be separated by preparative HPLC: 
Chiracel OD column, hexane/2-propanol, 99:1, 3 ml/min, 10 °C, /r  = 128.3 min 
(-)-enantiomer, ts = 143.9 min (+)-enantiomer: Enantiomer 2 (Rf= 143.9 min):
[<x]"= + 21.28 (c = 0.19, CHCI3, >99% ee); 'H-NMR, (CDC13, 250 MHz) 5H:
1.34 (3H, d, J  = 6.2 Hz, C tf3), 1.55 (1H, br s, OH), 2.89-2.95 (2H, m, ArCH2), 
4.10-4.22 (1H, m, CH), 6.96 (1H, ddd, J  = 7.9, 6.9, 2.2 Hz, H-arom), 7.25-7.36 
(2H, m, H-arom), 7.78 (1H, dd, J =  7.9, 1.0 Hz, H-arom); l3C NMR, (CDC13, 62.5 
MHz) 8 C: 23.0 (C-9), 49.9 (C-l) ,  67.7 (C-8 ), 101.2 (C-l), 128.4 (C-4), 128.4 (C-
3), 130.9 (C-5), 139.8 (C-6 ), 141.4 (C-2); MS (ES+): m/z (%) = 280 (5) 
[M+NH4f ,  262 (4), 218 (45), 105 (5), 91 (100), 45 (47); HRMS for C9H 15INO: 
calcd. 280.0193, found 280.0195 [M+NH4]+; IR (Neat): vmax = 3399, 2930, 1455, 
1380, 1151, 1031 cm '1.
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l-(2-Iodophenyl)propan-2-one9 - 57
Synthesised according to GP1 with l-(2-iodophenyl)propan-2-ol 55 (449 mg, 1.71 
mmol) in dichloromethane (15 ml) stirred with pyridinium chlorochromate (554 
mg, 2.57 mmol) in dichloromethane (10 ml) at 0°C. Yield 90% (401 mg, 1.54 
mmol) as a yellow oil. Spectroscopic data agrees with literature. ]H NMR, 
(CDC13, 250 MHz) 5h: 2.22 (3H, s, C //3), 3.89 (2H, s, ArCH2), 6.98 (1H, d, J  =
7.5 Hz, H-arom), 7.17 (1H, d, J =  7.7 Hz, //-arom), 7.31 (1H, d, J =  7.7 Hz, H- 
arom), 7.85 (1H, d, J =  7.5 Hz, H-arom). ,3C NMR(CDC13, 62.5 MHz) 5C: 30.4 
(C-9), 48.1 (C-7), 99.1 (C -l), 127.4 (C-4), 128.8 (C-5), 130.8 (C-3), 138.1 (C-6 ), 
140.3 (C-2), 208.2 (C-8 ); HRMS for C9H 13INO: calcd. 278.1750, found 278.1752 
[M+NH4]+; IR (Nujol): vmax = 1709 ( C O )  cm ' 1
(iS)-l-Iodo-2-(-2-methoxypropyl)benzene - 58
Synthesised according to GP5 with sodium hydride (53 mg, 2.22 mmol) 
suspended in DMF (2 ml) stirred with (5)-l-(2-iodophenyl)propan-2-ol 56 (193 
mg, 0.74 mmol) and methyl iodide (105 mg, 0.74 mmol). The product was 
purified by column chromatography hexane/ethyl acetate (4:1). Yield 96% (195
mg, 0.71 mmol) as a pale yellow oil. [a ]”  = + 41.22 (c = 0.12, CHC13). !H-NMR,
(CDC13, 250 MHz) 8 H: 1.10 (3H, d, J =  6.1 Hz, C //3), 2.67 (1H, dd, J =  13.5, 6 .6  
Hz, ArC//ACHB), 2.98 ( 1 H, dd, J  = 13.6, 6.5 Hz, ArCHAC //B), 3.28 (3H, s, 
OCHi), 3.52-3.57 (1H, m, CH), 6.81 (1H, ddd, J = 8.0, 6.5, 1.4 Hz, H-arom), 
7.12-7.21 (2H, m, H-arom), 7.74 (1H, dd, J =  8.0, 1.0 Hz, H-arom); 13C-NMR, 
(CDC13, 62.5 MHz) 5C; 18.0 (C-9), 28.7 (C-7), 49.1 (C-10), 55.5 (C-8 ), 100.3 (C-
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1), 127.0 (C-4), 127.1 (C-3), 130.1 (C-5), 138.4 (C-6 ), 140.7 (C-2); MS (ES+): mfz 
(%) = 276 (16) [M]+, 217 (34), 105 (9), 91 (100), 58 (37); HRMS for C 10H 14IO: 
calcd. 276.112, found 276.1115 [M+H]+; IR (Neat): vmax = 2820, 1544, 1469, 
1366, 1169, 1122, 1089, 1010, 907, 751, 717 cm-1. An authentic sample of 
racemic 58, (±  )-l-iodo-2-(-2-methoxypropyl)benzene, was prepared from 55 as 
described previously: HPLC conditions: Chiracel OD-H column, hexane/2- 
propanol, 99:1, 0.5 ml/min, 22 °C, /r = 8.4 min (-)-enantiomer, = 9.9 min (+)- 
enantiomer. The racemic ether gave baseline separation and a 1:1 ratio of 
integrated areas.
(S)-l-(-2-Ethoxypropyl)-2-iodobenzene - 59
Synthesised according to GP5 with sodium hydride (55 mg, 2.29 mmol) 
suspended in DMF (2 ml) stirred with (S)-l-(2-iodophenyl)propan-2-ol 56 (200 
mg, 0.76 mmol) and ethyl iodide (119 mg, 0.76 mmol). The product was purified 
by column chromatography hexane/ethyl acetate (4:1). Yield 90% (199 mg, 0.67 
mmol) as a pale yellow oil. [a ]^ 6 = + 39.28 (c = 0.17, CHCI3). !H-NMR, (CDCI3,
250 MHz) 8 h: 1.09 (3H, t, J =  7.0 Hz, CH3CH2), 1.15 (3H, d, J =  6.0 Hz, C //3), 
2.65 (1H, dd, J  = 13.4, 6.5 Hz, A rC //ACHB), 2.96 (1H, dd, J  = 13.4, 6.5 Hz, 
ArCHAC //B), 3.47-3.54 (1H, m, CH), 3.55 (2H, d, J  = 6.9 Hz, CH3C //2), 6.85 
(1H, atd, J =  7.9, 1.1 Hz, H-arom), 7.11-7.22 (2H, m, H-arom), 7.73 (1H, dd, J  = 
7.9, 1.0 Hz, H-arom); ,3C-NMR, (CDC13, 62.5 MHz) 5C; 16.9 (C-l 1), 20.2 (C-9),
37.7 (C-7), 64.0 (C-10), 66.1 (C-8 ), 99.3 (C-l), 127.0 (C-4), 127.6 (C-5), 130.0 
(C-3), 137.7 (C-6 ), 141.2 (C-2); MS (ES+): m/z (%) = 290 (11) [M]+, 261 (39), 
217 (30), 105 (11), 91 (100); HRMS for C 10H 14IO: calcd. 290.0201, found 
290.0197 [M+H]+; IR (Neat): vmax = 2957, 2920, 1559, 1449, 1371, 1110, 1013 
cm*1. An authentic sample o f racemic 59 (±  )-l-iodo-2-(-2-ethoxypropyl)benzene, 
was prepared from 55 as described above: HPLC conditions: Chiracel OD-H
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column, hexane/2-propanol, 99:1, 0.5 ml/min, 20 °C, /r = 8.9 min (-)-enantiomer, 
ts= 12.1 min (+)-enantiomer. The racemic ether gave baseline separation and 1:1 
ratio of integrated areas.
1 -((S)-2-Benzoxypropyl)-2-iodobenzene- 60
3 7 9
Synthesised according to GP5 with sodium hydride (55 mg, 2.29 mmol) 
suspended in DMF (2 ml) stirred with (S)-l-(2-iodophenyl)propan-2-ol 56 (200 
mg, 0.76 mmol) and benzyl chloride (130 mg, 0.76 mmol). The product was 
purified by column chromatography hexane/ethyl acetate (5:1). Yield 72% (194
mg, 0.55 mmol) as a pale yellow oil. [a]^ = + 50.02 (c = 0.22, CHCI3, >99% ee).
HPLC conditions: ‘H-NMR, (CDCI3 , 250 MHz) 8 H: 1.19 (3H, d, J  = 6.1 Hz, 
CH^,  2.64 (1H, dd , J =  12.9, 6.4 Hz, A rC //ACHB), 2.86 (1H, dd, J=  12.9, 6.4 Hz, 
ArCHAC //B), 3.45-3.54 (1H, m, CH), 3.60 (2H, d, J  = 7.0 Hz, OCH2), 6.83 (1H, 
atd, J =  7.8, 1.1 Hz, H-arom), 7.15-7.30 (7H, m, H-arom), 7.65 (1H, d d ,./ = 7.8,
1.0 Hz, H-arom); n C-NMR, (CDCI3, 62.5 MHz) 8 C: 20.1 (C-9), 38.7 (C-7), 69.1 
(C-8 ), 69.6 (C-10), 98.3 (C -l), 127.0 (C-4), 127.1 (C-5), 127.5 (C-Ar*), 127.8 (C- 
Ar*), 128.6 (C-Ar*) 130.1 (C-3), 138.4 (C-6 ), 138.6 (C-Ar*,) 141.7 (C-2); MS 
(EI+): m/z (%) = 352 (13) [M]+, 276 (44), 231 (36), 217 (19), 105 (100), 91 (21); 
HRMS for C i6H2|INO: calcd. 370.2348, found 370.2355 [M+NH4f ;  IR (Neat): 
vmm = 2957, 2920, 1559, 1462, 1431, 1372, 1121, 1057, 1009 cm '1. An authentic 
sample of racemic 60, 1 - (± )-2 -benzoxypropyl)-2 -iodobenzene, was prepared 
from 55 as described above: HPLC conditions: Chiracel OD-H column, hexane/2- 
propanol, 98:2, 0.5 ml/min, 21 °C, (r = 12.2 min (-)-enantiomer, ts = 17.9 min 
(+)-enantiomer. The racemic ether gave baseline separation and 1:1 ratio of 
integrated areas.
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(±  )-T-(-2-Trifluoroacetoxypropyl)-2-iodobenzene10 - 61
Synthesised according to GP6  with trifluoroacetic anhydride (220 mg, 1.05 mmol) 
added to a stirred solution o f (±  )-l-(2-iodophenyl)propan-2-ol 55 (229 mg, 0.87 
mmol) and triethylamine (106 mg, 1.05 mmol) in DCM (2 ml). The product was 
purified by column chromatography petroleum ether/diethyl ether (1:1). Yield 
69% (217 mg, 0.61 mmol) as a colourless oil. !H NMR, (CDCI3, 400 MHz) 5h:
1.34 (3H, d, J =  6.3 Hz, CHi), 2.99-3.04 (2H, m, ArCH2), 5.28-5.34 (1H, m, CH), 
6.85 (1H, atd, J =  7.4, 1.7 Hz, H-arom), 7.11 (1H, dd, J =  7.8, 1.7 Hz, H-arom), 
7.19 (1H, atd, J =  7.8, 1.7 Hz, H-arom), 7.74 (1H, dd, J =  7.4, 1.7 Hz, H-arom). 
13C NMR, (CDCI3, 100.7 MHz) 5C: 19.4 (C-9), 46.1 (C-7), 75.5 (C-8 ), 100.7 (C-
1), 115.0 (q, JCF = 288 Hz, C - ll) ,  128.4 (C-4), 128.9 (C-5), 130.3 (C-3), 139.7 
(C-6 ), 1403.7 (C-2), 158.7 (q, J CF = 39.5 Hz, C-10); MS (E f): m/z (%) = 358 
(100) [M]+, 334 (9), 318 (43), 304 (8 ), 91 (45); IR (Neat): vmax = 3102, 1712, 
1207, 1180, 1104 cm’1.
(±  )-l-(-2-Tert-Butoxypropyl)-2-iodobenzenen - 62
Synthesised according to GP7 with concentrated sulphuric acid (42 mg, 0.43 
mmol) added to a stirred suspension of anhydrous M gS04 (209 mg, 1.74 mmol) in 
cyclohexane (3 ml). fBuOH (160 mg, 2.2 mmol) and (± )-l-(2 - 
iodophenyl)propan-2-ol 55 (114 mg, 0.43 mmol) was added dropwise to the 
resulting solution. The product was purified by column chromatography 
petroleum ether/diethyl ether (5:1). Yield 87% (120 mg, 0.38 mmol) as a pale
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yellow oil. 'H-NMR, (CDC13, 250 MHz) 5H: 1.17 (9H, s, (CH3)3), 1.20 (3H, d, J  =
6.4 Hz, C //3), 2.78 (1H, dd, J  = 13.6, 4.7 Hz, ArC/7ACHB), 2.88 (1H, dd, J =  13.6,
4.7 Hz, ArCHAC //B), 4.04-4.09 (1H, m, C//), 6.85 ( 1H, atd, J =  7.8, 1.2 Hz, H- 
arom), 7.16-7.21 (2H, m, H-arom), 7.60 (1H, dd, J =  7.8, 1.0 Hz, //-arom); l3C- 
NMR, (CDC13, 62.5 MHz) 8 C: 22.2 (C-9), 29.6 (C-l 1), 39.8 (C-7), 66.1 (C-8 ),
73.0 (C-10), 98.4 (C -l), 127.0 (C-4), 127.4 (C-5), 129.0 (C-3), 137.5 (C-6 ), 141.5 
(C-2); MS (EI+): m/z (%) = 318 (12) [M]+, 261 (37), 217 (100), 105 (17), 91 (45); 
HRMS for C 13H20lO: calcd. 319.1966, found 319.1970 [M+H]+; IR (Neat): vmax = 
2967, 2885, 1580, 1480, 1459, 1368, 1110, 1070, 1013 cm '1.
(S)-l-(Diacetoxyiodo)-2-(-2-methoxypropyl)benzene - 63
I(OAc)2
Synthesised according to GP12 with peracetic acid (0.88 ml of a 30% solution in 
acetic acid) added to a stirred solution o f (5)-l-iodo-2-(-2-methoxypropyl)benzene 
58 (63 mg, 0.22 mmol) in acetic acid (5 ml). Product was isolated by 
recrystallisation from acetic acid/pentane. Yield 39% (35 mg, 0.09 mmol) as a 
white powder, mp = 107—110°C. [a]^ = + 89.41 (c = 0.34, CHCI3). !H NMR,
(CDCI3, 250 MHz) 6 h: 1.16 (3H, d, J =  6.1 Hz, CHi), 1.87 (6 H, s, {OCOCH2)2\  
2.94-3.01 (2H, m, ArCH2), 3.44 (3H, s, O C //3), 3.59-3.64 (1H, m, CH2CH), 7.19 
(1H, d, J  = 7.7 Hz, H-arom), 7.40-7.47 (2H, m, H-arom), 8.10 (1H, d, J =  7.8 Hz, 
H-arom); 13C-NMR, (CDC13, 62.5 MHz) 8 C: 20.3 ((OCOCH3)2, C-12), 21.3 (C-9),
33.9 (C-7), 49.1 (C-10), 58.9 (C-8 ), 118.3 (C-l), 127.9 (C-Ar), 127.1 (C-Ar),
130.1 (C-Ar), 139.0 (C-6 ), 141.7 (C-2), 175.6 (C=0, C -ll)), 175.7 (C=0, C-l 1); 
IR(Nujol): vmax = 2906, 1720, 1615, 1560, 1455, 1380, 1149, 1012cm '1.
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(iS)-l-(Diacetoxyiodo)-2-(-2-ethoxypropyl)benzene - 64
Synthesised according to G P11 with sodium perborate tetrahydrate (477 mg, 3.10 
mmol) added portion wise to a solution of (*S)-l-(-2-ethoxypropyl)-2-iodobenzene 
59 (89 mg, 0.31 mmol) in glacial acetic acid (5 ml). Product was isolated by 
recrystallisation from acetic acid/pentane. Yield 15% (19 mg, 0.047 mmol) as a
white powder, mp = 99-103 °C. [<x]£= + 61.1 (c = 0 .1 2 , CHC13). *H NMR,
(CDCI3, 250 MHz) 8 H: 1.16 (3H, t , J =  7.0 Hz, CH2C //3), 1.21 (3H, d, J =  6.0 Hz, 
C //3), 1.90 (6 H, s, (OCOC7 /3)2), 2.96-3.00 (2H, m, ArCH2), 3.75 (2H, q, J =  7.0 
Hz, OC//2CH3), 3.56-3.60 (1H, m, CH), 7.14 (1H, d, J  = 7.8 Hz, H-arom), 
7.39-7.44 (2H, m, //-arom ), 8.11 (1H, d, J =  8.0 Hz, //-arom); 13C-NMR, (CDC13,
62.5 MHz) 6 c: 2 0 . 0  (C-l 1 ), 2 0 .6 , ((OCOCH3)2, C-13), 21.3 (C-9), 33.5 (C-7), 49.6 
(C-10), 59.0 (C-8 ), 118.0 (C -l), 127.8 (C-Ar), 128.3 (C-Ar), 130.1 (C-Ar), 139.1 
(C-6 ), 142.5 (C-2), 175.9 (C =0, C -l2), 176.1 (C=0, C -l2); IR (Nujol): vmax = 
2944, 2910, 1710, 1559, 1455, 1375, 1122, 1013 cm '1.
(S)-l-(Diacetoxyiodo)-2-(-2-benzoxypropyl)benzene - 65
Synthesised according to G P11 with sodium perborate tetrahydrate (354 mg, 2.30 
mmol) added portion wise to a solution of (S)-l-(-2 -benzoxypropyl)-2 - 
iodobenzene 60 (100 mg, 0.23 mmol) in glacial acetic acid (5 ml). Product was 
isolated by recrystallisation from acetic acid/pentane. Yield 9% (12 mg, 0.026
mmol) as a white powder, mp = 110—113°C. [a ]^ 1 = + 77.2 (c = 0.12, CHCI3). !H-
NMR, (CDCI3, 250 MHz) 6 H: 1.19 (3H, d, J  = 6.1 Hz, C //3), 2.01 (6 H, s,
I(OAc)2
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(OCOC//3)2), 2.77 (1H, dd, J =  13.2, 6.7 Hz, ArC//ACHR), 2.96 (1H, dd, J  = 13.1,
7.2 Hz, ArCHAC //B), 3.38-3.42 ( 1 H, m, CH), 3.99 (2H, d, J  = 7.0 Hz, OCH2),
7.02 (1H, atd, J = 8.2, 1.1 Hz, //-arom ), 7.15-7.46 (7H, m, H-arom), 8.02 (1H, dd, 
J  = 8.2, 1.2 Hz, //-arom ); 13C-NMR, (CDC13, 62.5 MHz) 5C: 20.1 (C-9), 20.5 
((OCOCH3)2, C -l6 ), 38.7 (C-7), 69.1 (C-8 ), 69.6 (C-10), 127.5 (C-Ar), 127.8 (C- 
Ar), 128.6 (C-Ar), 129.8 (C-Ar), 130.2 (C-Ar), 130.9 (C-3), 132.2 (C-l), 138.6 
(C-Ar), 139.4 (C-6 ), 143.0 (C-2), 176.9 (C O , C-15), 177.0 (C O , C-15); No IR 
obtained.
(5)-l-[Bis(trifluoroacetoxy)iodo]-2-(-2-methoxypropyl)benzene -  66
I(OCOCF3)2
Synthesised according to GP15 with (S)-l-iodo-2-(-2-methoxypropyl)benzene 58 
(100 mg, 0.36 mmol) in DCM (2 ml) was added to a previously prepared 
trifluoroacetic anhydride (190 mg, 0.905 mmol) and urea hydrogen peroxide (341 
mg, 3.62 mmol) in DCM (5 ml). Yield 6 % (11 mg, 0.022 mmol) of a white 
powder. 'H NMR, (CDCI3 , 400 MHz) 8 H: 1.29 (3H, d, J =  6.1 Hz, C //3), 2.84- 
2.90 (2H, m, ArCHi), 3.47 (3H, s, O C //3), 4.00-4.05 (1H, m, CH), 7.09-7.25 (2H, 
m, //-arom), 7.60 (1H, d, J =  7.7 Hz, H-arom), 8.16 (1H, d, J  = 8.0 Hz, //-arom); 
l3C NMR (CDCI3 , 125.7 MHz): 8  = 24.0 (C-9), 39.0 (C-7), 57.5 (C-10), 83.4 (C- 
8 ), 113.0 (q, Jcf = 290  Hz, CF3, C -12), 126.9 (C-Ar), 128.6 (C-Ar), 131.4 (C-Ar),
133.4 (C-l), 141.4 (C-6 ), 144.3 (C-2), 161.5 (q, JCF = 40 Hz, C=0, C-l 1); No IR 
obtained.
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(±  )-2-(2-Iodophenyl)-l-phenylethanol12 -  67
Synthesised according to GP4 with phenylmagnesium bromide (1.275 g, 7.03 
mmol) and (2-iodophenyl) acetaldehyde 54 (1.730 g, 7.03 mmol) stirred in dry 
diethyl ether (10 ml). The product was columned using petroleum ether/diethyl 
ether (7:1). Yield 85% (1.94 g, 5.98 mmol), pale yellow oil. The enantiomers 
could be separated by preparative HPLC: Chiracel OD column, hexane/2- 
propanol, 93:7, 3 ml/min, 10 °C, = 17.2 min (+)-enantiomer, ts = 19.9 min (-)-
enantiomer: *H-NMR, (CDC13, 500 MHz) 8n: 1.82 (1H, br s, OH), 3.02 (1H, dd, J  
= 13.8, 9.0 Hz, A rC //ACHB), 3.09 (1H, dd, J  = 13.8, 4.3 Hz, ArCHAC //B) 4.93 
(1H, dd, J  = 9.0, 4.3 Hz, C //OH), 6 . 8 6  (1H, atd, J =  7.6, 1.7 Hz, //-arom), 7.12 
(1H, dd, J  = 7.7, 1.1 Hz, //-arom ), 7.18 (1H, dd, J  = 7.7, 7.2 Hz, //-arom), 7.22 
(1H, atd, J  = 7.3, 1.5 Hz, //-arom ), 7.29 (2H, d, J =  7.5 Hz, //-arom), 7.37 (2H, d, 
J =  7.5 Hz, H-arom), 7.79 (1H, dd, J =  7.6, 1.1 Hz, //-arom); 13C NMR, (CDC13, 
125 MHz) 6 C: 50.5 (C-7), 73.5 (C-8 ), 101.1 (C-2), 126.7 (C-5), 127.2 (C-Ar),
127.6 (C-Ar), 128.3 (C-4), 129.0 (C-Ar), 131.4 (C-3), 139.7 (C-6 ), 140.3, (C-9),
143.8 (C-l); MS (EI+): m/z (%) = 324 (1) [M]+, 307 (1), 218 (93), 107 (100), 90 
(17); HRMS for C hH hIO : calcd. 324.0011, found 324.0029 [M+H]+; IR (Neat): 
vmax = 3153, 2966, 2921, 2358, 2320, 1795, 1722, 1676, 1563, 1098 cm '1.
(iS)-2-(2-Iodophenyl)-l-phenylethanol12 -  68
Synthesised according to GP4 with phenylmagnesium bromide (1.275 g, 7.03 
mmol) and (2 -iodophenyl) acetaldehyde 54 (1.730 g, 7.03 mmol) stirred in dry
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diethyl ether (10 ml). The product was columned using petroleum ether/diethyl 
ether (7:1). Yield 85% (1.94 g, 5.98 mmol), o f a pale yellow oil. HPLC 
conditions: Chiracel OD-H column, hexane/2-propanol, 93:7, 0.5 ml/min, 10 °C,
tr = 10.2 min (+)-enantiomer, t$ = 14.7 min (-)-enantiomeaqr. [a ]^3 = -  48.72 (c =
0.26, CHC13, >99% ee); 'H-NMR, (CDC13, 500 MHz) 8 H: 1.82 (1H, br s, OH),
3.02 (1H, dd, J  = 13.8, 9.0 Hz, A rC //ACHB), 3.09 (1H, dd, J  = 13.8, 4.3 Hz, 
ArCHAC //B) 4.93 (1H, dd, J =  9.0, 4.3 Hz, C7/0H), 6 . 8 6  (1H, atd, J =  7.6, 1.7 Hz, 
//-arom), 7.12 (1H, dd, J =  7.7, 1.1 Hz, H-arom), 7.18 (1H, dd, J =  7.7, 7.2 Hz, H- 
arom), 7.22 (1H, atd, J  = 7.3, 1.5 Hz, //-arom), 7.29 (2H, d, J =  7.5 Hz, H-arom), 
7.37 (2H, d, J  = 7.5 Hz, H-arom), 7.79 (1H, dd, J  = 7.6, 1.1 Hz, H-arom); l3C 
NMR, (CDCI3, 125 MHz) Sc : 50.5 (C-7), 73.5 (C-8 ), 101.1 (C-2), 126.7 (C-5),
127.2 (C-Ar), 127.6 (C-Ar), 128.3 (C-4), 129.0 (C-Ar), 131.4 (C-3), 139.7 (C-6 ),
140.3, (C-9), 143.8 (C -l); MS (EI+): mlz (%) = 324 (1) [M]+, 307 (1), 218 (93), 
107 (100), 90 (17); HRMS for C 14H 14IO: calcd. 324.0011, found 324.0029 
[M+H]+; IR (Neat): vmax = 3153,2966,2921,2358, 2320, 1795, 1722, 1676, 1563, 
1098 c m 1.
(iS)-l-(-2-(2-Iodophenyl)-l-methoxyethyl)benzene - 69
Synthesised according to GP5 with sodium hydride (14 mg, 0.593 mmol) 
suspended in DMF (2 ml) stirred with (5)-2-(2-iodophenyl)-l-phenylethanol 6 8  
(64 mg, 0.197 mmol) and methyl iodide (28 mg, 0.197 mmol). The product was 
purified by column chromatography petroleum ether/diethyl ether (2 0 :1 ).
Yield 95% (63 mg, 0.188 mmol) as a pale yellow oil. [a]33= -  57.80 (c = 0.20,
CHCI3): ’H-NMR, (CDCI3, 500 MHz) 6 h: 2.92 (1H, dd, J  = 13.8, 9.0 Hz, 
ArC//ACHB), 3.11 ( 1 H, dd, J =  13.8, 8 . 2  Hz, ArCHAC //B), 4.35 (1H, dd, J =  8.2,
5.3 Hz, CH), 5.20 (3H, s, O C //3) 6.81 (1H, atd, J =  7.7, 1.7 Hz, //-arom), 6.99
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(1H, dd, J  = 7.6, 1.7 Hz, //-arom), 7.12 (1H, dd, J  = 7.5, 1.7 Hz, H-arom), 
7.15-7.28 (5H, m, H-arom), 7.75 (1H, dd, J  = 7.7, 1.2 Hz, //-arom); 13C NMR, 
(CDC13, 125.7 MHz) 5C: 49.3 (C-7), 57.0 (C-13), 83.0 (C-8 ), 101.0 (C-l), 126.7 
(C-Ar), 127.6 (C-4), 128.3 (C-5), 128.4 (C-Ar), 129.0 (C-Ar), 131.5 (C-3), 139.3 
(C-6 ), 141.2, (C-9), 141.5 (C-2); MS (EI+): m/z (%) = 338 (36) [M]+, 323 (100), 
307 (12), 231 (40); HRMS for Ci5Hi6IO: calcd. 338.1282, found 338.1282 
[M+H]+; IR (Neat): vmax -  3079, 3054, 2901, 1610, 1586, 1190, 1159, 1037, 1002 
cm'1. An authentic sample o f racemic 69, (±  )-l-(-2-(2-iodophenyl)-l- 
methoxyethyl)benzene, was prepared from 67 as described above: HPLC 
conditions: Chiracel OD-H column, hexane/2-propanol, 98:2, 0.5 ml/min, 24 °C, 
Jr = 14.3 min (+)-enantiomer, t$ = 17.7 min (-)-enantiomer. The racemic ether 
gave baseline separation and a 1 :1  ratio o f integrated areas.
(,S)-l-(-l-Ethoxy-2-(2-iodophenyl)ethyl)benzene - 70
Synthesised according to GP5 with sodium hydride (18 mg, 0.759 mmol) 
suspended in DMF (2 ml) stirred with (S)-2-(2-iodophenyl)-1 -phenylethanol 6 8  
(82 mg, 0.253 mmol) and ethyl iodide (39 mg, 0.253 mmol). The product was 
purified by column chromatography petroleum ether/diethyl ether (2 0 :1).
Yield 85% (76 mg, 0.215 mmol) as a pale yellow oil. [a]^°= -  57.76 (c = 0.11,
CHCI3): ‘H-NMR, (CDCI3, 500 MHz) 5H: 1.01 (1H, t, J  = 7.0 Hz, C //3), 2.92 (1H, 
dd, J  = 13.8, 4.9 Hz, A rC //ACHB), 3.10 (1H, dd, J =  13.8, 8 . 6  Hz, ArCHAC //B), 
3.40 (2H, q, J =  7.0 Hz, C //2CH3), 4.43 (1H, dd, J =  8 .6 , 4.9 Hz, CH), 6.79 (1H, 
atd, J  = 8.0, 1.7 Hz, H-arom), 6.99 (1H, dd, J =  7.6, 1.6 Hz, //-arom), 7.10 (1H, 
atd, J  = 7.5, 1.0 Hz, //-arom ), 7.18-7.26 (4H, m, //-arom), 7.37 (1H, d, J  = 7.4 
Hz, H-arom), 7.73 (1H, dd, J  — 8.0, 0.9 Hz, //-arom); 13C NMR, (CDCI3, 125.7 
MHz) 5C: 15.2 (C-14), 49.4 (C-7), 46.5 (C-13), 81.0 (C-8 ), 101.1 (C-l), 126.6 (C-
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Ar), 127.5 (C-4), 127.7 (C-5), 128.0 (C-Ar), 128.3 (C-Ar), 131.6 (C-3), 139.2 (C-
6 ), 141.4, (C-9), 142.3 (C-2); MS (CI+): mtz (%) = 370 (43) [M+NH4]+, 324 (100), 
307 (6 ), 244 (45), 198 (81); HRMS for Ci6H2 iINO: calcd. 370.0662, found 
370.0662 [M+NH4]+; IR (Neat): vmax = 3055, 2898, 2875, 1609, 1570, 1455, 
1165, 1042, 999 cm '1. An authentic sample of racemic 70, (±  )-l-(-l-ethoxy-2-(2- 
iodophenyl)ethyl)benzene, was prepared from 67 as described above: HPLC 
conditions: Chiracel OD-H column, hexane/2-propanol, 98:2, 0.5 ml/min, 24 °C, 
/R = 12.0 min (+)-enantiomer, ts = 16.3 min (-)-enantiomer. The racemic ether 
gave baseline separation and a 1 :1  ratio of integrated areas.
(S)-l-(-l-(Benzyloxy)-2-(2-iodophenyl)ethyl)benzene - 71
Synthesised according to GP5 with sodium hydride (17 mg, 0.723 mmol) 
suspended in DMF (2 ml) stirred with (S)-2-(2-iodophenyl)-l-phenylethanol 6 8  
(78 mg, 0.241 mmol) and benzyl chloride (41 mg, 0.241 mmol). The product was 
purified by column chromatography petroleum ether/diethyl ether (20:1). Yield
74% (74 mg, 0.179 mmol) as a pale yellow oil. [a]„ = -  35.56 (c = 0.50, CHC13): 
'H-NMR, (CDCI3, 400 MHz) SH: 2.96 (1H, dd, J  = 13.8, 4.9 Hz, ArC//ACHB), 
3.15 (1H, dd, J =  13.8, 8 . 6  Hz, ArCHAC //B), 4.47 (2H, s, OCHi), 4.55 (1H, dd, J  
= 8 .6 , 4.9 Hz, CH), 6.72 (2H, dd, J =  7.6, 1.7 Hz, //-arom), 6.77 (2H, dd, J =  7.7,
7.5 Hz, //-arom), 6.81 (1H, a td .,/ = 7.9. 1.6 Hz, H-arom), 7.02 (1H, dd, J =  7.3,
2.0 Hz, //-arom), 7.05 (1H, dd, J  = 7.5, 1.8 Hz, H-arom), 7.12 (1H, d d ,./ = 7.5, 
0.9 Hz, //-arom), 7.15-7.30 (5H, m, //-arom), 7.72 (1H, dd, J =  7.9, 1.0 Hz, H- 
arom); l3C NMR, (CDCI3, 125.7 MHz) 8 C: 49.5 (C-7), 70.6 (C-13), 80.4 (C-8 ),
101.1 (C-l), 126.8 (C-5), 127.4 (C-Ar), 127.5 (C-4), 127.7 (C-Ar), 127.8 (C-Ar),
127.7 (C-Ar), 128.1 (C-Ar), 128.2 (C-Ar), 128.3 (C-Ar), 131.8 (C-3), 138.4 (C-
17
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14), 139.3 (C-6 ), 141.2, (C-9), 141.6 (C-2); MS (CI+): m/z (%) = 432 (83) 
[M+NH4]+, 324 (74), 306, (76), 198 (100); HRMS for C2iH23INO: calcd. 
432.0819, found 432.0821 [M+NH4]+; IR (Neat): vmax = 3056, 2980, 2930, 2822, 
1449, 1399, 1356, 1209, 1110, 1003 cm '1. An authentic sample of racemic 71, 
(±  )-l-(-l-ethoxy-2-(2-iodophenyl)ethyl)benzene, was prepared from 67 as 
described above: HPLC conditions: Chiracel OD-H column, hexane/2-propanol, 
99:1, 0.5 ml/min, 23 °C, *r = 18.3 min (+)-enantiomer, ts = 22.1 min (-)- 
enantiomer. The racemic ether gave baseline separation and a 1:1 ratio of 
integrated areas.
(±  )-2-(2-Iodophenyl)-l-phenylethyl 2,2,2-trifluoroacetate10 - 72
Synthesised according to GP6  with trifluoroacetic anhydride (108 mg, 0.514 
mmol) added to a stirred solution o f (±  )-l-(2-iodophenyl)propan-2-ol 57 (139 
mg, 0.428 mmol) and triethylamine (52 mg, 0.514 mmol) in DCM (2 ml). The 
product was purified by column chromatography petroleum ether/diethyl ether 
(1:1). Yield 55% (99 mg, 0.236 mmol) as a colourless oil. NMR, (CDCI3, 250 
MHz) 6 h: 2.98 (1H, dd, J =  13.0, 3.1 Hz, A rC //ACHB), 3.20 (1H, dd, J =  13.0, 7.9 
Hz, ArC//ACHB), 5.49 (1H, dd, J =  7.9, 3.1 Hz, CH), 6.84 (1H, d, J =  13  Hz, H- 
arom), 6.96 (1H, d, J =  7.6 Hz, //-arom ), 7.15-7.28 (6 H, m, //-arom), 7.60 (1H, d, 
J =  7.9 Hz, H-arom); ,3C NMR, (CDC13, 125.7 MHz) 6 C: 45.2 (C-7), 77.5 (C-8 ),
100.6 (C-l), 114.4 (q, JCF = 290 Hz, C-14), 127.0 (C-Ar), 127.7 (C-Ar), 128.0 (C- 
4), 128.6 (C-5), 129.1 (C-Ar), 130.9 (C-3), 139.7 (C-6 ), 140.5 (C-9), 142.7 (C-2),
158.1 (q, J c f  = 3 9 .5  Hz, C -l3); No IR obtained, product is unstable at room 
temperature.
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(iS)-l-(-2-(2-(Diacetoxy)iodophenyl)-l-methoxyethyl)benzene - 73
Synthesised according to G P11 with sodium perborate tetrahydrate (505 mg, 3.28 
mmol) added portion wise to a solution of (S)-l-(-2 -(2 -iodophenyl)-l- 
methoxyethyl)benzene 69 (150 mg, 0.328 mmol) in glacial acetic acid (5 ml). 
Product was isolated by recrystallisation from acetic acid/pentane. Yield 2% (3 
mg, 0.07 mmol) as a white powder. ^ -N M R , (CDCI3, 500 MHz) 8 h: 2.01 (6 H, s, 
(OCOC//3)2), 2.98-3.02 (2H, m, ArCH2), 3.19 (3H, s, OC//3), 4.42-1.48 (1H, m, 
C//), 7.01 (1H, d, J  = 7.7 Hz, //-arom ), 7.14 (1H, d, J  = 7.6 Hz, H-arom), 7.20 
(2H, d, J  — 7.5 Hz, H-arom), 7.30-7.55 (4H, m, H-arom), 8.03 (1H, d, J =  7.8 Hz, 
//-arom); No 13C obtained, insufficient quantity synthesised.
(S)-l-(-2-(2-[Bis(trifluoroacetoxy)iodo]phenyl)-l-methoxyethyl)benzene- 74
Synthesised according to GP15 with (iS)-l-iodo-2-(-2-methoxypropyl)benzene 69 
(110 mg, 0.325 mmol) in DCM (2 ml) added to a solution of trifluoroacetic 
anhydride (171 mg, 0.813 mmol) and urea hydrogen peroxide (306 mg, 3.25 
mmol) in DCM (5 ml). Yield 2% (4 mg, 0.006 mmol) of a white powder. *H 
NMR, (CDCI3, 400 MHz) 8 H: 1.30 (3H, d, J  = 6.1 Hz, C //3), 2.96-3.00 (2H, m, 
ArCH2), 3.15 (3H, s, O C //3), 4.18-1.23 (1H, m, CH), 6.90 (1H, d, J =  6.9 Hz, H- 
arom), 7.05 (2H, d, J  = 7.7 Hz, H-arom), 7.15 (1H, d, J =  7.8 Hz, H-arom), 7.27 
(1H, d, J =  7.7 Hz, H-arom), 7.39-7.60 (3H, m, H-arom), 8.18 (1H, d, J =  7.8 Hz, 
H-arom); No 13C obtained, insufficient quantity synthesised.
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(±  )-l-(2-Iodophenyl)-3-methylbutan-2-ol -  75
Synthesised according to GP4 with isopropylmagnesium chloride (723 mg, 7.03 
mmol) and (2-iodophenyl) acetaldehyde 54 (1.73 g, 7.03 mmol) stirred in dry 
diethyl ether (5 ml). The product was columned using petroleum ether/diethyl 
ether (6:1). Yield 87% (1.775 g, 6.12 mmol), pale yellow oil. HPLC conditions: 
Chiracel OD-H column, hexane/2-propanol, 90:10, 0.5 ml/min, 10 °C, /r = 16.8 
min (-)-enantiomer, ts = 19.4 min (+)-enantiomer: ^ -N M R , (CDCI3, 500 MHz) 
6 h: 0.93 (3H, d, J =  6 . 8  Hz, CH3), 0.98 (3H, d, J =  6 . 8  Hz, CH3), 1.60 (1H, br s, 
OH), 1.72-1.81 (1H, m, CH(CH3)2), 2.64 (1H, dd, J =  13.7, 9.9 Hz, ArCi/ACHB), 
2.95 (1H, dd, J =  13.7, 2.9 Hz, ArCHAC //B), 3.62 (1H, ddd, J =  9.9, 5.1, 2.9 Hz, 
CH), 6 . 8 6  (1H, atd, J  = 7.5, 2.0 Hz, H-arom), 7.19-7.24 (2H, m, H-arom), 7.77 
(1H, d, J  = 7.5 Hz, H-arom); l3C NMR, (CDC13, 125.7 MHz) 6 C: 17.5 (C-10),
33.7 (C-9), 45.1 (C-7), 75.7 (C-8 ), 101.1 (C-l), 128.3 (C-4), 128.4 (C-5), 131.0 
(C-3), 139.7 (C-6 ), 142.0 (C-2); MS (CI+): m/z {%) = 308 (37) [M+NH4]+, 291 
(40), 249 (17), 221 (100); HRMS for C u H |9INO; calcd. 308.0255, found 
308.0250 [M+NH4]+; IR (Neat): vma* = 3385, 2969, 2928, 1583, 1560, 1465, 
1433, 1374, 1088, 1008 cm '1.
(/?)-l-(2-Iodophenyl)-3-methylbutan-2-ol -  76
Synthesised according to GP4 with isopropylmagnesium chloride (723 mg, 7.03 
mmol) and (2 -iodophenyl) acetaldehyde 54 (1.73 g, 7.03 mmol) stirred in dry 
diethyl ether (5 ml). The product was columned using petroleum ether/diethyl
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ether (6:1). Yield 87% (1.775 g, 6.12 mmol), pale yellow oil. The enantiomers 
could be separated by preparative HPLC: Chiracel OD column, hexane/2 - 
propanol, 92:8, 2 ml/min, 10 °C, /r  = 19.8 min (-)-enantiomer, ts = 23.7 min (+)-
enantiomer: Enantiomer 1 (Rf = 19.8 min): [a]Jj = -  66.02 (c = 0.26, CHCI3,
>99% ee); 'H-NMR, (CDC13, 500 MHz) §H: 0.93 (3H, d, J =  6 . 8  Hz, C //3), 0.98 
(3H, d, J =  6 . 8  Hz, O h ) ,  1.60 (1H, br s, OH), 1.72-1.81 (1H, m, CH(CH2)2), 2.64 
(1H, dd, J  = 13.7, 9.9 Hz, A rC //ACHB), 2.95 (1H, dd, J  = 13.7, 2.9 Hz, 
ArCHAC //B), 3.62 (1H, ddd, J =  9.9, 5.1, 2.9 Hz, CH), 6 . 8 6  (1H, atd, J =  7.5, 2.0 
Hz, H-arom), 7.19-7.24 (2H, m, H-arom), 7.77 (1H, d, J =  7.5 Hz, H-arom); ,3C 
NMR, (CDCI3, 125.7 MHz) 8 C: 17.5 (C-10), 33.7 (C-9), 45.1 (C-7), 75.7 (C-8 ),
101.1 (C-l), 128.3 (C-4), 128.4 (C-5), 131.0 (C-3), 139.7 (C-6 ), 142.0 (C-2); MS 
(CI+): m/z (%) = 308 (37) [M+NH4]+, 291 (40), 249 (17), 221 (100); HRMS for 
C ||H |9INO: calcd. 308.0255, found 308.0250 [M +N H tf; IR (Neat): vmax = 3385, 
2969,2928, 1583, 1560, 1465, 1433, 1374, 1088, 1008 cm"1.
(/?)-l-Iodo-2-(-2-methoxy-3-methylbutyl)benzene - 77
Synthesised according to GP5 with sodium hydride (18 mg, 0.754 mmol) 
suspended in DMF (2 ml) stirred with (i?)-l-(2-iodophenyl)-3-methylbutan-2-ol 
76 (73 mg, 0.252 mmol) and methyl iodide (36 mg, 0.252 mmol). The product 
was purified by column chromatography petroleum ether/diethyl ether (14:1).
Yield 96% (74 mg, 0.243 mmol) as a pale yellow oil. [a ]^ 5 = -  72.54 (c = 0.78,
CHCI3): 'H-NMR, (CDCI3, 500 MHz) 5h: 0.94 (3H, d, J  = 6 . 8  Hz, Ctf3), 0.98 
(3H, d, J  = 6 . 8  Hz, C //3), 1.71-1.80 (1H, m, C//(CH3)2), 2.71 (1H, dd, J  -  13.8,
8.9 Hz, ArCH2\  2.82 ( 1 H, dd, J  = 13.3, 3.6 Hz, ArC//2), 3.08 (3H, s, OCH3), 3.16 
(1H, td J  = 8.9, 3.6 Hz CH), 6.82 (1H, ddd, J  = 8.0, 7.6, 1.9 Hz, H-arom), 
7.18 -  7.23 (2H, m, H-arom), 7.74 (1H, dd, J  = 8.0, 1.1 Hz, H-arom); 13C-NMR, 
(CDCI3, 125.7 MHz) 8 C: 18.5 (C -ll) , 29.7 (C-9), 42.4 (C-7), 58.8 (C-l 1), 85.7 (C-
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8 ), 100.8 (C-l), 127.9 (C-4), 129.4, (C-5), 131.4 (C-3), 139.4 (C-6 ), 142.4 (C-2); 
MS (EI+): m/z (%) = 304 (28) [M f, 273 (100), 231 (42), 217 (29); HRMS for 
C |2Hi8IO: calcd. 304.0299, found 304.300 [M+H]+; IR (Neat); vmax = 3055, 2970, 
2929, 2821, 1575, 1456, 1411, 1331, 1204, 1111, 1071, 1000 cm'1. An authentic 
sample of racemic 77, (±  )-l-iodo-2-(-2-methoxy-3-methylbutyl)benzene, was 
prepared from 75 as described previously: HPLC conditions: Chiracel OD-H 
column, hexane/2-propanol, 98:2, 0.5 ml/min, 20 °C, /r = 16.9 min (-)- 
enantiomer, ts = 22.0 min (+)-enantiomer. Enantiomer 1 (Rf = 16.9 min): The 
racemic ether gave baseline separation and a 1 :1  ratio of integrated areas.
(/?)-!-(2-Ethoxy-3-methylbutyl)-2-iodobenzene - 78
Synthesised according to GP5 with sodium hydride (17 mg, 682 mmol) suspended 
in DMF (2 ml) stirred with (R)-l-(2-Iodophenyl)-3-methylbutan-2-ol 76 ( 6 6  mg, 
0.227 mmol) and ethyl iodide (53 mg, 0.227 mmol). The product was purified by 
column chromatography petroleum ether/diethyl ether (14:1). Yield 81% (57 mg, 
0.184 mmol) as a pale yellow oil. [a]^5= -  82.69 (c = 0.39, CHCI3). *H NMR
(CDCI3, 500 MHz) 5: 0.89 (3H, t, J =  7.0 Hz, CH2C //3), 0.93 (3H, d, J =  6 .8  Hz, 
(C//3)), 0.96 (3H, d , J =  6 . 8  Hz, (C //3)), 1.76 (1H, m, C//(CH3) 2 ), 2.68 (1H, dd, J  
= 13.6, 9.3 Hz, A rC //ACHB), 2.86 (1H, dd, J =  13.6, 3.8 Hz, ArCHAC //B), 3.28 
(1H, ddd, J =  9.3, 4.9, 3.8 Hz, C//) , 3.40 (2H, q, J  = 7.0, Hz, CH2CH3), 6.81 (1H, 
ddd, J =  7.9, 7.4. 1.6 Hz, H-arom), 7.19 (1H, d, J =  7.6 Hz, //-arom ), 7.23 (1H, 
dd, 7.6, 7.4 Hz, //-arom ), 7.73 (1H, dd, J  = 7.9, 1.1 Hz, //-arom); l3C-NMR, 
(CDC13, 125.7 MHz) So 15.4 (C-10), 18.8 (C-12), 32.2 (C-9), 43.4 (C-7), 65.5 (C-
11), 83.9 (C-8 ), 100.8 (C -l), 127.8 (C-4), 128.0, (C-5), 131.6 (C-3), 139.3 (C-6 ),
142.6 (C-2); MS (EI+): m/z (%) = 318 (25) [M]+, 303 (31), 261 (39), 217 (30), 105 
(11), 91 (100);HRMS for C 13H2oIO: calcd. 318.1833, found 318.1830 [M+H]+; IR 
(Neat); vmax = 3057, 2964, 2927, 2820, 1574, 1455, 1411, 1366, 1203, 1112, 1059,
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1006 cm''.An authentic sample of racemic 78, (±  )-l-(2-ethoxy-3-methylbutyl)-2- 
iodobenzene, was prepared from 75 as described previously: HPLC conditions: 
Chiracel OD-H column, hexane/2-propanol, 98:2, 0.5 ml/min, 19 °C, /r  = 15.7 
min (-)-enantiomer, ts = 19.9 min (+)-enantiomer. Enantiomer 1 (Rf= 15.7 min): 
The racemic ether gave baseline separation and a 1:1 ratio of integrated areas.
(/?)-! -(l-(2-Iodophenyl)-3-methylbutan-2-yloxy)benzene -  79
Synthesised according to GP5 with sodium hydride (18 mg, 0.765 mmol) 
suspended in DMF (2 ml) stirred with (R)-1 -(2-iodophenyl)-3-methylbutan-2-ol 
76 (74 mg, 0.255 mmol) and benzyl bromide (44 mg, 0.255 mmol). The product 
was purified by column chromatography petroleum ether/diethyl ether (14:1).
Yield 72% (70 mg, 0.184 mmol) as a pale yellow oil. [a ]^ 5 = -  81.11 (c = 0.50,
CHC13). 'H NMR (CDCI3, 500 MHz) 8 : 0.96 (3H, d, J =  6 . 8  Hz, C //3), 1-00 (3H, 
d, J =  6.9 Hz, C //3), 1.83-1.90 (1H, m, C//(CH3)2), 2.78 (1H, dd, 13.7, 6.3 Hz, 
ArC//ACHB), 2.89 (1H, dd, J =  13.7, 3.9 Hz, ArCHAC //B), 3.44 (1H, ddd, J  = 6.3,
4.7, 3.9 Hz, C /0, 4.04 (2H, s, OCH2), 6.84 (1H, ddd, J  = 7.7, 7.5, 1.3 Hz, H- 
arom), 7.05, (2H, d, J  -  7.2 Hz, //-arom ), 7.13-7.21 (3H, m, //-arom), 7.23 (2H, 
dd, J =  7.6, 1.7 Hz, H-arom), 7.74 (1H, dd, J =  7.9, 1.1 Hz, H-arom); 13C-NMR, 
(CDCI3, 125.7 MHz) 8 C: 18.5 (C-10), 31.7 (C-9), 42.6 (C-7), 72.2 (C-l 1), 83.5 (C- 
8 ), 100.9 (C-l), 127.7 (C-4), 127.8 (C-13), 128.0 (C-15), 128.2 (C-5), 128.4 (C- 
14), 131.8 (C-3), 138.4 (C-l 1), 139.4 (C-6 ), 142.4 (C-2); MS (CI+): m/z (%) = 398 
(100) [M+NH4]+, 22 (51), 182 (47), 106 (74) 91 (15); HRMS for Ci8H25INO: 
calcd. 398.3012, found 398.3002 [M+NH4]+; IR (Neat): vmax = 3056, 2972, 2927, 
2820, 1451, 1399, 1366, 1228, 1109, 1003 cm '1. An authentic sample of racemic 
79, (± )-l-(l-(2-Iodophenyl)-3-methylbutan-2-yloxy)benzene, was prepared from 
75 as described previously: HPLC conditions: Chiracel OD-H column, hexane/2- 
propanol, 98:2, 0.5 ml/min, 23 °C, /r = 21.3 min (-)-enantiomer, ts = 26.8 min
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(+)-enantiomer: Enantiomer 1 (Rf= 21.3 min): The racemic ether gave baseline 
separation and a 1 :1  ratio o f integrated areas.
(/?)-!-Iodo-2-(-2-trifIuoroacetoxy-3-methylbutyl)benzene10 - 80
Synthesised according to GP6  with trifluoroacetic anhydride (64 mg, 0.306 mmol) 
added to a stirred solution o f (/?)-l-(2-iodophenyl)-3-methylbutan-2-ol 76 (74 mg, 
0.255 mmol) and triethylamine (312 mg, 0.306 mmol) in DCM (2 ml). The 
product was purified by column chromatography petroleum ether/diethyl ether
(1:1). Yield 65% (64 mg, 0.165 mmol) as a colourless oil. [a ]^5 = -  106.77 (c =
0.89, CHC13). 1 H-NMR, (CDCI3 , 250 MHz) 8 H: 0.99 (3H, d, J  = 7.0 Hz, CH3),
1.04 (3H, d, J =  7.0 Hz, C //3), 1.87 (1H, m, C//(CH3)2), 2.93 (1H, dd, J =  14.6,
8 .8  Hz, A tC//aCHb), 3.04 ( 1 H, dd, J  = 14.5, 3.7 Hz, ArCHAC //B), 5.40 ( 1H, m, 
CH), 6.84 (1H, atd, J  = 7.8, 1.0 Hz, //-arom ), 7.17-7.25 (2H, m, //-arom), 7.74 
(1H, dd, J =  7.8, 1.2 Hz, //-arom ); 13C-NMR, (CDC13, 62.3 MHz) 8 C: 20.5 (C-10),
29.9 (C-9), 44.3 (C-7), 85.0 (C-8 ), 101.8 (C-l), 115.6 (q, JCF = 291 Hz, C-12),
128.5 (C-4), 129.0 (C-5), 130.4 (C-3), 139.4 (C-6 ), 141.3 (C-2), 157.6 (q, J Cf  = 40 
Hz, C-l 1). No IR obtained, product is unstable at room temperature.
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(/?)-!-Iodo-2-(-2-methoxy-3-methylbuty])benzene - 81
Synthesised according to G P11 with sodium perborate tetrahydrate (371 mg, 2.41 
mmol) added portion wise to a solution of (7?)-l-iodo-2-(-2-methoxy-3- 
methylbutyl)benzene 77 (70 mg, 0.241 mmol) in glacial acetic acid (5 ml). 
Product was isolated by recrystallisation from acetic acid/pentane. Yield 2% (2 
mg, 0.005 mmol) as a white powder. !H-NMR, (CDCI3, 500 MHz) 6 9 : 1-01 (3H, 
d, J =  6.9 Hz, C //3), 1.05 (3H, d, J =  6.9 Hz, C //3), 1.79 (1H, m, C//(CH3)2), 2.04 
(6 H, s, (OCOC7 /3)2), 2.90 (1H, dd, J =  13.6, 8.9 Hz, A rC //ACHB), 3.00 (1H, dd, J  
= 13.6, 3.6 Hz, ArCHAC //B), 3.32 (3H, s, O C //3), 3.49 (1H, ddd J =  8.9, 8 .8 , 3.6 
Hz CH), 7.01 (1H, d, J  = 7.9, Hz, H-arom), 7.30-7.43 (2H, m, H-arom), 8.08 (1H, 
d, J  -  7.9 Hz, //-arom ); No 13C obtained, insufficient quantity synthesised.
(/?)-!-(-2-Ethoxy-3-methylbutyl)-2-(diacetoxyiodo)benzeiie -  82
I(OAc)2
Synthesised according to G P11 with sodium perborate tetrahydrate (265 mg, 1.72 
mmol) added portion wise to a solution of (/?)-l-(2-ethoxy-3-methylbutyl)-2- 
iodobenzene 78 (50 mg, 0.172 mmol) in glacial acetic acid (5 ml). Product was 
isolated by recrystallisation from acetic acid/pentane. Yield 2% (2 mg, 0.003 
mmol) as a white powder. 'H  NMR (CDCI3, 500 MHz) 5: 1.01 (3H, d , J =  7.0 Hz, 
CH}), 1.05 (3H, d, J  = 7.0 Hz, C7 /,), 1.18 (3H, t, J  = 7.0 Hz, CH2CH3), 1.94 (1H, 
m, CN(CH3) 2 ), 2.06 (6 H, s, (OCOCff3)2), 2.80 (1H, dd, J  = 14.0, 9.1 Hz, 
A rC//ACHB), 2.92 (1H, dd, J  = 14.0, 4.3 Hz, ArCHAC //B), 3.43 (2H, q, J  = 7.0, 
Hz, C //2CH3), 3.57 (1H, ddd, J  = 9.1, 7.9, 4.3 Hz, CH), 7.09 (1H, d, J  = 7.6 Hz,
171
Chapter Seven: Experimental
H-arom), 7.34-7.52 (2H, m, H-arom ), 8.10 (1H, d, J  -  7.6 Hz, //-arom); No 13C 
obtained, insufficient quantity synthesised.
l-(2-Iodophenyl)butan-3-one13 -  84
o
Synthesised according to GP8  with 2-iodobenzyl chloride 83 (3.0g, 11.88 mmol), 
2,4-pentanedione (1.35 ml, 13.08 mmol) and potassium carbonate (1.65 g, 12 
mmol) in ethanol (30 ml). The product was purified by column chromatography 
hexane / ethyl acetate (4:1). Yield 84% (2.74 g, 10.0 mmol) as a colourless oil. 
Spectroscopic data agrees with literature. *H NMR, (CDCI3, 250 MHz) 5h: 2.20 
(3H, s, C //3), 2.78 (2H, t, J  = 7.7 Hz, ArCH2C //2), 3.03 (2H, t, J  = 7.7 Hz, 
ArC//2), 6.93 (1H, atd, J  = 7.7, 1.9 Hz, //-arom), 7.24-7.31 (2H, m, H-arom), 7.84 
(1H, d, J =  7.7 Hz, //-arom ); 13C NMR, (CDC13, 62.5 MHz) 5C: 30.1 (C-10), 34.8 
(C-8 ), 43.7 (C-7), 100.3 (C -l), 128.1 (C-4), 128.6 (C-5), 129.7 (C-5), 139.6 (C-6 ),
143.6 (C-2), 207.5 (C-9); IR (Neat) : vmax = 2941, 2909, 1716, 1500, 1440, 1326, 
1186, 1153, 1017 cm '1.
( ± )-4-(2-Iodophenyl)butan-2-ol -  85
Synthesised according to GP10 with l-(2-iodophenyl)butan-3-one 84 (2.0 g, 7.3 
mmol) added to a stirred solution of sodium borohydride (152 mg, 4.02 mmol) in 
ethanol (10 ml). The product was purified by column chromatography petroleum 
ether/diethyl ether (4:1). Yield 97% (1.95 g, 7.08 mmol) as a colourless oil. HPLC
OH
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conditions: Chiracel OD-H preparative column, hexane/2-propanol, 93:7, 0.5 
ml/min, 15 °C, /R = 18.6 min (-)-enantiomer, ts = 23.7 min (+)-enantiomer: lH 
NMR, (CDC13, 250 MHz) 8 H: 1.20 (3H, d, J  = 6.2, CH3), 1.43 (1H, br s, OH), 
1.64-1.70 (2H, m, ArCH2CH2), 2.70 (1H, ddd, J =  13.7, 9.6, 6.9 Hz, ArC//ACHB),
2.80 (1H, ddd, J =  13.7, 9.5, 6.4 Hz, ArCHACHB), 3.81 (1H, dqd, J =  8.4, 6.2, 4.1, 
Hz, CH), 6.81 (1H, ddd, J  = 7.9, 7.5, 2.0 Hz, //-arom), 7.15-7.22 (2H, m, H- 
arom), 7.74 (1H, dd, J =  7.9, 1.1 Hz H-arom); ,3C NMR, (CDCI3, 62.5 MHz) 8 C:
23.6 (C-10), 37.1 (C-8 ), 39.6 (C-7), 67.5 (C-9), 100.6 (C-l), 127.8 (C-4), 128.5 
(C-5), 129.5 (C-3), 139.5 (C-6 ), 144.6 (C-2); MS (EI+): m/z (%) = 276 (16) [M]+, 
258 (54), 217 (6 8 ), 107 (80), 91 (100); HRMS for C 10Hi7INO: calcd. 294.0349, 
found 294.0353 [M+NILi]+; IR (Neat): vmax = 3371,2922, 1463, 1376, 1155, 1010
(S)-4-(2-Iodophenyl)butan-2-ol -  86
OH
Synthesised according to GP9 with l-(2-iodophenyl)butan-3-one 84 (2.70 g, 9.85 
mmol) added to a stirred solution of (-)-^-chlorodiisopinocampheylborane (3.48 
g, 10.84 mmol) in dry THE (15 ml). Diethyl ether (20 ml) was added along with 
diethanolamine (2.28 g, 21.67 mmol). The product was purified by column 
chromatography petroleum ether/diethyl ether (4:1). Yield 57%, 53% ee (1.55 g,
5.62 mmol) as a colourless oil. The enantiomers could be separated by preparative 
HPLC: Chiracel OD preparative column, hexane/2-propanol, 93:7, 4.5 ml/min, 15 
°C, /R = 23.2 min (-)-enantiomer, ts = 32.5 min (+)-enantiomer. Enantiomer 2 (Z?f
= 32.5 min): [<x]“ = + 9.25 (c = 1.14, CHC13, >99% ee); 'H NMR, (CDC13, 250
MHz) 8 h: 1.20 (3H, d, J  = 6.2, CH3), 1.43 (1H, br s, OH), 1.64-1.70 (2H, m, 
ArCH2C //2), 2.70 ( 1 H, d d d ,./ = 13.7, 9.6, 6.9 Hz, ArC//ACHB), 2.80 ( 1 H, ddd, J=
13.7, 9.5, 6.4 Hz, ArCHAC tfB), 3.81 ( 1H, dqd, 7 =  8.4, 6.2, 4.1, Hz, CH), 6.81 
( 1H, ddd, J =  7.9, 7.5, 2.0 Hz, //-arom), 7.15-7.22 (2H, m, //-arom), 7.74 (1H, dd,
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J =  7.9, 1.1 Hz //-arom ); 13C NMR, (CDCI3, 62.5 MHz) 6 C: 23.6 (C-10), 37.1 (C- 
8 ), 39.6 (C-7), 67.5 (C-9), 100.6 (C-l), 127.8 (C-4), 128.5 (C-5), 129.5 (C-3),
139.5 (C-6 ), 144.6 (C-2); MS (EI+): m/z (%) = 276 (16) [M]+, 258 (54), 217 (6 8 ), 
107 (80), 91 (100); HRMS for C io H n IN O : calcd. 294.0349, found 294.0353 
[M + N H 4] +; IR (Neat): vmax = 3371,2922, 1463, 1376, 1155, 1010 cm '1.
HPLC conditions:
(R)-4-(2-Iodophenyl)butan-2-ol -  87
oh
Synthesised according to GP10 with l-(2-iodophenyl)butan-3-one 84 (2.0 g, 7.3 
mmol) added to a stirred solution o f sodium borohydride (152 mg, 4.02 mmol) in 
ethanol (10 ml). The product was purified by column chromatography petroleum 
ether/diethyl ether (4:1). Yield 97% (1.95 g, 7.08 mmol) as a colourless oil. The 
enantiomers could be separated by preparative HPLC: Chiracel OD preparative 
column, hexane/2-propanol, 93:7, 4.5 ml/min, 15 °C, fa = 23.2 min (-)- 
enantiomer, /s = 32.5 min (+)-enantiomer. Enantiomer 1 (Rf= 23.2 min): [a ]^6 =
-  10.54 (c = 0.93, CHC13, >99% ee): !H NMR, (CDCI3, 250 MHz) 8 H: 1.20 (3H, 
d, J =  6.2, C //3), 1.43 (1H, br s, OH ), 1.64-1.70 (2H, m, ArCH2C //2), 2.70 (1H, 
ddd, J  = 13.7, 9.6, 6.9 Hz, A rC //ACHB), 2.80 (1H, ddd, J  = 13.7, 9.5, 6.4 Hz, 
ArCHAC //B), 3.81 (1H, dqd, J  = 8.4, 6.2, 4.1, Hz, CH), 6.81 (1H, ddd, 7 =  7.9, 
7.5, 2.0 Hz, H-arom), 7.15-7.22 (2H, m, H-arom), 7.74 (1H, dd, J =  7.9, 1.1 Hz 
H-arom); ,3C NMR, (CDC13, 62.5 MHz) 8 C: 23.6 (C-10), 37.1 (C-8 ), 39.6 (C-7),
67.5 (C-9), 100.6 (C -l), 127.8 (C-4), 128.5 (C-5), 129.5 (C-3), 139.5 (C-6 ), 144.6 
(C-2); MS (EI+): m/z (%) = 276 (16) [M]+, 258 (54), 217 (6 8 ), 107 (80), 91 (100); 
HRMS for CioHnINO: calcd. 294.0349, found 294.0353 [M+NH4]+; IR (Neat): 
Vmax = 3371, 2922, 1463, 1376, 1155, 1010 cm '1.
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(iS)-l-Iodo-2-(3-methoxybutyl)benzene - 88
o-—"
Synthesised according to GP5 with sodium hydride (261 mg, 10.87 mmol) 
suspended in DMF (15 ml) stirred with (S)-4-(2-iodophenyl)butan-2-ol 8 6  (1.0 g 
mg, 3.62 mmol) and methyl iodide (515 mg, 3.62 mmol). The product was 
purified by column chromatography hexane/ethyl acetate (4:1). Yield 96% (1.01 
g, 3.47 mmol) as a pale yellow oil. [a]2» = + 53.02 (c = 0.91, CHC13); lH NMR,
(CDCI3, 400 MHz) 8 H: 1-14 (3H, d, J =  6.2 Hz, C //3), 1.68 (2H, m, ArCH2CHi),
2.69 (1H, ddd, J  = 13.4, 10.2,5.6 Hz, A rC //ACHB), 2.73 (1H, ddd, J =  13.4, 10.0,
6.4 Hz, ArCHAC //B), 3.19 (1H, m, CH), 3.38 (3H, s, OCH3), 6.80 (1H, atd, J  =
7.9, 1.3 H-arom), 7.15 (1H, d, J =  7.7 Hz, //-arom), 7.20 (1H, atd, J = 7.7, 7.6 Hz, 
//-arom), 7.74 (1H, dd, J =  7.9, 1.2 Hz, //-arom); 13C NMR, (CDC13, 100.4MHz) 
6 C: 19.4 (C-10), 37.0 (C-8 ), 37.5 (C-7), 56.4 (C-9), 76.4 (C -ll), 100.9 (C-l),
128.1 (C-4), 128.7 (C-5), 129.9 (C-3), 139.9 (C-6 ), 145.3 (C-2); MS (EI+): m/z 
{%) = 290 (22) [M]+, 276 (27), 259 (13), 217 (6 8 ), 107 (100), 91 (50); HRMS for 
Cn H 16IO: calcd. 291.0240, found 291.0239 [M+H]+; IR (Neat): vmax = 3059, 
2824, 2819, 1465, 1434, 1372, 1169, 1136, 1093, 1010 cm '1. An authentic sample 
of racemic 88, (±  )-l-iodo-2-(3-methoxybutyl)benzene, was prepared from 85 as 
described previously: HPLC conditions: Chiracel OD-H column, hexane/2- 
propanol, 95:5, 0.5 ml/min, 20 °C, tR = 8.9 min (-)-enantiomer, ts = 12.4 min (+)- 
enantiomer. Enantiomer 2 (Rf  = 12.4 min). The racemic ether gave baseline 
separation and a 1 :1  ratio o f integrated areas.
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(5)-l-Iodo-2-(3-ethoxybutyl)benzene- 89
Synthesised according to GP5 with sodium hydride (131 mg, 5.47 mmol) 
suspended in DMF (5 ml) stirred with («S)-4-(2-iodophenyl)butan-2-ol 8 6  (500 mg, 
1.82 mmol) and ethyl iodide (285 mg, 1.82 mmol). The product was purified by 
column chromatography hexane/ethyl acetate (5:1). Yield 81% (449 mg, 1.48
mmol) as a pale yellow oil. [ot]^ 7 = + 36.77 (c = 1.05, CHC13): !H NMR (CDC13,
500 M Hz) 8 h: 1-02, (3H, t, J =  6.7 Hz, CH2C //3), 1.14 (3H, d, J =  6.1 Hz, CHi),
1.62 (1H, dddd, J  = 13.4, 7.4, 7.1, 6.9 Hz, ArCH2C //ACHB), 1.77 (1H, dddd, J  = 
13.4, 9.9, 8.0, 5.3 Hz, ArCH2CHAC //B), 2.44 (1H, ddd, J =  13.3, 8.0, 7.1 Hz, 
ArC//ACHB), 2.59 (1H, ddd, J  = 13.3, 9.9, 6.9 Hz, ArCHAC //B), 3.09 (1H, m, 
CH), 3.33 (2H, q, J =  6.7 Hz, CH2CH3), 6.83 (1H, atd, J  = 7.9, 1.6, H-arom), 7.17 
(1H, dd, J =  7.8, 1.6 Hz, //-arom ), 7.24 (1H, atd, J =  7.8, 1.2 Hz, //-arom), 7.70 
(1H, dd, J  = 7.9, 1.2 Hz, //-arom ); ,3C NMR, (CDC13, 125.7 MHz) 8 C: 16.9 (C- 
12), 18.8 (C-10), 29.0 (C-7), 36.6 (C-7), 39.8 (C-8 ), 60.2 (C -ll), 88.0 (C-9),
100.0 (C-l), 127.4 (C-4), 128.0 (C-5), 128.9 (C-3), 138.1 (C-6 ), 142.4 (C-2); MS 
(EI+): m/z (%) = 305 (44) [M]+, 276 (100), 217 (33), 107 (39), 91 (16); HRMS for 
Ci2Hi8IO: calcd. 305.1653, found 305.1650 [M+H]+; IR (Neat): vmax = 2844, 
2815, 1470, 1437, 1370, 1170, 1133, 1089, 1004 cm '1. An authentic sample of 
racemic 89, (±  )-l-iodo-2-(3-ethoxybutyl)benzene, was prepared from 85 as 
described previously: HPLC conditions: Chiracel OD-H column, hexane/2- 
propanol, 96:4, 0.5 ml/min, 22 °C, tR = 13.2 min (-)-enantiomer, ts = 16.6 min 
(+)-enantiomer. Enantiomer 2 (Rf= 16.6 min). The racemic ether gave baseline 
separation and a 1 :1  ratio o f integrated areas.
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(iS)-l-(4-(2-Iodophenyl)butan-2-methyl)benzene - 90
Synthesised according to GP5 with sodium hydride (26 mg, 1.095 mmol) 
suspended in DMF (4 ml) stirred with (S)-4-(2-iodophenyl)butan-2-ol 8 6  (100 mg, 
0.365 mmol) and benzyl chloride (46 mg, 0.365 mmol). The product was purified 
by column chromatography hexane/ethyl acetate (5:1). Yield 72% (96 mg, 0.263 
mmol) as a pale yellow oil. [ct]2D° = + 48.00 (c = 0.70, CHC13): !H NMR (CDCI3,
500 MHz) 6H: 1.17 (3H, d, J  -  6.2 Hz, C # 3), 1.79 (1H, dddd, J  = 13.4, 9.4, 7.3,
5.4 Hz, ArCH2C //ACHB), 1.90 (1H, dddd, J  = 13.4, 9.9, 8.0, 6.3 Hz, 
ArCH2CHAC //B), 2.81 (1H, ddd, J  = 13.7, 9.4, 6.3 Hz, ArC//ACHB), 2.99 (1H, 
ddd, J  = 13.7, 9.9, 7.3 Hz, ArCHAC //B), 3.67 (1H, dqd, J =  8.0, 6.2, 5.4 Hz, CH), 
4.39 (2H, s, OCH2), 6.85 ( 1H, atd, J =  7.9, 1.3 Hz, H-arom), 7.03-7.31 (7H, m, H- 
arom), 7.72 (1H, dd, J =  7.9, 1.0 Hz, H-arom); 13C NMR, (CDC13, 125.7 MHz) 6 C:
20.9 (C-10), 29.1 (C7), 35.7 (C-8 ), 72.2 (C -ll) , 80.3 (C-9), 101.1 (C-l), 125.5 (C- 
Ar), 125.6 (C-Ar), 126.8 (C-5), 127.5 (C-4), 127.7 (C-Ar), 131.8 (C-3), 138.4 (C-
12), 139.3 (C-6 ), 141.6 (C-2); MS (EI+): m/z (%) = 366 (17) [M]+, 305 (26) 276 
(51), 217 (100), 107 (42), 91 (39); HRMS for C 17H 19IO: calcd. 366.2404, found 
366.2406 [M]+; IR (Neat): vmax = 2860, 2819, 1471, 1430, 1363, 1164, 1129, 
1070, 1007 cm '1. An authentic sample of racemic 90, (±)-l-(4-(2-
iodophenyl)butan-2-methyl)benzene, was prepared from 85 as described 
previously: HPLC conditions: Chiracel OD-H column, hexane/2-propanol, 98:2, 
0.5 ml/min, 25 °C, tR = 11.9 min (-)-enantiomer, ts = 17.7 min (+)-enantiomer. 
Enantiomer 2 (Rf= 17.7 min). The racemic ether gave baseline separation and a 
1 :1  ratio of integrated areas.
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( ± )-4-(2-Iodopheny])butan-3-trifluoroacetate10 -  91
o
X
o / ^ c f 3
Synthesised according to GP6  with trifluoroacetic anhydride (202 mg, 0.96 mmol) 
added to a stirred solution o f ( ± )-4-(2-iodophenyl)butan-2-ol 85 (221 mg, 0.80 
mmol) and triethylamine (97 mg, 0.96 mmol) in DCM (2 ml). The product was 
purified by column chromatography petroleum ether/diethyl ether (1:1). Yield 
71% (212 mg, 0.570 mmol) as a colourless oil. lH NMR, (CDCI3, 400 MHz) 5h:
1.35 (3H, d, J  = 6.3 Hz, CH3), 1.89 (2H, m, ArCH2C7/2) 2.70 (2 H, m, ArCH2),
5.08 (1H, m, CH), 6.85 (1H, atd, J =  8.1, 1.2 Hz, tf-arom), 7.13 (1H, dd, J =  7.7,
1.2 Hz, H-arom), 7.20 (1H, atd, J =  7.7, 1.0 Hz, H-arom), 7.75 (1H, d d , J  = 8.2,
1.0 Hz H-arom); 13C NMR, (CDC13, 125.7 MHz) 8 C: 19.5 (C-10), 36.4 (C-7), 46.2 
(C-8 ), 75.8 (C-9), 100.8 (C-2), 114.5 (q, J =  286 Hz, C-12), 128.2 (C-4), 129.4 
(C-5), 130.9 (C-6 ), 139.7 (C-3), 143.2 (C -l), 157.2 (q, J =  42 Hz, C -ll) . No IR 
obtained, product decomposes at room temperature.
(±  )-l-(3-tert-Butoxybutyl)-3-iodobenzene - 92
Synthesised according to GP7 with concentrated sulphuric acid (46 mg, 0.47 
mmol) added to a stirred suspension of anhydrous MgSC>4 (226 mg, 1 .8 8  mmol) in 
cyclohexane (4 ml). lBuOH (174 mg, 2.35 mmol) and (±  )-4-(2-iodophenyl)butan-
2-ol 85 (130 mg, 0.47 mmol) was added dropwise to the resulting solution. The 
product was purified by column chromatography petroleum ether/diethyl ether
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(8:1). Yield 58% (91 mg, 0.274 mmol) as a pale yellow oil. 'H-NMR, (CDCI3, 
250 MHz) 8 h: 1.16 (9H, s, (CH3)3), 1.21 (3H, d,7 =  6.5 Hz, CH,), 1.70 (1H, dddd, 
7 = 13.6, 8.9, 6.4, 5.2 Hz, ArCH2C77ACHB), 1.88 (1H, dddd, 7 =  13.6, 9.1, 8.1, 6.5 
Hz, ArCH2CHAC //B), 2.56 (1H, ddd, 7  = 13.4, 9.1, 6.4 Hz, ArC//ACHB). 2.87 
(1H, ddd, 7  = 13.4, 8.9, 6.5 Hz, ArCHAC7/B), 2.98 (1H, dqd, 7  = 8.1, 6.5, 5.2 Hz, 
CH), 6.85 (1H, atd, 7  = 7.8, 1.6 Hz, 77-arom), 7.19-7.26 (2H, m, H-arom), 7.60 
(1H, dd, 7  = 7.6, 1.0 Hz, //-arom); l3C-NMR, (CDCh, 62.5 MHz) 8 C: 21.2 (C-10),
27.7 (C-7), 30.3 (C-12), 38.6 (C-8 ), 69.1 (C-9), 70.1 (C-l 1), 100.4 (C-l), 127.4 
(C-5), 127.7 (C-4), 129.2 (C-3), 137.7 (C-6 ), 141.5 (C-2); MS (El3): m/z (%) = 
332 (57) [M f, 275 (100), 242 (29), 217 (38), 117 (17); HRMS for Ci4H22IO: 
calcd. 333.2190, found 333.2188 [M+H]+. No IR obtained.
(<S)-l-(2-Diacetoxyiodophenyl)-3-methoxybutane - 93
I(OAc)2
Synthesised according to GP12 with peracetic acid (0.88 ml of a 30% solution in 
acetic acid) added to a stirred solution of (S)-l-iodo-2-(3-methoxybutyl)benzene 
8 8  ( 8 8  mg, 0.22 mmol) in acetic acid (5 ml). Product was isolated by 
recrystallisation from acetic acid/pentane. Yield 47% (58 mg, 0.143 mmol) as a
white powder, mp = 114-117 °C. [a ]"  = + 105.41 (c = 1.01, CHC13). 'H  NMR,
(CDC13, 400 MHz) 8 h: 1.90 (1H, d, 7  = 6.7 Hz, C773), 1.96 (1H, dddd, 7 =  14.0, 
10.1, 6.1, 4.9 Hz, ArCH2C7/ACHB), 2.02 (6 H, s, (OCOC//3)2), 2.09 (1H, dddd, 7 =  
14.0, 8 .6 , 8.1, 5.4 Hz, ArCH2CHAC77B), 2.90 (1H, ddd, 7  = 14.3, 8 .6 , 6.1 Hz, 
ArC77ACHB), 3.06 (1H, ddd, 7  = 14.3, 10.1, 5.4 Hz, ArCHAC //B), 3.18 (3H, s, 
OCH}), 4.10 (1H, dqd, 7 =  8.1, 6.7, 4.9 Hz, CH), 7.22 (1H, atd, 7 =  7.7, 1.8 Hz, 77- 
arom), 7.42 (1H, dd, 7  = 7.6, 1.8 Hz, 77-arom), 7.47 (1H, atd, 7 =  7.6, 1.2 Hz, 77- 
arom), 8.11 (1H, dd, 7 =  7.7, 1.2 Hz, 77-arom); l3C NMR, (CDC13, 100.5 MHz) 8 C:
20.3 (C-10), 20.4 ((OCOCH3)2), C-13), 35.7 (C-7), 39.3 (C-8 ), 56.7 (C-l 1), 82.4 
(C-9), 127.8 (C-Ar), 128.7 (C-Ar), 130.2 (C-3), 132.2 (C-l), 141.7 (C-6 ), 144.0
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(C-2), 176.4 (C =0, C - l2), 176.6 (C =0, C-12). IR (Nujol): vmax = 2965, 2906, 
2855, 1660, 1623, 1563, 1462, 1377, 1201, 1170, 1001 cm'1.
(5)-l-(2-Diacetoxyiodophenyl)-3-ethoxybutane - 94
I(OAc)2
Synthesised according to GP12 with peracetic acid (1.73 ml of a 30% solution in 
acetic acid) added to a stirred solution o f (»S)-l-iodo-2-(3-ethoxybutyl)benzene 89 
(132 mg, 0.433 mmol) in acetic acid (10 ml). Product was isolated by 
recrystallisation from acetic acid/pentane. Yield 12% (22 mg, 0.052 mmol) as a
white powder, mp = 110-114°C. [oc]^ 5 = + 99.41 (c = 0.82, CHC13). lH NMR,
(CDC13, 400 MHz) 5h: 1.14, (3H, t, J =  7.0 Hz, CH2C //3), 1.19 (1H, d, J =  7.4 Hz, 
C //3), 2.00 (6 H, s, ((O C O C //3)2), 2.08 (2H, m, ArCH2C //2), 2.91 (1H, ddd, J  =
14.3, 9.5, 6.2 Hz, A rC //ACHB), 3.08 (1H, ddd, J =  14.3, 9.7, 5.4 Hz, ArCHAC //B), 
3.55 (2H, q, J =  7.0 Hz, O C //2), 4.20 (1H, dqd, J  = 8.2, 7.4, 4.8 Hz, CH), 7.21- 
7.26 (2H, m, H-arom), 7.47 (1H, d, J =  7.4 Hz, //-arom), 8.08 (1H, d, J =  7.9 Hz, 
//-arom); No 13C obtained, insufficient quantity synthesised.
(S)-l-(2-Diacetoxyiodophenyl)-3-benzoxybutane - 95
Synthesised according to GP11 with sodium perborate tetrahydrate (321 mg, 
2.065 mmol) added portion wise to a solution of (S)-l-(4-(2-iodophenyl)butan-2- 
methyl)benzene 90 (76 mg, 0.206 mmol) in glacial acetic acid (5 ml). Product was
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isolated by recrystallisation from acetic acid/pentane. Yield 5% (5 mg, 0.010 
mmol) as a white powder, mp -  109-112°C. *H NMR, (CDC13, 400 MHz) 8 H:
1.80 (1H, d, J  = 6.7 Hz, C //3), 1.89 (1H, dddd, J  = 13.8, 10.7, 7.9, 6.1 Hz, 
ArCH2C //ACHB), 2.00 (1H, dddd, J  = 13.8, 9.4, 6.4, 5.0 Hz, ArCH2CHAC //B),
2.06 (6 H, s, (OCOC//3)2), 2.85 (1H, ddd, J = 14.3, 9.4, 6.1 Hz, ArC//ACHB), 3.01 
(1H, ddd, J =  14.3, 10.7, 6.4 Hz, ArCHAC //B), 3.80 (1H, dqd, J = 7.9, 6.7, 5.0 Hz, 
CH), 4.19 (2H, s, OCH2), 7.19 (1H, dd, J  = 7.9, 1.6 Hz, H-arom), 7.24 (2H, atd, J  
= 7.7, 1.4 Hz, H-arom), 7.28 (2H, dd, J =  7.7, 1.6 Hz, H-arom), 7.37 (1H, dd, J  =
7.9, 7.4 Hz, //-arom ), 7.49 (1H, dd, 7.6, 1.3 Hz, //-arom), 7.57 (1H, d, J  = 7 A  
Hz, //-arom), 8.14(1 H, d, J = 1 .9 Hz, //-arom); No 13C obtained.
(iS)-l-(2-[Bis(trifluoroacetoxy)iodo]phenyl)-3-methoxybutane - 96
Synthesised according to GP15 with (S)-l-iodo-2-(3-methoxybutyl)benzene 8 8  
(53 mg, 0.184 mmol) in DCM (2 ml) added to a previously prepared solution of 
trifluoroacetic anhydride (193 mg, 0.920 mmol) and urea hydrogen peroxide (211 
mg, 0.307 mmol) in DCM (5 ml). Yield 21% (20 mg, 0.039 mmol) of a white
powder, [a];; = + 92.9 (c = 0.77, CHCI3): 'H  NMR, (CDCI3, 400 MHz) SH: 2.00
(3H, d, J  = 6.7 Hz, C //3), 2.88 (1H, dddd, J  = 14.2, 9.0, 7.5 6.7 Hz, 
ArCH2C //ACHB), 3.02 (1H, dddd, J  = 14.2, 8 .8 , 5.5, 5.2 Hz, ArCH2CHAC //B),
3.10 (1H, ddd, 7 =  14.3, 9.0, 5.5 Hz, ArC//ACHB), 3.06 (1H, ddd, J =  14.3, 8 .8 ,
6.7 Hz, ArCHAC tfB), 3.18 (3H, s, O C //3), 4.08^4.15 (1H, dqd, J  = 7.5, 6.7, 5.2 
Hz, CH), 7.25 (1H, d, J  = 7.7 Hz, H-arom), 7.40 (1H, d, J=  6.9 Hz, H-arom), 7.55 
(1H, d, J =  6.9 Hz, H-arom) 8.15 (1H, d, J = 7.7 Hz, H-arom); ,3C NMR, (CDC13,
100.7 MHz) 5C: 36.0 (C-10), 38.1 (C-7), 40.3 (C-8 ), 60.7 (C-l 1), 85.4 (C-9),
111.8 (q, JCF = 290 Hz, CF3), 127.4 (C-Ar), 128.5 (C-Ar), 129.9 (C-3), 133.4 (C- 
1), 141.0 (C-6 ), 144.3 (C-2), 164.7 (q, J CF = 40 Hz, C=0). IR (Nujol): vmax = 
2939, 2870, 1731, 1711, 1465, 1379, 1240, 1195, 1150,996 cm '1.
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(*S)-l-(2-[Bis(trifluoroacetoxy)iodo]phenyl)-3-ethoxybutane - 97
I(OCOCF3)2
Synthesised according to GP15 with (S)-l-iodo-2-(3-ethoxybutyl)benzene 89 (55 
mg, 0.184 mmol) in DCM (2 ml) added to a previously prepared solution of 
trifluoroacetic anhydride (193 mg, 0.920 mmol) and urea hydrogen peroxide (211 
mg, 0307 mmol) in DCM (5 ml). Yield 15% (15 mg, 0.028 mmol) of a white 
powder, [a ]”  = +100.6 (c = 0.95, CHC13): !H NMR, (CDC13, 250 MHz) 8 H: 1.35,
(3H, d , J  = 6.7 Hz, CH2C //3) 1.41 (3H, d, J =  6.7 Hz, C //3), 2.41-2.49 (1H, m, 
ArCH2C //ACHB), 2.58-2.65 (1H, m, ArCH2CHAC //B), 3.00 (1H, ddd, J  = 14.3, 
9.2, 7.3 Hz, A rC //ACHB), 3.03 (2H, q , J =  6.7 Hz, OC//2CH3), 3.02-3.08 (1H, m, 
ArC//ACHB), 4.20-4.5 (1H, m, C H ), 7.28-7.35 (2H, m, //-arom), 7.58 (1H, d, J  =
6.9 Hz, H-arom), 8.15 (1H, d, J =  7.7 Hz, H-arom); 13C NMR, (CDC13, 67.5 MHz) 
8 C: 33.4 (C -l2), 36.6 (C-10), 37.7 (C-7), 42.1 (C-8 ), 62.6 (C -ll), 84.5 (C-9),
114.6 (q, J =  285 Hz, CF3), 127.7 (C-Ar), 127.8 (C-Ar), 130.2 (C-3), 134.1 (C-l),
141.6 (C-6 ), 144.6 (C-2), 166.3 (q, J =  39 Hz, C=0). No IR obtained.
(S)-l-(2-[Bis(trifluoroacetoxy)iodo]phenyl)-3-benzoxybutane - 98
Synthesised according to GP15 with (S)-l-(4-(2-iodophenyl)butan-2- 
methyl)benzene 90 (60 mg, 0.164 mmol) in DCM (2 ml) added to a previously 
prepared solution o f  trifluoroacetic anhydride (172 mg, 0.819 mmol) and urea 
hydrogen peroxide (172 mg, 0.247 mmol) in DCM (2 ml). Yield 6% ( 6  mg, 0.010 
mmol) o f a white powder. !H NMR, (CDC13, 400 MHz) 8 B* 2.05 (3H, d, J  — 7.0
I(OCOCF3)2
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Hz, C //3), 2.83-2.95 (2H, m, ArCH2C //2), 2.94 <1H, ddd, J  = 13.0, 10.1, 6.9 Hz, 
A rC //ACHB), 3 .11 ( 1 H, ddd, J =  13.1, 1 0 .1 , 5.4 Hz, ArCHAC //B), 3.80 (1 H, dqd, J  
= 7.9, 7.0, 5.0 Hz, CH), 4.63 (2H, s, OCf/2), 7.30 (1H, d, J  = 6.3 Hz, //-arom), 
7.49-7.57 (2H, m, H-arom), 8.17 (1H, d, J =  7.9 Hz, H-arom); No l3C obtained, 
insufficient quantity synthesised.
3-(2-Iodophenyl)-l-phenyIpropan-l-one9,13 - 99
o
Synthesised according to G P 8  with 2-iodobenzyl chloride 83 (5.0g, 19.67 mmol), 
dibenzoyl methane (4.64 g, 20.65 mmol) and potassium carbonate (2.99 g, 21.64 
mmol) in ethanol (50 ml). The product was purified by column chromatography 
hexane/ethyl acetate (9:1). Yield 84% (5.55 g, 16.52 mmol) as colourless crystals, 
mp 49-50 °C;. Spectroscopic data agrees with literature. *H NMR, (CDCI3, 250 
MHz) 5h: 3.10 (2H, t, J =  8.1 Hz, ArCH2\  3.22 (2H, t, J =  8.1 Hz, ArCH2C //2), 
6.84 (1H, ddd, J  = 7.6, 7.5, 2.0 Hz, H-arom), 7.16-7.54 (4H, m, H-arom), 7.75 
(1H, d, J =  8.0 Hz, H-arom), 7.90 (2H, dd, J =  8.4, 7.9 Hz, //-arom), 7.98 (1H, dd, 
J =  8.2, 1.0 Hz, H-arom); ,3C NMR, (CDC13, 62.5 MHz) 6 C: 35.2 (C-8 ), 38.9 (C-
7), 100.3 (C-l), 128.1 (C -l2), 128.3 (C-5), 128.5 (C-4), 128.6 (C -ll), 129.5 (C- 
3), 129.9 (C -l3), 133.1 (C-6 ), 133.9 (C-10), 139.6 (C-2), 198.8 (C-9); MS (EI+): 
m/z (%) = 336 (21) [M]+, 274 (42), 217 (100), 119 (34), 105 (39), 91 (16); HRMS 
for C 15H 14IO: calcd. 336.1712, found 336.1709 [M+H]+; IR (Neat): vmax = 1706, 
1688 cm '1;
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(±  )-3-(2-Iodophenyl)-l-phenylpropan-l-ol - 1 0 0
OH
Synthesised according to GP10 with l-(2-iodophenyl)butan-3-one 99 (1.0 g, 2.975 
mmol) added to a stirred solution o f sodium borohydride (62 mg, 1.636 mmol) in 
ethanol (10 ml). The product was columned using petroleum ether/diethyl ether 
(15:1). Yield 90% (0.91 g, 2.677 mmol), pale yellow oil. HPLC conditions: 
Chiracel OD-H column, hexane/ 2-propanol, 90:10, 0.5 ml/min, 15 °C, /r = 19.8 
min (-)-enantiomer, ts = 22.2 min (+)-enantiomer. *H NMR, (CDCI3, 250 MHz) 
5h: 1.60 (1H, br s, 0 /7), 1.91-2.04 (2H, m, ArCH2C/72), 2.65 (1H, ddd, J  = 13.9,
10.3, 5.1 Hz, A rC //ACHB), 2.78 (1H, ddd, J  = 13.9, 9.6, 6 . 6  Hz, ArCHACHB),
4.69 (1H, dd, J  = 8.0, 5.2 Hz, C/7), 6.79 (1H, ddd, J =  7.6, 7.5, 1.9 Hz, H-arom),
7.12 (2H, ddd, J  = 7.9, 7.6, 1.4 Hz, H-arom), 7.18-7.24 (1H, m, //-arom), 
7.27-7.35 (4H, m, H-arom), 7.72 (1H, dd, J  -  7.6, 1.0 Hz, H-arom); 13C NMR, 
(CDCI3, 62.5 MHz) 5C: 23.6 (C-7), 37.1 (C-8 ), 74.5 (C-9), 100.0 (C-l), 126.2 (C-
13), 127.8 (C-5), 128.0 (C-4), 129.3 (C -ll) , 129.5 (C-12), 129.8 (C-3), 137.9 (C-
10), 139.2 (C-6 ), 140.7 (C-2); MS (CI+): m/z (%) = 356 (34) [M+NH4]+, 338 (59), 
228 (100), 212 (13), 52 (36); HRMS for C 15H 19INO: calcd. 356.0506, found 
356.0505 [M+NH4]+; IR (Neat): vmax = 3345, 2952, 2923, 1795, 1576, 1563, 
1244, 1168, 1098, 1017 cm '1.
(S)-3-(2-Iodophenyl)-l-phenylpropan-l-ol -1 0 1
OH
3 z 11
Synthesised according to GP9 with 3-(2-iodophenyl)-1-phenylpropan-l-one 99 
(4 . 0  g, 11.90 mmol) added to a stirred solution of (-)-/?-
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chlorodiisopinocampheylborane (4.20 g, 13.89 mmol) in dry THF (20 ml). 
Diethyl ether (25 ml) was added along with diethanolamine (2.75 g, 26.18 mmol). 
The product was columned using petroleum ether/diethyl ether (15:1). Yield 79%,
>99% ee (3.18 g, 9.40 mmol), pale yellow oil. [a j^5 = + 46.10 (c = 1.03, CHCI3).
HPLC conditions: Chiracel OD-H column, hexane/2-propanol, 90:10, 0.5 ml/min, 
15 °C, (r = 19.8 min (-)-enantiomer, ts = 22.2 min (+)-enantiomer. Enantiomer 2 
(Rr= 22.2 min); ‘H NMR, (CDC13, 250 MHz) 5H: 1.60 (1H, br s, OH), 1.91-2.04 
(2H, m, ArCH2C772), 2.65 (1H, ddd, J  = 13.9, 10.3, 5.1 Hz, ArC77ACHB), 2.78 
(1H, ddd, J =  13.9, 9.6, 6 . 6  Hz, ArCHAC7/B), 4.69 (1H, dd, J =  8.0, 5.2 Hz, CH), 
6.79 (1H, ddd, J =  7.6, 7.5, 1.9 Hz, 77-arom), 7.12 (2H, ddd, .7 = 7.9, 7.6, 1.4 Hz, 
77-arom), 7.18-7.24 (1H, m, 77-arom), 7.27-7.35 (4H, m, 77-arom), 7.72 ( 1 H, dd, J  
= 7.6, 1.0 Hz, 77-arom); l3C NMR, (CDCI3, 62.5 MHz) 8 C: 23.6 (C-7), 37.1 (C-8 ),
74.5 (C-9), 100.0 (C -l), 126.2 (C-13), 127.8 (C-5), 128.0 (C-4), 129.3 (C -ll),
129.5 (C -l2), 129.8 (C-3), 137.9 (C-10), 139.2 (C-6 ), 140.7 (C-2); MS (CI+): mlz 
(%) = 356 (34) [M+NH4]+, 338 (59), 228 (100), 212 (13), 52 (36); HRMS for 
CI5HioINO: calcd. 356.0506, found 356.0505 [M+NH4]+; IR (Neat): vmax = 3345, 
2952, 2923, 1795, 1576, 1563, 1244, 1168, 1098, 1017 cm '1.
(/?)-3-(2-Iodophenyl)-l-phenylpropan-l-ol -1 0 2
Synthesised according to GP10 with l-(2-iodophenyl)butan-3-one 99 (1.0 g, 2.975 
mmol) added to a stirred solution o f sodium borohydride (62 mg, 1.636 mmol) in 
ethanol (10 ml). The product was columned using petroleum ether/diethyl ether 
(15:1). Yield 90% (0.91 g, 2.677 mmol), pale yellow oil. The enantiomers could 
be separated by preparative HPLC: Chiracel OD column, hexane/2-propanol, 
90:10, 2.5 ml/min, 15 °C, tR = 17.0 min (-)-enantiomer, ts = 25.1 min (+)-
enantiomer. Enantiomer 1 (Rf = 17.0 min): [oc]^5 = -4 5 .6 1  (c = 0.12, CHCI3). !H
NMR, (CDCI3, 250 MHz) 5H: 1.60 (1H, br s, OH), 1.91-2.04 (2H, m,
OH
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ArCH2C //2), 2.65 (1H, ddd, ./ = 13.9, 10.3, 5.1 Hz, A iC//aCHb), 2.78 ( 1H, ddd, J  
= 13.9, 9.6, 6 . 6  Hz, ArCHAC //B), 4.69 (1H, dd, J =  8.0, 5.2 Hz, CH), 6.79 (1H, 
ddd, J  = 7.6, 7.5, 1.9 Hz, H-arom), 7.12 (2H, ddd, J  = 7.9, 7.6, 1.4 Hz, H-arom), 
7.18-7.24 (1H, m, //-arom ), 7.27-7.35 (4H, m, //-arom), 7.72 (1H, dd, J  = 7.6,
1.0 Hz, //-arom ); l3C NMR, (CDC13, 62.5 MHz) 8 C: 23.6 (C-7), 37.1 (C-8 ), 74.5 
(C-9), 100.0 (C -l), 126.2 (C-13), 127.8 (C-5), 128.0 (C-4), 129.3 (C -ll), 129.5 
(C -l2), 129.8 (C-3), 137.9 (C-10), 139.2 (C-6 ), 140.7 (C-2); MS (CI+): m/z (%) = 
356 (34) [M+NH4f ,  338 (59), 228 (100), 212 (13), 52 (36); HRMS for 
C 15H 19INO: calcd. 356.0506, found 356.0505 [M+NH4]+; IR (Neat): vmax = 3345, 
2952, 2923, 1795, 1576, 1563, 1244, 1168, 1098, 1017 cm’1.
(tS)-l-(3-(2-Iodophenyl)-l-methoxypropyl)benzene - 103
3 ?  11
Synthesised according to GP5 with sodium hydride (213 mg, 8.89 mmol) 
suspended in DMF (10 ml) stirred with (S)-3-(2-iodophenyl)- 1-phenylpropan-l-ol 
101 (1.0 g, 2.96 mmol) and methyl iodide (420 mg, 2.96 mmol). The product was 
purified by column chromatography petroleum ether/diethyl ether (10:1). Yield
85% (0.88 g, 2.499 mmol) as a pale yellow oil. [a ]^2 = + 38.92 (c = 1.12, CHCI3);
!H NMR (CDCI3, 500 M H z)6 h: 1-87 (1H, dddd, J =  13.7, 10.5, 6 .6 , 6.2 Hz, 
ArCH2CHACHB), 1.97 (1H, dddd, J  = 13.7, 10.1, 8.1, 5.9 Hz, ArCH2CHAC //B),
2.65 (1H, ddd, J  = 13.9, 10.5, 5.9 Hz, A rC //ACHB), 2.78 (1H, ddd, J =  13.9, 10.1,
6 . 6  Hz, ArCHAC //B), 3.18 (3H, s, OCH3), 4.06 (1H, dd, J=  8.1, 6.2 Hz, CH), 6.79 
(1H, ddd, J  = 7.6, 7.6, 1.3 Hz, H-arom), 7.12 (1H, dd, 7 =  7.6, 1.7 Hz, H-arom),
7.17 (1H, dd, J =  7.3, 1.0 Hz, H-arom), 7.18-7.31 (5H, m, H-arom), 7.72 (1H, dd, 
J =  7.9, 1.0 Hz, //-arom ); ,3C NMR, (CDC13, 125.7 MHz) 6 C: 36.1 {Cl), 37.3 (C- 
8 ), 55.6 (C -l4), 82.0 (C-9), 99.5 (C-l), 125.6 (C -ll), 126.5 (C-13), 126.6 (C-5),
127.2 (C-4), 127.2 (C -l2), 128.4 (C-3), 138.4 (C-6 ), 140.9 (C-10), 143.5 (C-2); 
MS (EI+): m!z (%) = 352 (36) [M]+, 337 (56), 321 (100), 274 (29), 107 (61), 91
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(19); HRMS for C 10H2 iINO: calcd. 370.0662, found 370.0662 [M+NH4]+; IR 
(Neat): vmax = 3045, 2952, 2843, 2815, 1526, 1463, 1435, 1359, 1227, 1099, 1025 
cm '1. An authentic sample of racemic 103, (±  )- l-(3-(2-iodophenyl)-1- 
methoxypropyl)benzene, was prepared from 100 as described previously: HPLC 
conditions: Chiracel OD-H column, hexane/2-propanol, 98:2, 0.5 ml/min, 24 °C, 
tr = 13.5 min (-)-enantiomer, ts = 17.4 min (+)-enantiomer. Enantiomer 2 (Rf = 
17.4 min): The racemic ether gave baseline separation and a 1:1 ratio of integrated 
areas.
(S)-l-(l-Ethoxy-3-(2-iodophenyl)propyl)benzene - 104
Synthesised according to GP5 with sodium hydride (213 mg, 8.89 mmol) 
suspended in DMF (10 ml) stirred with (S)-3-(2-iodophenyl)-1-phenylpropan-l-ol 
101 (1.0 g, 2.96 mmol) and ethyl iodide (462 mg, 2.96 mmol). The product was 
purified by column chromatography petroleum ether/diethyl ether (10:1). Yield
80% (0.86 g, 2.359 mmol) as a pale yellow oil. [a]1^ = + 35.19 (c = 0.87, CHCI3);
!H NMR, (CDCI3, 500 MHz) SH: 114 (3H, t, J  = 7.0 Hz, CH2C //3), 1.87 (1H, 
dddd, J =  13.6, 9.4, 6.5, 5.1Hz, ArCH2C //ACHB), 1.97 (1H, dddd, J =  13.6, 9.9, 
8.2, 5.2 Hz, ArCH2CHAC //B), 2.67 (1H, ddd, J  = 13.8, 9.9, 6.5 Hz, ArC//ACHB),
2.78 (1H, ddd, J  = 13.8, 9.4, 5.2 Hz, ArCHAC //B), 3.41 (2H, q, J  = 7.0 Hz, 
ArC//2CH2), 4.16 (1H, dd, J =  8.2, 5.1 Hz, CH), 6.79 (1H, ddd, J  = 7.6, 7.5, 1.7 
Hz, H-arom), 7.13 (1H, dd, J  — 7.7, 1.7 Hz, H-arom), 7.17 (1H, dd, J  — 7.3, 0.9 
Hz, //-arom), 7.18-7.30 (5H, m, H-arom), 7.72 (1H, dd, J=  7.9, 0.8 Hz, H-arom); 
13C NMR, (CDCI3, 125.7 MHz) 5C: 15.3 (C -l5), 37.2 (C-8 ), 38.4 (C-7), 64.2 (C-
14), 81.2 (C-9), 100.7 (C -l), 126.6 (C-13), 127.5 (C-5), 127.6 (C-4), 128.3 (C- 
12), 128.4 (C -ll) , 129.5 (C-3), 139.5 (C-6 ), 142.8 (C-10), 144.6 (C-2); MS (CI+): 
m/z (%) = 383 (55) [M+NH4]+, 321 (34), 217 (45), 107 (100), 91 (30); HRMS for 
Ci7H23INO: calcd. 384.0819, found 384.0817 [M+NH4]+; IR(Neat): vmax = 3044,
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2950, 2929, 2851, 2822, 1541, 1459, 1435, 1366, 1219, 1112, 1014 cm '1. An 
authentic sample o f racemic 104, (±  )-l-(3-(2-iodophenyl)-l-
ethoxypropyl)benzene, was prepared from 100 as described previously: HPLC 
conditions: Chiracel OD-H column, hexane/2-propanol, 99:1, 0.5 ml/min, 24 °C, 
tr  = 17.0 min (-)-enantiomer, = 24.6 min (+)-enantiomer. Enantiomer 2 (Rf =
24.6 min): The racemic ether gave baseline separation and a 1:1 ratio of integrated 
areas.
(5)-l-(l-(Benzyloxy)-3-(2-iodophenyl)propyl)benzene - 105
Synthesised according to GP5 with sodium hydride (213 mg, 8.89 mmol) 
suspended in DMF (10 ml) stirred with (S)-3 -(2-iodophenyl) - 1 -phenylpropan-1 -ol 
101 (1.0 g, 2.96 mmol) and benzyl bromide (506 mg, 2.96 mmol). The product 
was purified by column chromatography petroleum ether/diethyl ether (1 0 :1 ).
Yield 71% (0.90g, 2.100 mmol) as a pale yellow oil. [a ]^3 = + 40.06 (c = 1.19,
CHC13): !H NMR (CDCI3 , 500 MHz) bH: 1.92 (1H, dddd, J  = 13.5, 10.3, 6.3, 5.2 
Hz, ArCH2C //ACHB), 2.01 (1H, dddd, J  = 13.5, 10.1, 8.0, 5.1 Hz, 
ArCH2CHAC //B), 2.70 (1H, ddd, J  = 13.4, 10.1, 6.3 Hz, A rC//ACHB), 2.81 (1H, 
ddd , J =  13.4, 10.3,5.1 Hz, ArCHAC //B), 4.15 (1H, d d ,. /=  8.0, 5.2 Hz, CH), 4.49 
(2H, s, O C //2), 6.81 (1H, ddd, J =  7.8, 6.7, 1.4 Hz, H-arom), 7.12-7.16 (5H, m, H- 
arom), 7.18-7.35 (7H, m, H-arom), 7.75 (1H, dd, J =  8.0, 1.2 Hz, //-arom); 13C 
NMR, (CDCI3 , 125.7 MHz) 8 C: 28.1 (C7), 36.9 (C-8 ), 74.9 (C-14), 85.3 (C-9),
100.6 (C -l), 125.5 (C-Ar), 125.6 (C-Ar), 126.5 (C-Ar), 126.6 (C-5), 127.2 (C-4),
127.2 (C-Ar), 128.4 (C-3), 128.9 (C-Ar), 129.5 (C-Ar), 138.4 (C-6 ), 139.9 (C-Ar),
140.3 (C-Ar), 143.5 (C-2); MS (CI+): m/z (%) = 428 (27) [M+H]+, 337 (12), 321
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(46), 217 (100), 107 (41), 91 (19); HRMS for C22H22IO: calcd. 428.0901, found 
428.0899 [M+H]+; No IR obtained. An authentic sample of racemic 105, (± )- l-  
(l-(benzyloxy)-3-(2-iodophenyl)propyl)benzene, was prepared from 1 0 0  as 
described previously: HPLC conditions: Chiracel OD-H column, hexane/2- 
propanol, 99:1, 0.5 ml/min, 24 °C, tR = 15.9 min (-)-enantiomer, ts = 26.5 min 
(+)-enantiomer. Enantiomer 2 (Rf = 26.5 min): The racemic ether gave baseline 
separation and a 1 :1  ratio o f integrated areas.
(<S)-(l-(l-Methoxy-3-(2-(diacetoxy)iodophenyl)propyl)benzene - 106
I(OAc)2
Synthesised according to G P11 with sodium perborate tetrahydrate (734 mg, 4.77 
mmol) added portion wise to a solution o f (S)-l-(3-(2-iodophenyl)-l- 
methoxypropyl)benzene 103 (168 mg, 0.477 mmol) in glacial acetic acid (5 ml). 
Product was isolated by recrystallisation from acetic acid/pentane. Yield 87%
(195 mg, 0.415 mmol) as a white powder, mp = 120-122°C. [a ]^6 = + 75.1 (c =
0.97, CHCfO^H NMR, (CDC13, 400 MHz) 8 H: 1.93-2.04 (2H, m, ArCH2CH2),
2.05 (6 H, s, (O CO C//3)2), 2.91 (1H, ddd, J  = 14.0, 10.6, 6.0 Hz, ArC//ACHB),
3.12 (1H, ddd, J =  14.0, 10.8, 5.4 Hz, ArCHAC //B), 3.46 (3H, s, OCH3), 4.06 (1H, 
dd, J =  8.1, 4.9 Hz, CH), 7.10 (1H, dd, J  = 8.0. 1.9 Hz, H-arom) 7.18 (1H, dd, J  =
7.6, 1.5 Hz, H-arom), 7.21-7.40 (5H, m, H-arom), 7.48 (1H, dd, J =  8.0, 1.8 Hz, 
H-arom), 8.11 (1H, d, J  = 7.9 Hz, H-arom); 13C NMR (CDCI3, 100.6 MHz): 8  = 
20.3 ((OCOCH3)2), 35.7 (C-8 ), 39.3 (C-7), 56.7 (C-14), 82.8 (C-9), 124.9 (C-l),
126.5 (C-l 1), 127.8 (C -l3), 128.5 (C-12), 128.7 (C-5), 130.2 (C-4), 132.7 (C-3),
137.9 (C-10), 141.7 (C-6 ), 144.0 (C-2), 176.4 ((OCOCH3)2); IR (Nujol): vmax = 
2950, 2910, 2889, 1659, 1620, 1560, 1477, 1462, 1380, 1304, 1147, 1009 cm’1.
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(iS)-l-(l-Ethoxy-3-(2-(diacetoxy)iodophenyl)propyl)benzene - 107
I(OAc)2
Synthesised according to G P11 with sodium perborate tetrahydrate (574 mg, 3.73 
mmol) added portion wise to a solution of (S)-l-(3-(2-iodophenyl)-l- 
ethoxypropyl)benzene 104 (137 mg, 0.373 mmol) in glacial acetic acid (5 ml). 
Product was isolated by recrystallisation from acetic acid/pentane. Yield 89% 
(161 mg, 0.333 mmol) as a white powder, mp = 120-123°C. [a ]^5 = + 70.7 (c =
1.09, CHC13). !H NMR, (CDCI3 , 500 MHz) 5H: 1.14 (3H, t, J=  7.1 Hz, CH2C //3),
2.02 (6 H, s, (C //3COO)2), 2.07 (1H, dddd, J  = 14.0, 10.7, 5.5, 5.1 Hz, 
ArCH2CH2), 2.19 (1H, dddd, J  = 14.0, 9.8, 8.2, 6.5 Hz, ArCH2CH2), 2.93 (1H, 
ddd, J  = 13.9, 10.7, 6.5 Hz, ArC //2), 3.05 (1H, ddd, J=  13.9, 9.8, 5.5 Hz, Ai CH2), 
3.95 (2H, q, J  = 7.1 Hz, C //2CH3), 4.20 (1H, dd, J  = 8.2, 5.1 Hz, CH), 7.09 (1H, 
d, J=  7.2 Hz, //-arom ), 7.20 (1H, dd, J =  7.6, 1.7 Hz, //-arom), 7.25-7.49 (5H, m, 
H-arom), 7.79 (1H, d, J  = 6.9 Hz, H-arom), 8.15 (1H, dd, J  = 7.8, 1.0 Hz, H- 
arom); ,3C NMR, (CDC13, 125.7 MHz) 8 C: 20.0 (C -l5), 20.6 ((OCOCH3)2), 39.9 
(C-8 ), 41.2 (C-7), 66.2 (C-14), 85.3 (C-9), 126.6 (C-13), 127.5 (C-Ar), 127.6 (C-
11), 128.3 (C -l2), 128.4 (C-Ar), 131.0 (C-3), 133.5 (C-l), 140.4 (C-6 ), 143 (C-
10), 145.7 (C-2), 175.5 ((OCOCH3)2). IR (Nujol): vmax = 2979, 2915, 2872, 1690, 
1560, 1477, 1462, 1380, 1304, 1147, 1000 cm '1.
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(Y)-l-(l-(Benzyloxy)-3-(2-(diacetoxy)iodophenyl)propyl)benzene - 108
I(OAc)2
Synthesised according to GP13 with (S)-l-(l-(benzyloxy)-3-(2- 
iodophenyl)propyl)benzene 105 (63 mg, 0.146 mmol) added to a stirred solution 
of acetic anhydride (8.76 ml, 92.7 mmol) and hydrogen peroxide (2.34 ml o f a 
30% solution in acetic acid) in glacial acetic acid (5 ml). Product was isolated by 
recrystallisation from acetic acid/pentane. Yield 5% (4 mg, 0.007 mmol) as a 
white powder, mp = 120-123°C. *H NMR, (CDC13, 400 MHz) 5H: 2.02 (6 H, s, 
(OCOC//3)2), 2.04-2.10 (H, m, ArCH2C //ACHB), 2.20 (1H, ddd, J  = 14.2, 9.7,
6.1, 5.0 Hz, ArCH2CHAC //B), 2.99 (1H, ddd, J =  14.3, 9.9, 6.1 Hz, ArC//ACHB),
3.17 (1H, ddd, J  = 14.3, 9.7, 5.7 Hz, ArCHAC //B), 3.89 (1H, dd, J =  8.0, 5.0 Hz, 
CH), 4.19 (2H, s, O C //2), 6.90 (2H, atd, J =  7.9, 1.6 Hz, H-arom), 7.12 (1H, dd, J  
= 7.6, 1.6 Hz, //-arom ), 7.15-7.48 (9H, d, 7 =  6.3 Hz, //-arom), 7.57 (1H, t, J  = 
1A  Hz, H-arom), 8.14 (1H, d, J =  7.9 Hz, H-arom); No 13C obtained, insufficient 
quantity synthesised.
(S)-l-(3-(2-[Bis(trifluoroacetoxy)iodo]phenyl)-l-methoxypropyl)benzene -109
Synthesised according to GP15 with (<S)-l-(3-(2-iodophenyl)-l- 
methoxypropyl)benzene 103 (52 mg, 0.147 mmol) in DCM (2 ml) added to a 
previously prepared solution o f trifluoroacetic anhydride (154 mg, 0.733 mmol) 
and urea hydrogen peroxide (23 mg, 0.249 mmol) in DCM (2 ml). Product was
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isolated by recrystallisation from acetic acid/pentane. Yield 59% (50 mg, 0.086 
mmol) of a white powder, mp = 99-102°C. [ot]J4 = + 82.0 (c = 0.56, CHC13). *H
NMR (CDC13, 500 MHz) SH: = 2.00-2.13 (2H, m, ArCH2C //2), 2.90-2.99 (1H, m, 
A rC//ACHB), 3.08 (1H, m, ArCHAC //B), 3.19 (3H, s, OC//3), 4.15 (1H, dd, J  =
8.0, 2.8 Hz, C//) , 7.10-7.31 (6 H, m, H-arom), 7.5 (1H, d, J =  8.2 Hz, H-arom), 
7.58 (1H, atd, J  = 7.6, 2.0 Hz, //-arom), 8.21 (1H, d, 8.1 Hz, //-arom); 13C 
NMR (CDCI3, 125.7 MHz): 5 = 35.5 (C-8 ), 39.3 (C-7), 56.6 (C-14), 83.4 (C-9),
112.9 (q, J cf  = 288 Hz, CF3), 126.5 (C-Ar, 126.8 (C-Ar), 128.5 (C-5), 128.7 (C- 
Ar), 129.5 (C-4), 131.1 (C-3), 134.6 (C-l), 138.3 (C-10), 141.0 (C-6 ), 144.5 (C- 
2 ), 161.0 (q, JCF = 40 Hz, COCF3); IR (Nujol): vmax = 2930, 2861, 1739, 1709, 
1469, 1390, 1362, 1234, 1189, 1147, 990 cm '1.
(S)-l-(l-Ethoxy-3-(2-(diacetoxy)iodophenyl)propyl)benzene - 110
I(OCOCF3)2
Synthesised according to GP15 with (S)-1 -(3-(2-iodophenyl)-l - 
ethoxypropyl)benzene 104 (33 mg, 0.090 mmol) in DCM (2 ml) added to a 
previously prepared solution o f trifluoroacetic anhydride (94 mg, 0.450 mmol) 
and urea hydrogen peroxide (14 mg, 0.153 mmol) in DCM (2 ml). Product was 
isolated by washing with pentane. Yield 17% (9 mg, 0.015 mmol) of a white
powder, mp = 100—104°C. [a ]^  — + 76.9 (c = 0.22, CHCI3). !H NMR, (CDCI3,
500 MHz) §H: 1-29 (3H, t, J =  7.0 Hz, CH2C //3), 2.27 (1H, dddd, 13.7, 10.6,
7.9, 5.4 Hz, ArCH2C //ACHB), 2.45 (1H, dddd, J  = 13.7, 9.9, 6.5, 5.1 Hz, 
ArCH2CHAC //B), 3.10 (1H, ddd, J  = 14.0, 10.6, 6.5 Hz, ArC//ACHB), 3.33 (1H, 
ddd, J  = 14.0, 9.9, 5.4 Hz, ArCHAC //B), 3.60 (2H, q, J =  7.0 Hz, C //2CH3), 3.61 
(1H, dd, J  = 7.9, 5.1 Hz, CH), 6.99 (1H, d, J  = 6 . 8  Hz, //-arom), 7.10 (1H, atd, J  =
6.9, 1.8 Hz, H-arom), 7.16-7.49 (5H, m, //-arom), 7.60 (1H, d, J  = 7.2 Hz, H-
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arom), 8.22 (1H, dd, J  = 8.1, 1.0 Hz, //-arom); No 13C obtained, insufficient 
sample synthesised.
l-(2-Iodophenyl)-4,4-dimethylpentan-3-one-  111
o
Synthesised according to GP8  with 2-iodobenzyl chloride 83 (3.00 g, 12.24 
mmol), 2,2,6,6-tetramethyl-3,5-heptandione (2.481 g, 13.46 mmol) and potassium 
carbonate (1774 g, 12.85 mmol) in ethanol (50 ml). The product was purified by 
column chromatography hexane/ethyl acetate (20:1). Yield 49% (1.83 g, 5.78 
mmol) as a colourless oil. *H NMR, (CDCI3, 500 MHz) 5h: 1.05 (9H, s, (0 7 /3)3),
2.72 (2H, t, J =  7.7 Hz, ArCH2C //2), 2.90 (2H, t, J = 7.7, ArC//2CH2), 6.82 (1H, 
atd, J =  7.5, 2.1, H-arom), 7.12-7.24 (2H, m, H-arom), 7.73 (1H, dd, J — 7.9, 0.9 
Hz, H-arom); ,3C NMR, (CDC13, 125.7 MHz) 5C: 26.3 (C -ll), 35.2 (C-7), 36.8 
(C-8 ), 44.2 (C-10), 100.2 (C -l), 127.9 (C-5), 128.4 (C-4), 129.8 (C-3), 139.6 (C-
6 ), 144.1 (C-2), 214.6 (C-9); MS (EI+): m/z (%) = 316 (10) [M]+, 259 (9), 217 
(19), 105 (13), 85 (32), 57 (100); HRMS for Ci3Hi6IO: calcd. 315.0255, found 
315.0246 [M -  H]+; IR (Neat): vmax = 2979, 2891, 1719, 1485, 1369, 1344, 1277, 
1138, 1012 cm '1.
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(±  )-l-(2-Iodophenyl)-4,4-dimethylpentan-3-ol - 1 1 2
OH
Synthesised according to GP10 with l-(2-iodophenyl)-4,4-dimethylpentan-3-one 
111 (3.00 g, 9.488 mmol) added to a stirred solution of sodium borohydride (251 
mg, 6.642 mmol) in ethanol (20 ml). The product was columned using petroleum 
ether/diethyl ether (8:1). Yield 64% (1.933 g, 6.074 mmol), pale yellow oil. HPLC 
conditions: Chiracel OD column, hexane/ 2-propanol, 95:5, 2.5 ml/min, 10 °C, /r 
= 9.9 min (-)-enantiomer, ts = 15.5 min (+)-enantiomer. *H NMR, (CDCI3, 500 
MHz) 6 h: 0.83 (9H, s, (C //3)3), 1.44 (1H, dddd, J =  13.9, 10.6, 10.4, 4.9, Hz, 
ArCH2C //ACHB), 1.52 (1H, s, OH), 1.80 (1H, dddd, J =  13.9, 10.8, 6.1, 1.7 Hz, 
ArCH2CHAC //B), 2.66 (1H, ddd, J  = 13.6, 10.4, 6.1 Hz, ArC//ACHB), 2.95 (1H, 
ddd, J  = 13.6, 10.8, 4.9 Hz, ArCHAC //B), 3.20 (1H, dd, J  = 10.6, 1.7 Hz, OH), 
6.81 (1H, ddd, J  — 8.1, 6 .6 , 1.3 Hz, H-arom), 7.17-7.23 (2H, m, H-arom), 7.74 
(1H, d, J  = 8.2 Hz, tf-arom); l3C NMR, (CDCh, 125.7 MHz) 6 C: 25.7 (C-l 1),
32.2 (C-7), 35.1 (C-8 ), 38.4 (C-10), 79.6 (C-9), 100.6 (C-l), 127.7 C-5), 128.4 (C-
4), 129.6 (C-3), 129.5 (C-6 ), 145.0 (C-2); MS (EI+): nth (%) = 318 (100) [M f, 
300 (82), 285 (90); HRMS for C I3H i9IO: calcd. 318.0475, found 318.0473 [M]+; 
IR (Neat): 3395, 2975, 2878, 1480, 1456, 1383, 1200, 1195, 1017 cm '1.
(/?)-l-(2-Iodophenyl)-4,4-dimethylpentan-3-ol -1 1 3
OH
Synthesised according to GP10 with l-(2-iodophenyl)-4,4-dimethylpentan-3-one 
111 (3.00 g, 9.488 mmol) added to a stirred solution of sodium borohydride (251 
mg, 6.642 mmol) in ethanol (20 ml). The product was columned using petroleum
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ether / diethyl ether (8:1). Yield 64% (1.933 g, 6.074 mmol), pale yellow oil. The 
enantiomers could be separated by preparative HPLC: Chiracel OD column, 
hexane/ 2-propanol, 95:5, 2.5 ml/min, 10 °C, Ir = 9.9 min (-)-enantiomer, ts =
15.5 min (+)-enantiomer. Enantiomer 1 (9.9 mins). [a]^ = -  81.06 (c = 1.03,
CHCI3, >99% ee). 'H  NMR, (CDC13, 500 MHz) SH: 0.83 (9H, s, (C7 /3)3), 1.44 
(1H, dddd, J =  13.9, 10.6, 10.4, 4.9, Hz, ArCH2C //ACHB), 1.52 (1H, s, OH), 1.80 
(1H, dddd, J =  13.9, 10.8, 6.1, 1.7 Hz, ArCH2CHAC //B), 2.66 (1H, ddd, ./=  13.6,
10.4, 6.1 Hz, A rC //ACHB), 2.95 (1H, ddd, J  = 13.6, 10.8, 4.9 Hz, ArCiIAC //B).
3.20 (1H, dd, J =  10.6, 1.7 Hz, C/7), 6.81 (1H, ddd, J =  8.1, 6 .6 , 1.3 Hz, //-arom),
7.17-7.23 (2H, m, //-arom ), 7.74 (1H, d, J =  8.2 Hz, H-arom); l3C NMR, (CDCI3,
125.7 MHz) 5C: 25.7 (C -ll) , 32.2 {C-l), 35.1 (C-8 ), 38.4 (C-10), 79.6 (C-9),
100.6 (C-l), 127.7 C-5), 128.4 (C-4), 129.6 (C-3), 129.5 (C-6 ), 145.0 (C-2); MS 
(EI+): mtz (%) = 318 (100) [M]+, 300 (82), 285 (90); HRMS for C 13H 19IO: calcd.
318.0475, found 318.0473 [M]+; IR (Neat): 3395, 2975, 2878, 1480, 1456, 1383, 
1200, 1195, 1017 cm '1.
(iS)-l-(2-Iodophenyl)-4,4-dimethylpentan-3-ol -1 1 4
OH
Synthesised according to GP10 with l-(2-iodophenyl)-4,4-dimethylpentan-3-one 
1 1 1  (3 . 0 0  g, 9.488 mmol) added to a stirred solution o f sodium borohydride (251 
mg, 6.642 mmol) in ethanol (20 ml). The product was columned using petroleum 
ether / diethyl ether (8:1). Yield 64% (1.933 g, 6.074 mmol), pale yellow oil. The 
enantiomers could be separated by preparative HPLC: Chiracel OD column, 
hexane/ 2-propanol, 95:5, 2.5 ml/min, 10 °C, tR = 9.9 min (-)-enantiomer, ts =
15.5 min (+)-enantiomer. Enantiomer 2 (15.5 mins). [a ]^5 = + 80.35 (c = 1.02,
CHC13, >99% ee). 'H  NMR, (CDCI3 , 500 MHz) 8 H: 0.83 (9H, s, (C //3)3), 1.44 
(1H, dddd, J =  13.9, 10.6, 10.4, 4.9, Hz, ArCH2C //ACHB), 1.52 (1H, s, OH), 1.80 
( 1 H, dddd, J =  13.9, 10.8, 6.1, 1.7 Hz, ArCH2CHAC //B), 2.66 (1H, ddd, J =  13.6,
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10.4, 6.1 Hz, A rC //ACH B), 2.95 (1H, ddd, 7 =  13.6, 10.8, 4.9 Hz, ArCHAC //B),
3.20 (1H, dd, 7 =  10.6, 1.7 Hz, CH), 6.81 (1H, ddd, 7 =  8.1, 6 .6 , 1.3 Hz,//-arom),
7.17-7.23 (2H, m ,//-arom ), 7.74 (1H, d ,7 = 8 .2  Hz,//-arom); l3C NMR, (CDC13,
125.7 MHz) 8 C: 25.7 (C -ll) , 32.2 (C-7), 35.1 (C-8 ), 38.4 (C-10), 79.6 (C-9),
100.6 (C-l), 127.7 C-5), 128.4 (C-4), 129.6 (C-3), 129.5 (C-6 ), 145.0 (C-2); MS 
(EI+): miz (%) = 318 (100) [M]+, 300 (82), 285 (90); HRMS for C 13H 19IO: calcd.
318.0475, found 318.0473 [M f; IR (Neat): 3395, 2975, 2878, 1480, 1456, 1383, 
1200, 1195, 1 0 1 7 cm 1.
(/?)-l-Iodo-2-(3-methoxy-4,4-dim ethylpentyl)benzene -  115
Synthesised according to GP5 with sodium hydride (42 mg, 1.754 mmol) 
suspended in DMF (5 ml) stirred with (i?)-l-(2-iodophenyl)-4,4-dimethylpentan- 
3-ol 113 (186 mg, 0.585 mmol) and methyl iodide (83 mg, 0.585 mmol). The 
product was purified by column chromatography hexane/ethyl acetate (4:1). Yield
70% (136 mg, 0.409 mmol) as a pale yellow oil. [ a ]^4 = -  67.82 (c = 0.55,
CHCI3). *H NMR, (CDCI3, 500 MHz) 6 H: 0.84 (9H, s, (C //3)3), 1.52 (1H, dddd, J  
= 14.0, 11.9, 9.4, 4.8, ArCH2C //ACHB), 1.75 (1H, dddd, J  = 14.1, 11.0, 4.0, 2.4, 
ArCH2CHAC //B), 2.64 (1H, ddd, J =  13.4, 11.9, 4.9, ArC//ACHB), 2.75 (1H, dd, J  
= 9.4, 2.4, CH), 2.90 (1H, ddd, J  = 13.4, 11.0, 4.8, ArCHAC //B), 3.46 (3H, s, 
OC//3 ), 6.80 (1H, atd, J =  7.5, 2.1 Hz, //-arom), 7.19 (2H, m, //-arom), 7.73 (1H, 
d ,J =  7.8 Hz, H-arom); ,3C NMR, (CDC13, 125.7 MHz) 8 C: 26.3 (C -ll), 32.1 (C-
7), 36.1 (C-8 ), 38.9 (C-10), 61.5(C-12), 90.4 (C-9), 100.7 (C-l), 127.7 (C-5),
128.4 (C-4), 129.3 (C-3), 139.5 (C-6 ), 145.3 (C-2); MS (EI+): m/z (%) = 332 (9) 
[M]+, 300 (10), 274 (53), 243 (34), 217 (100); HRMS for Ci4H2 iIO: calcd. 
332.0637, found 332.0622 [M]+; IR (Neat): 2996, 2888, 1469, 1436, 1373, 1170, 
1139, 1008 cm '1. An authentic sample o f racemic 115, (±  )-l-iodo-2-(3-methoxy- 
4 ,4 -dimethylpentyl)benzene, was prepared from 112 as described previously:
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HPLC conditions: Chiracel OD-H column, hexane/2-propanol, 95:5, 0.5 ml/min, 
20 °C, /r = 7.8 min (-)-enantiomer, ts = 9.5 min (+)-enantiomer. Enantiomer 1 (Rf 
= 7.8 min). The racemic ether gave baseline separation and a 1:1 ratio of 
integrated areas.
(/?)-! -(3-Ethoxy-4,4-dimethylpentyl)-2-iodobenzene -1 1 6
Synthesised according to GP5 with sodium hydride (45 mg, 1.895 mmol) 
suspended in DMF (5 ml) stirred with (/?)-l-(2-iodophenyl)-4,4-dimethylpentan- 
3-ol 113 (201 mg, 0.632 mmol) and ethyl iodide (99 mg, 0.632 mmol). The 
product was purified by column chromatography hexane/ethyl acetate (4:1). Yield 
69% (151 mg, 0.436 mmol) as a pale yellow oil. [a ]^7 = -  71.02 (c = 1.09,
CHC13): !H NMR, (CDCI3, 500 MHz) 6 H: 1.14 (9H, s, (C# 3)3), 1.18 (3H, t, J  =
6.9 Hz, CH2C //3), 1.42 (1H, dddd, J  = 13.9, 10.6, 10.4, 4.9 Hz, ArCH2C //ACHB),
1.78 (1H, dddd, J  = 13.9, 10.8, 6.0, 1.7 Hz, ArCH2CHAC //B), 2.65 (1H, ddd, J  =
13.6, 10.4, 6.0 Hz, A rC //ACHB), 2.94 (1H, ddd, J  = 13.6, 10.8, 4.9 Hz, 
ArCHAC //B), 3.20 (1H, dd, J  = 10.6, 1.7 Hz, CH), 3.54 (2H, q, J  = 6.9 Hz, 
C //2CH3), 6.89 ( 1 H, ddd, J =  8 .2 , 6.5, 2 . 6  Hz, //-arom), 7.17-7.23 (2 H, m, H- 
arom), 7.72 (1H, d , J =  8.2 Hz, //-arom ); ,3C NMR, (CDC13, 125.7 MHz) 6 C: 25.7 
(C -l3), 26.4 (C -ll) , 32.1 (C-7), 35.1 (C-8 ), 38.4 (C-10), 66.3, (C -l2), 79.5 (C-9),
100.6 (C-l), 127.7 (C-5), 128.4 (C-4), 129.6 (C-3), 129.5 (C-6 ), 145.1 (C-2); MS 
(EI+): m/z (%) = 346 (17) [M]+, 332 (12), 300 (20), 274 (76), 243 (21), 217 (100); 
HRMS for Ci4H2 iIO: calcd. 346.0794, found 346.0790 [M]+; IR (Neat): 3002, 
2850, 2819, 1475, 1426, 1366, 1170, 1140, 1001 cm '1. An authentic sample of 
racemic 116, (±  )-l-iodo-2-(3-ethoxy-4,4-dimethylpentyl)benzene, was prepared 
from 112 as described previously: HPLC conditions: Chiracel OD-H column, 
hexane/2 -propanol, 95:5, 0.5 ml/min, 2 0  °C, /r = 13.6 min (-)-enantiomer, ts =
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26.6 min (+)-enantiomer. Enantiomer 1 (Rf = 13.6 min). The racemic ether gave 
baseline separation and a 1 :1  ratio of integrated areas.
(/?)-1 -((1 -(2-Iodophenyl)-4-methylpetitan-3-yloxy)methyl)benzene -117
Synthesised according to GP5 with sodium hydride (50 mg, 2.065 mmol) 
suspended in DMF (5 ml) stirred with (R)-1 -(2-iodophenyl)-4,4-dimethylpentan- 
3-ol 114 (219 mg, 0.688 mmol) and benzyl bromide (118 mg, 0.688 mmol). The 
product was purified by column chromatography hexane/ethyl acetate (4:1). Yield 
69% (129 mg, 0.317 mmol) as a pale yellow oil. [a ]^6 = -  73.99 (c = 1.00,
CHC13): *H NMR, (CDCI3, 500 MHz) SH: 0.90 (9H, s, (C //3)3), 1.62 (1H, dddd, J  
= 14.1, 11.7, 9.0, 5.2 Hz, ArCH2C //ACHB), 1.80 (1H, dddd, J  = 14.1, 11.9, 4.8, 
2.7 Hz, ArCH2CHAC //B), 2.63 (1H, ddd, J=  13.4, 11.7, 4.8 Hz, ArCHAC //B), 2.90 
(1H, ddd, J  = 13.4, 11.9, 5.2 Hz, ArCHAC //B), 3.05 (1H, dd, J=  9.0, 2.7 Hz, CH), 
4.39 (2H, s, OCH2), 6.78 ( 1 H, ddd, J -  7.6, 7.5, 1.7 Hz, //-arom), 7.11 (2H, dd, J  
= 7.7, 1.6 Hz, H-arom), 7.16-7.20 (2H, m, //-arom), 7.27-7.34 (2H, m, H-arom),
7.72 (1H, dd, J  = 7.9, 0.8 Hz, H-arom); 13C NMR, (CDC13, 125.7 MHz) 6 C: 
26.6(C-11), 32.2 (C-l), 36.4 (C-8 ), 39.0 (C-10), 75.1 (C-12), 88.3 (C-9), 100.7 
(C-2), 127.4 (C-5), 127.6 (C-Ar), 128.3 (C-Ar), 128.4 C-3), 129.3 (C-3), 139.3 
(C-Ar), 139.5 (C-6 ), 145.3 (C -l); MS (ES+): m/z (%) = 426 (43) [M+NH4j+, 300 
(34), 208 (100), 106 (48), 91, (13); HRMS for C10H17INO: calcd. 426.1288, found 
426.1288 [M+NH4]+. An authentic sample of racemic 117, (± )-l-((l-(2 - 
Iodophenyl)-4-methylpentan-3-yloxy)methyl)benzene, was prepared from 112 as 
described previously: HPLC conditions: Chiracel OD-H column, hexane/2- 
propanol, 95:5, 0.5 ml/min, 20 °C, tR = 15.9 min (-)-enantiomer, ts = 23.1 min
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(+)-enantiomer. Enantiomer 1 (Rf= 15.9 min). The racemic ether gave baseline 
separation and a 1 :1  ratio o f integrated areas.
(i?)-l-(Diacetoxy)iodo-2-(3-methoxy-4,4-dimethylpeiityl)benzene -1 1 8
I(OAc)2
Synthesised according to GP11 with sodium perborate tetrahydrate (484 mg, 
3.103 mmol) added portion wise to a solution of (R)-l-iodo-2-(3-methoxy-4,4- 
dimethylpentyl)benzene 115 (100 mg, 0.310 mmol) in glacial acetic acid (5 ml). 
Product was isolated by recrystallisation from acetic acid/pentane. Yield 6 % ( 8  
mg, 0.018 mmol) as a white powder. NMR, (CDCI3, 500 MHz) 8 h: 1.20 (9H, 
s, (CH3)3), 1.88-2.00 (2H, m, ArCH2C //2), 2.07 (6 H, s, (OCOC//3)2), 2.77-2.84 
(1H, m, A rC //ACHB), 2.95-3.02 (1H, m, ArCHAC //B), 3.46 (3H, s, OCH3), 3.66 
(1H, dd, J =  8 .6 , 2.8, CH), 7.33 (1H, d, J =  7.4 Hz, H-arom), 7.42 (1H, d J =  7.4, 
H-arom), 7.63 (1H, d, J =  7.8 Hz, H-arom), 8.03 (1H, d, J =  7.8 Hz, //-arom). No 
13C obtained, insufficient quantity synthesised.
(i?)-l-(3-Ethoxy-4,4-dimethylpentyl)-2-(diacetoxyiodo)benzene -1 1 9
Synthesised according to GP12 with peracetic acid (1.12 ml of a 30% solution in 
acetic acid) added to a stirred solution o f (R)-1 -(3-ethoxy-4,4-dimethylpentyl)-2- 
iodobenzene 116 (97 mg, 0.280 mmol) in acetic acid (10 ml). Product was 
isolated by recrystallisation from acetic acid/pentane. Yield 5% (7 mg, 0.014 
mmol) as a white powder. JH NMR, (CDCI3, 500 MHz) 8 h* 1.20 (3H, t, J  — 6.9
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Hz, CH2C //3), 1.24 (9H, s, (C //3)3), 1.51-161 (2H, m, ArCH2C//2), 2.02 (6 H, s, 
(OCOC//3)2), 2.77-2.84 (1H, m, ArCH2), 2.98-3.05 (1H, m, ArC//2), 3.58 (2H, q, 
J =  6.9 Hz, C //2CH3), 3.74 (1H, d, J =  10.6 Hz, CH), 7.35 (1H, d, J =  7.5 Hz, H- 
arom), 7.62 (2H, m, H-arom), 8.07 (1H, d, J  = 7.8 Hz, H-arom). No ,3C obtained, 
insufficient quantity synthesised.
(/?)-l-(Bis(trifluoroacetoxy)iodo]-2-(3-methoxy-4,4-dimethyIpentyl)benzene -120
I(OCOCF3)2
Synthesised according to GP15 with (.ft)-l-iodo-2-(3-methoxy-4,4- 
dimethylpentyl)benzene 115 (110 mg, 0.341 mmol) in DCM (2 ml) added to a 
previously prepared solution o f trifluoroacetic anhydride (358 mg, 1.705 mmol) 
and urea hydrogen peroxide (55 mg, 0.580 mmol) in DCM (5 ml). Yield 2% (4 
mg, 0.014 mmol) o f a white powder. JH NMR, (CDC13, 400 MHz) 6 h: 1.70 (9H, 
s, (C //3)3), 2.87-2.95 (1H, m, ArCH2C //ACHB), 3.02-3.09 (1H, m,
ArCH2CHAC //B), 3.11-3.21 (2H, m, ArCH2), 3.18 (3H, s, OCH3), 4.10-4.13 (1H, 
m, CH), 7.24 (1H, d , J  = 7.7 Hz, //-arom ), 7.44 (1H, d, J =  6.9 Hz, H-arom), 7.57 
(1H, d, J  = 6.9 Hz, //-arom ) 8.22 (1H, d, J =  7.7 Hz, //-arom); No 13C obtained, 
insufficient quantity synthesised.
(/?)-l,2-Bis(tosyloxy)phenylethane14 -125
OTs
Synthesised according to GP20 with styrene added to a stirred mixture of the (S)- 
l-(l-ethoxy-3 -(2 -(diacetoxyiodo)phenyl)propyl)benzene 107 (165 mg, 0.34
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mmol) and /?Ts0 H*H2 0  (129 mg, 0.68 mmol) in DCM (5 ml) at 25°C. The 
product was purified by column chromatography using hexane/ethyl acetate ( 1 :1 ). 
Yield 75%, 10% ee (116 mg, 0.259 mmol) as a white powder. Spectroscopic data 
agrees with literature. HPLC conditions: Chiracel OD-H column, hexane/2 - 
propanol, 90:10, 0.5 ml/min, 254 nm, 20 °C, /r  = 14.2 min (R), ts = 17.0 min (S). 
'H NMR, (CDCI3 , 500 MHz) 8 H: 2.42 (3H, s, CH3), 2.48 (3H, s, CH3), 4.05 (1H, 
dd, J  = 1 1 .2 , 4.2 Hz, C //ACHB), 4.13 ( 1 H, dd, J  = 1 1.2, 7.8 Hz, CHAC //B), 5.49 
(1H, dd, J  = 7.8, 4.2 Hz, CH), 7.15-7.26 (7H, m, H-arom), 7.62-7.67 (4H, m, H- 
arom).
(*S)-l-Phenyl-oxo-2-tosyloxypropane15 -126
O
Synthesised according to GP21 with propiophenone (67 mg, 0.5 mmol) added to a 
stirred mixture o f (5)-l-iodo-2-(-2-methoxypropyl)benzene 58 (14 mg, 0.05 
mmol), />TsOH*H20  (285 mg, 1.5 mmol), raCPBA (366 mg, 1.5 mmol) in 
acetonitrile (3 ml). The product was purified by column chromatography using 
hexane/ethyl acetate (4:1). Yield 76%, 3% ee (116 mg, 0.379 mmol) as a white 
powder. Spectroscopic data agrees with literature. HPLC conditions: Chiracel 
OB-H column, hexane/2-propanol, 40:60, 0.5 ml/min, 40 °C, fa = 18.1 min, ts =
21.6 min. *H NMR, (CDC13, 400 MHz) 8 H: 1.51 (3H, d, J =  7.0 Hz, CH3), 2.31 
(3H, s, arom-C/A), 5.72 (1H, q, J  — 7.0 Hz, CH), 7.04 (2H, dd, J =  7.8, 1.8 Hz, H- 
arom), 7.19 (2H, d , J  = 7.7 Hz, H-arom), 7.48 (1H, atd, J =  7.4, 1.8 Hz, H-arom), 
7.68 (2H, d, J =  7.7 Hz, H-arom), 7.81 (2H, dd, 7.8, 7.4, Hz, H-arom).
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l-[Bis(trifluoroacetoxy)iodo]-3-methylbenzene 16 -177
I(OCOCF3)2
Synthesised according to GP14 with 3-iodotoluene 166 (200 mg, 0.917 mmol) in 
DCM (2 ml) added to a previously prepared solution of trifluoroperacetic acid 
(918 mg, 9.17 mmol) in DCM (5 ml). Product was isolated by washing with 
pentane. Yield 65% (265 mg, 0.596 mmol) of a white powder, mp = 96—97°C. 
Spectroscopic data agrees with literature. *H NMR (CDCI3, 500 MHz) §h- 2.39 
(3H, s, C //3), 7.41 (1H, t, J =  7.8 Hz, //-arom), 7.47 (1H, d, ./ = 7.8 Hz, //-arom), 
7.62 (1H, d, J — 7.6 Hz, //-arom ), 7.94 (1H, s, //-arom).
l-[Bis(trifluoroacetoxy)iodo]-4-(fluoro)benzene 6 -1 7 9
Synthesised according to GP14 with 4-fluoro-1-iodobenzene (201 mg, 0.917 
mmol), added to a previously prepared solution of trifluoroperacetic acid (918 mg,
9.17 mmol) in DCM (5 ml). Product was isolated by washing with pentane. Yield 
90% (368 mg, 0.822 mmol) o f colourless crystals, mp = 94-96°C. Spectroscopic 
data agrees with literature. !H NMR (CDCI3, 400 MHz) 6 h- 7.23 (2H, dd, J  — 8.9,
5.1 Hz, H-arom), 8.16 (2H, dd, J  — 8.9, 5.1 Hz, H-arom); 13C NMR (CDCI3, 125.7 
MHz) 5C: 11 2 .8  (q, J CF = 286 Hz, COCF3), 116.4 (C-l), 119.8 (d, JCF = 23 Hz, C- 
3 & 5), 138.3 (d, J c f  = 9 Hz, C-2 & 6 ), 161.2 (q, JCF= 41 Hz, COCF3), 165.3 (q, 
JCF =259 Hz, COCF3).
F
I(OCOCF3)2
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l-[Bis(trifluoroacetoxy)iodo]-4-(trifluoromethyl)benzene17 -1 8 0
I(OCOCF3)2
Synthesised according to GP14 with 4-trifluoromethyl-l-iodobenzene (249 mg, 
0.917 mmol), added to a previously prepared solution of trifluoroperacetic acid 
(918 mg, 9.17 mmol) in DCM (5 ml). Product was isolated by washing with 
pentane. Yield 81% (369 mg, 0.714 mmol) of colourless crystals, mp = 62°C. 
Spectroscopic data agrees with literature. H 1 NMR (CDCI3, 400 MHz) 8 h: 7.74 
(2H, d, J  = 8.3 Hz, H-arom), 8.26 (2H, d, J=  8.3 Hz, //-arom).
l-Trifluoroacetoxy-I,2-benziodoxoI-3(lH)-one18 -181
Synthesised according to GP15 with 2-iodobenzoic acid (223 mg, 0.917 mmol) in 
DCM (2 ml) added to a previously prepared solution of trifluoroacetic anhydride 
(1.926 g, 9.17 mmol) and urea hydrogen peroxide (216 mg, 2.29 mmol) in DCM 
(5 ml). Product was isolated by washing with pentane. Yield 26% (112 mg, 0.239 
mmol) of a white powder. JH NM R (CDCI3, 400 MHz) 5h: 7.74 (1H, atd, J =  7.4,
1.5 Hz, H-arom), 7.90 (1H, d, J  = 8.3 Hz, //-arom), 7.90-8.10 (1H, m, H-arom), 
8.23 (1H, dd, J =  7.9, 1.5 Hz, //-arom ).
O
OCOCF3
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l-[Bis(trifluoroacetoxy)iodo]-4-(methyl)benzene16 - 182
I(OCOCF3)2
Synthesised according to GP15 with 4-iodotoluene 166 (140 mg, 0.642 mmol) in 
DCM (2 ml) added to a previously prepared solution of trifluoroacetic anhydride 
(672 mg, 3.195 mmol) and urea hydrogen peroxide (100 mg, 1.067 mmol) in 
DCM (2 ml). Product was isolated by washing with pentane. Yield 91% (259 mg, 
0.584 mmol) o f a white powder, mp = 114-115°C. Spectroscopic data agrees with 
literature. H 1 NMR (CDCI3 , 500 MHz) 8 H: 2.43 (3H, s, CH}), 7.32 (2H, d, J =  8.5 
Hz, //-arom), 8.01 (2H, d, J  — 8.5 Hz, //-arom);
2-[Bis(trifluoroacetoxy)iodo]acetonitrile - 1 8 3
Synthesised according to GP15 with 2-iodoacetonitrile 191 (223 mg, 0.917 mmol) 
in DCM (2 ml) added to a previously prepared solution of trifluoroacetic 
anhydride (1.926 g, 9.17 mmol) and urea hydrogen peroxide (216 mg, 2.29 mmol) 
in DCM (5 ml). Product was isolated by washing with pentane. Yield 26% (112 
mg, 0.239 mmol) o f a white powder. *H NMR (CDCI3, 500 MHz) 6 9 : 4.30 (2H, s, 
CH2\  7.57 (1H, dd, .7=7.8 , 1.3 H z,//-arom ), 7.87 (1H, atd, J=  7.7, 1.1 Hz, H- 
arom), 7.99 (1H, dd, .7=7.7 , 1.3 H z,//-arom ), 8.40 (1H, d, .7=7.8, 1.1 Hz, H- 
arom); 13C NMR (CDC13, 125.7 MHz) 5C: 27.5 (C-7), 112.6 (q, JCF= 289 Hz, 
CF3), 115.2 (C-8 ), 126.2 (C -l), 130.7 (C-5), 131.9 (C-4), 134.0 (C-3), 135.4 (C-
6 ), 138.2 (C-2), 161.3 (q, J CF= 41 Hz, COCF3). No IR obtained.
I(OCOCF3)2
9 10
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(±  )-l-(2-iodo-3-methoxyphenyl)ethanol19 - 187
OM e
Synthesised according to GP23 with l-(3-methoxyphenyl)ethanol (9.034 g, 59.36 
mmol), stirred in hexane/diethyl ether (3:1, 200 ml), wBuLi (7.60 g, 118.72 mmol 
of a 2.5 M solution in hexanes) and iodine (7.71 g, 59.36 mmol) in diethyl ether 
(50 ml). The product was columned using pentane/ethyl acetate (10:1). Yield 24% 
(3.96 g, 14.25 mmol) as a crystalline solid. *H NMR (CDCI3, 500 MHz) 8 9 : 1.46 
(3H, d, J  = 6.4 Hz, CH (O H )C//3), 2.00 (1H, br s, OH), 3.89 (3H, s, O C//3), 5.19 
(1H, qd, J  = 6.2, 2.2 Hz, CH), 6.77 (1H, dd, J =  8.0, 1.4 Hz, H-arom), 7.19 (1H, 
dd, J  = 7.8, 1.4 Hz, //-arom ), 7.32 (1H, dd, J =  8.0, 7.8 Hz, H-arom); 13C NMR, 
(CDCI3, 125.7 MHz) 8 C: 23.5 (C-8 ), 56.5 (C-9), 73.7 (C-7), 89.6 (C-l), 109.7 (C-
5), 118.6 (C-4), 129.4 (C-3), 149.6 (C-2), 157.8 (C-6 ); MS (EI+): m/z (%) = 278 
(100) [M]+, 263 (93), 218 (5), 135 (37), 107 (12), 92 (19); HRMS for C9H 11IO: 
calcd. 277.9814, found 277.9804 [M]+; IR (Neat): vmax = 3604, 2867, 1567, 1466, 
1427, 1059 cm ' 1
202-Iodo-3-methoxy acetophenone —188
Synthesised according to GP1 with (±  )-l-(2-iodo-3-methoxyphenyl)ethanol 187 
(5.72 g, 20.58 mmol) in dichloromethane ( 2 0  ml) stirred with pyridinium 
chlorochromate (6.65 g, 30.87 mmol) in dichloromethane (50 ml) at 0 °C. The 
product was columned using hexane/diethyl ether (10:1). Yield 96% (5.45 g, 
19.75 mmol), as a pale yellow solid. Spectroscopic data consistent with literature
O
O M e
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'H NMR (CDCI3, 500 M H z)8 h: 2.53 (3H, s, COC//3), 3.84 (3H, s, O C//3), 6.80 
(1H, d, J =  8.2 Hz, //-arom ), 6.84 (1H, d, J  — 7.5 Hz, //-arom), 7.28 (1H, atd, J  =
8.2, 7.5 Hz, 77-arom); l3C NMR, (CDC13, 125.7 MHz) 8 C: 30.3 (C-8 ), 56.7 (C-9),
83.0 (C -l), 112.0 (C-5), 119.4 (C-4), 129.7 (C-3), 147.9 (C-2), 158.3 (C-6 ), 203.5 
(C-7).
l-(2-Iodophenyl)-l-methyl-2-methoxyethene -  189
.OMe
O M e
Synthesised according to GP2 with (methoxymethyl)triphenylphosphonium 
chloride (7.141 g, 20.83 mmol) in dry THF (10 ml), 2-iodo-3-methoxy 
acetophenone 188 (5.476 g, 19.85 mmol) stirred in the presence of rcBuLi (13.3 
ml, 33.33 mmol o f a 2.5 M solution in hexanes) and diisopropylamine (3.373 ml, 
33.33 mmol) in dry THF (5 ml). The product was purified by column 
chromatography using petroleum ether/diethyl ether (15:1) to yield the desired 
product. Yield 84% (5.067 g, 16.66 mmol) as a pale yellow oil. NMR (CDCI3, 
500 MHz) 6 h: 1.71 (3H, s, A rC C //3), 3.51 (3H, s, OC//3), 3.66 (3H, s, ArOC//3),
6.21 (1H, s, C//OM e), 6.89 (1H, d , J  = 7.0 Hz, H-arom), 7.05 (1H, d, 6 . 6  Hz, 
//-arom), 7.13 (1H, dd, J =  7.0, 6 . 6  Hz, //-arom). No ,3C obtained.
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( ± )-2-(2-iodo-3-methoxyphenyl)propanal -  190
OM e
10
Synthesised according to GP3 with l-(2-iodophenyl)-l-methyl-2-methoxyethene 
189 (5.30 g, 17.73 mmol) stirred in formic acid (16 ml, 348.6 mmol) in DCM (50 
ml). Yield 71% (3.59 g, 12.37 mmol), as a pale yellow oil. The product was 
purified by column chromatography using petroleum ether/diethyl ether (15:1) to 
yield the desired product. 'H NMR (CDCI3, 500 MHz) 5H: 1.41 (3H, d, J =  7.3 Hz, 
CHi), 3.66 (1H, q , J  = 7.3 Hz, C //C II3), 3.62 (1H, s, OC//3), 6.89 (1H, atd, J  =
7.0, 1.8 Hz, H-arom), 7.25 (1H, atd, J =  7.4, 1.8 Hz, //-arom), 7.59 (1H, dd, J  =
7.4, 7.0 Hz, //-arom ), 9.89 (1H, s, C/ZO); ,3C NMR, (CDCI3, 125.7 MHz) 6 C: 12.7 
(C-9), 48.9 (C-7), 56.0 (C-10), 95.1 (C -l), 118.4 (C-5), 125.8 (C-3), 129.2 (C-4),
143.8 (C-2), 165.3 (C-6 ), 199.9 (C-8 ). MS (EI+): m/z (%) = 291 (65) [M]+, 260 
(30), 230 (21), 217 (100), 104 (33); HRMS for Ci0H u IO2: calcd. 289.9804, found 
289.9802 [M]+; IR (Neat): vmax = 3045, 2939, 2867, 1727, 1577, 1464, 1430, 1011
( ± )-2-(2-iodophenyl)propanenitrile -  192
Synthesised according to GP24 with a solution of (2-iodophenyl) acetonitrile 191 
(1.5 g, 6.17 mmol) in dry THF (2 ml) was added to a previously prepared solution 
of «BuLi (2.47 ml, 6.17 mmol o f a 2.5 M solution in hexanes) and 
diisopropylamine (0.87 ml, 6.17 mmol) in dry THF (3 ml). Methyl iodide (920 
mg, 6.48 mmol) was added to yield the crude product. The product was purified 
by column chromatography using hexanes/ethyl acetate (9:1). Yield 87% (1.38 g,
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5.37 mmol) as a colourless oil. ‘H NMR, (CDC13, 500 MHz) 8 H: 1.49 (3H, d, J  = 
1 2  Hz, C //3), 4.13 (1H, q, J =  7.1 Hz, ArC//), 6.92 (1H, atd, J =  7.7, 1.0 Hz, H- 
arom), 7.35 (1H, atd, J  = 8.0, 1.3 Hz, //-arom), 7.50 (III, d , ./ = 7.7 Hz, //-arom),
7.74 (1H, d, J =  8.0 Hz, H-arom); l3C NMR, (CDCb, 125.7 MHz) 6 C: 20.6 (C-9),
36.3 (C-l), 98.4 (C -l), 121.2 (C-8 ), 127.4 (C-4), 127.7 (C-5), 129.9 (C-3), 139.9 
(C-6 ), 140.1 (C-2); MS (EI+): mtz (%) = 257 (100) [M]+, 242 (43), 229 (5), 130 
(39), 84 (35); HRMS for C9H8IN: calcd. 256.9702, found 256.9706 [M]+; IR 
(Neat): vmax = 3075, 3025, 2991, 2939, 2867, 2242, 1590, 1473, 1399, 1072, 1025, 
990 cm '1.
( ± )-2-(2-iodophenyl)butanenitrile -  193
Synthesised according to GP24 with a solution of (2-iodophenyl) acetonitrile 191 
(1.5 g, 6.17 mmol) in dry THF (2 ml) was added to a previously prepared solution 
of «BuLi (2.47 ml o f a 2.5 M solution in hexanes, 6.17 mmol,) and 
diisopropylamine (0.87 ml, 6.17 mmol) in dry THF (3 ml). Ethyl iodide (0.518 
ml, 6.48 mmol) was added to yield the crude product. The product was purified by 
column chromatography using hexanes/ethyl acetate (8:1). Yield 87% (1.29 g,
4.75 mmol) o f a colourless oil. ]H NMR, (CDCI3, 500 MHz) 8 h: 1.04 (3H, dt, J  —
7.4, 7.2 Hz, C //3), 1.71 (1H, ddq, J =  14.8, 8 .8 , 7.2 Hz, C //ACHBCH3 ), 1.83 (1H, 
dqd, J  = 14.8, 7.4, 5.2 Hz, CHAC //BCH3), 4.04 (1H, dd, J  = 8 .8 , 5.2, ArCH), 6.95 
(1H, atd, J  = 7.7, 1.5 Hz, H-arom), 7.33 (1H, atd, J =  7.6, 1.1 Hz, H-arom), 7.49 
(1H, dd, J  = 8.0, 1.5 Hz, //-arom ) 7.78 (1H, d, J  = 8.0, 1.1 Hz, //-arom); 13C 
NMR, (CDC13, 125.7 MHz) 5C: 11.7 (C-10), 28.2 (C-9), 43.4 (C-7), 99.2 (C-l),
121.5 (C-8 ), 128.4 (C-4), 129.5 (C-5), 130.5 (C-3), 139.8 (C-6 ), 140.3 (C-2); MS 
(EI+): m/z (%) = 271 (100) [M]+, 242 (58), 217 (17), 144 (4), 117 (21), 115 (50), 
89 (26); HRMS for C i0H i0IN: calcd. 270.9858, found 270.9860 [M]+; IR (Neat):
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vmax = 3071, 3030, 2987, 2920, 2870, 2237, 1599, 1480, 1410, 1090, 1022, 994 
cm '1.
( ± )-2-(2-iodophenyl)-3-phenylpropanenitrile -194
Synthesised according to GP24 with a solution of (2-iodophenyl) acetonitrile 191 
(1.5 g, 6.17 mmol) in dry THF (2 ml) was added to a previously prepared solution 
of «BuLi (2.47 ml, 6.17 mmol o f a 2.5 M solution in hexanes) and 
diisopropylamine (0.87 ml, 6.17 mmol) in dry THF (3 ml). Benzyl chloride (0.746 
ml, 6.48 mmol) was added to yield the crude product. The product was purified by 
column chromatography using hexanes/ethyl acetate (10:1). Yield 84% (1.73 g,
5.18 mmol) as a colourless oil. ’H NMR, (CDCI3, 500 MHz) 5B: 2.89 (1H, dd, J  =
13.6, 9.9 Hz, C //ACHBAr), 3.13 (1H, dd, J =  13.6, 4.6 Hz, CHAC //BAr), 4.43 (1H, 
dd, J  = 9.9, 4.6 Hz, ArC//) , 6.87 (1H, atd, J  -  7.7, 1.5 Hz, //-arom), 7.14-7.16 
(6 H, m, //-arom), 7.37 (1H, dd, J  = 8.0, 1.5 Hz, H-arom), 7.72 (1H, dd, J  = 8.0,
1.0 Hz , //-arom); ,3C NM R, (CDC13, 125.7 MHz) 8 C: 40.8 (C-7), 44.7 (C-9), 99.1 
(C-l), 120.1 (C-8 ), 127.7 (C-13), 128.7 (C-4), 128.8 (12), 129.2 (C-5), 129.4 (C-
11), 130.2 (C-3), 136.1 (C-10), 138.0 (C-6 ), 140.2 (C-2); MS (El+): mlz (%) = 333 
(27) [M]+, 270 (38), 256 (44), 242 (100), 217 (55), 117 (9); HRMS for C i5H 12IN: 
calcd. 333.1669, found 333.1670 [M]+; IR (Neat): vmax = 3046, 3029, 2977, 2894, 
2865,2244, 1584, 1481, 1418, 1077, 1019,990 cm’1.
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( ± )-2-(2-iodophenyl)-propanal -  195
Synthesised according to GP25 with DIBAL (1.29 ml, 7.78 mmol of a 1M 
solution in toluene) was added to a stirred solution of 2 -(2 - 
iodophenyl)propanenitrile 192 (1.00 g, 3.89 mmol) in dry toluene (10 ml). The 
product was purified by column chromatography using petroleum ether/diethyl 
ether (12:1). Yield 20% (202 mg, 0.777 mmol) as a colourless oil. *H NMR, 
(CDC13, 500 MHz) 5h: 1.33 (3H, d, J  = 7.0 Hz, C //3), 4.02 (1H, q, J  = 7.0 Hz, 
ArC//), 6.92 (1H, atd, J =  7.7, 1.6 Hz, //-arom ), 6.94 (1H, dd, J=  7.9, 1.6 Hz, H- 
arom), 7.30 (1H, dd, J =  7.7, 1.2 Hz, //-arom ), 7.85 (1H, d, J =  7.9, 1.2 H-arom),
9.66 (1H, s, C //0 ); ,3C NMR, (CDC13, 125.7 MHz) 6 C: 14.5 (C-9), 29.9 (C-7),
99.4 (C-l), 127.7 (C-4) 129.4 (C-5), 129.8 (C-3), 139.9 (C-6 ), 140.1 (C-2), 200.3 
C-8 ); MS (EI+): m/z (%) = 260 (8 ) [M]+, 257 (45), 231 (100), 217 (7), 133 (5), 104 
(32); HRMS for C9H9IO: calcd. 259.9698, found 259.9702 [M]+; IR (Neat): vmax = 
3061,2990, 2953,2836, 1725, 1580, 1469, 1422, 1149, 1061, 1009 cm '1.
( ± )-2-(2-iodophenyl)butanal -  196
Synthesised according to GP25 with DIBAL (1.22 ml, 7.36 mmol o f a 1M 
solution in toluene) was added to a stirred solution o f 2 -(2 - 
iodophenyl)butanenitrile 192 (1.00 g, 3.68 mmol) in dry toluene (10 ml). The 
product was purified by column chromatography using petroleum ether/diethyl 
ether (12:1). Yield 11% (111 mg, 0.406 mmol) as a colourless oil. *H NMR, 
(CDCI3, 500 MHz) 5h: 0.89 (3H, t, J =  7.3 Hz, C //3), 1.70 (1H, ddq, J =  14.5, 8 .6 ,
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7.3 Hz, C //ACHBCH3), 1.98 (1H, dqd, J =  14.5, 7.3, 5.3 Hz, CHAC //BCH3), 3.92 
(1H, dd, J =  8 .6 , 5.3 Hz, ArC//), 6.92 (1H, atd, J  = 7.9, 1.0 Hz, H-arom), 6.98 
(1H, dd, J  = 7.8, 1.6 Hz, //-arom ) 7.29 (1H, atd, J =  7.8, 1.0 Hz, H-arom), 7.85 
(1H, dd, J  = 7.9, 1.6 Hz, //-arom ), 9.62 (1H, s, C //0 ); 13C NMR, (CDC13, 
125MHz) 8 C: 11.4 (C-10), 29.9 (C-9), 56.7 (C-7), 99.2 (C-l), 128.3 (C-5), 129.0 
(C-4), 129.8 (C-3), 138.6 (C-6 ), 140.1 (C-2), 200.1 (C-8 ); MS (EI+): m/z (%) = 
274 (49) [M]+, 257 (13), 231 (57), 217 (100), 133 (15); HRMS for Ci0H n IO: 
calcd. 274.0982, found 274.0979 [M]+; IR (Neat): vmax = 3055, 2999, 2970, 2848, 
1724, 1567, 1480, 1428, 1152, 1070, 1002 cm '1.
( ± )-2-(2-iodophenyl)-3-phenyIpropanal -  197
Synthesised according to GP25 with DIBAL (0.994 ml, 6.00 mmol of a 1M 
solution in toluene) was added to a stirred solution of 2-(2-iodophenyl)-3- 
phenylpropanenitrile 194 (1.00 g, 3.00 mmol) in dry toluene (10 ml). The product 
was purified by column chromatography using petroleum ether/diethyl ether 
(12:1). Yield 14% (141 mg, 0.419 mmol) as a colourless oil. *H NMR, (CDC13, 
500 MHz) 5h: 2.89 (1H, dd, J =  13.6, 9.9 Hz, C //ACHBAr), 3.13 (1H, dd, J =  13.6,
4.6 Hz, CHAC //BAr), 4.05 (1H, dd, J =  9.9, 4.6 Hz, ArC//), 6.97 (1H, atd, J=  7.9,
1.6 Hz, H-arom), 7.15-7.28 (5H, m, H-arom), 7.32 (1H, atd, J =  7.7, 1.2 Hz, H- 
arom), 7.44 (1H, dd, J =  7.7, 1.6 Hz, H-arom), 7.81 (1H, dd, J =  7.9, 1.2 Hz, H- 
arom), 9.65 (1H, s, C/ZO); 13C NMR, (CDC13, 125MHz) 8 c: 40.8 (C-9), 44.5 (C-
7), 98.9(C-2), 126.4 C-Ar), 127.6 (C-5), 128.0 (C-Ar), 128.7 (C-Ar), 129.5 (C-4),
130.5 (C-3), 138.0 (C-6 ), 139.8 (C-10), 140.1 (C-2), 199.1 (C-8 ); No MS 
obtained.
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